"[{'verified': False, 'country': 'USA', 'id': '1441120940381782027', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This paper is important to read if you are considering treating your patient with smoldering myeloma or enrolling them on a clinical trial for smoldering myeloma. https://t.co/Fz4rjfTefC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Fz4rjfTefC'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This paper is important to read if you are considering treating your patient with smoldering myeloma or enrolling them on a clinical trial for smoldering myeloma. '}, {'verified': False, 'country': 'USA', 'id': '1441120859834359816', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$BIIB IGNORE THE NOISE. Talk to the patients. THE DRUG WORKS.\\n\\nhttps://t.co/3nGNJgav11\\n \\n$penn $mara $fsr $sos $srne $snap $any $btbt $aal $mvis $sndl $nakd $nio $fb $bbig $fubo $amd $amc $gme $coin $pltr $wkhs $riot $dkng $QQQ $HOOD $BTC $HUT $BABA $SAVA $ATER $ROOT $SPRT $MSOS', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/3nGNJgav11'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$BIIB IGNORE THE NOISE. Talk to the patients. THE DRUG WORKS.\\n\\n\\n \\n$penn $mara $fsr $sos $srne $snap $any $btbt $aal $mvis $sndl $nakd $nio $fb $bbig $fubo $amd $amc $gme $coin $pltr $wkhs $riot $dkng $QQQ $HOOD $BTC $HUT $BABA $SAVA $ATER $ROOT $SPRT $MSOS'}, {'verified': False, 'country': 'USA', 'id': '1441120684436975616', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Read our CEO Shawn Singh's closing remarks addressing the alarming trends of #MentalHealth in America and the launch of our PALISADE Phase 3 clinical trial for PH94B as a potential treatment for #SocialAnxiety at our Virtual Shareholders Meeting. https://t.co/7MB7Z2J0y2 $VTGN\", 'tweet_lang': 'en', 'hashtags': ['MentalHealth', 'SocialAnxiety'], 'mentions': [], 'tweet_urls': ['https://t.co/7MB7Z2J0y2'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Read our CEO Shawn Singh's closing remarks addressing the alarming trends of  in America and the launch of our PALISADE Phase 3 clinical trial for PH94B as a potential treatment for  at our Virtual Shareholders Meeting.  $VTGN\"}, {'verified': False, 'country': 'USA', 'id': '1441118760715227144', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Having a fantastic night at the PharmaTimes International Clinical Researcher Awards representing @MYorksResearch for our partnership with @SpectrumCIC on the Provent trial. Finalists for Clinical Site Team of the year! https://t.co/dD9xiAHTrH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['MYorksResearch', 'SpectrumCIC'], 'tweet_urls': [], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Having a fantastic night at the PharmaTimes International Clinical Researcher Awards representing  for our partnership with  on the Provent trial. Finalists for Clinical Site Team of the year! https://t.co/dD9xiAHTrH'}, {'verified': False, 'country': 'USA', 'id': '1441118418342604813', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'In the latest Health Innovation Roundup sponsored by @HealthCities:\\n\\n\u2022 Blood transfusions from recovered COVID-19 patients are an ineffective treatment for virus @ualberta \\n\u2022 @pacylex announced its Phase 1 clinical trial for an anti-cancer drug\\n\\nhttps://t.co/nWwoIRdjVD', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['HealthCities', 'UAlberta', 'pacylex'], 'tweet_urls': ['https://t.co/nWwoIRdjVD'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'In the latest Health Innovation Roundup sponsored by :\\n\\n\u2022 Blood transfusions from recovered COVID-19 patients are an ineffective treatment for virus @ualberta \\n\u2022  announced its Phase 1 clinical trial for an anti-cancer drug\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441118373992022020', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Day 1 clinical trial. So far no ill effects. I\u2019m doing something in the infusion room I haven\u2019t tried before. I woke up w/a scene in my head so I\u2019m writing. Steroids have me rocking! Next time I\u2019ll bring my laptop! #writing #endcancer #OvarianCancer https://t.co/ap36xaKL2o', 'tweet_lang': 'en', 'hashtags': ['writing', 'endcancer', 'OvarianCancer'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Day 1 clinical trial. So far no ill effects. I\u2019m doing something in the infusion room I haven\u2019t tried before. I woke up w/a scene in my head so I\u2019m writing. Steroids have me rocking! Next time I\u2019ll bring my laptop!    https://t.co/ap36xaKL2o'}, {'verified': False, 'country': 'USA', 'id': '1441116428862586883', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dr. Kush Dhody, our resident oncology and wound healing expert is teaching Clinical Trial Project Management Montgomery College.\\n\\nThere\u2019s still time to register at https://t.co/mhTqC6uyqI https://t.co/daa2xxDXNo', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/mhTqC6uyqI'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dr. Kush Dhody, our resident oncology and wound healing expert is teaching Clinical Trial Project Management Montgomery College.\\n\\nThere\u2019s still time to register at  https://t.co/daa2xxDXNo'}, {'verified': False, 'country': 'USA', 'id': '1441116035386535942', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'American Gene Technologies HIV Cure Clinical Trial Shows Additional Progress with No Serious Adverse Events (SAEs) - PR Web https://t.co/IdugNPnOj5 #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #pharmaceutical #biotech #pharma', 'tweet_lang': 'en', 'hashtags': ['strategy', 'competitiveintelligence', 'marketing', 'healthcare', 'competitivemarketing', 'pharmaceutical', 'biotech', 'pharma'], 'mentions': [], 'tweet_urls': ['https://t.co/IdugNPnOj5'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'American Gene Technologies HIV Cure Clinical Trial Shows Additional Progress with No Serious Adverse Events (SAEs) - PR Web         '}, {'verified': False, 'country': 'USA', 'id': '1441115485861416963', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study Scavenger Clinical Trial Platform\\nLabcorp Madison Paid Clinical Trial Study for healthy men, research study 8419-737 in Madison, WI. Compensation $3,800\\n\\nhttps://t.co/USpwDF4JVX\\n\\n#Healthy #Volunteers #Studies #ClinicalTrials #Clinicalresearch  #Medicalresearch #phase1', 'tweet_lang': 'en', 'hashtags': ['Healthy', 'Volunteers', 'Studies', 'ClinicalTrials', 'Clinicalresearch', 'Medicalresearch', 'phase1'], 'mentions': [], 'tweet_urls': ['https://t.co/USpwDF4JVX'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study Scavenger Clinical Trial Platform\\nLabcorp Madison Paid Clinical Trial Study for healthy men, research study 8419-737 in Madison, WI. Compensation $3,800\\n\\n\\n\\n       '}, {'verified': False, 'country': 'USA', 'id': '1441115315773980675', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Excited to have been shortlisted for the Pharma Times International Clinical Researcher of the Year 2021 awards, 1st global recruit to Covid antibody trial was in Wakefield\ud83e\udd73 #ptintcr @MidYorkshireNHS @davidfmelia @TheMD_midyorks @SpectrumCIC @weareconnexus @NIHRCRN_yorks https://t.co/qkYRwl73FR', 'tweet_lang': 'en', 'hashtags': ['ptintcr'], 'mentions': ['MidYorkshireNHS', 'davidfmelia', 'TheMD_midyorks', 'SpectrumCIC', 'weareconnexus', 'NIHRCRN_yorks'], 'tweet_urls': [], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Excited to have been shortlisted for the Pharma Times International Clinical Researcher of the Year 2021 awards, 1st global recruit to Covid antibody trial was in Wakefield\ud83e\udd73        https://t.co/qkYRwl73FR'}, {'verified': False, 'country': 'USA', 'id': '1441115170932023302', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Trying to understand S1P space and UC. But question: Why is Entyvio so popular if its clinical trial delta wasn't that great? Does it work better in real world or just + tolerability profile?\\n\\n4-Component Mayo is easier to hit vs. the 3-Component as I understand it bc RB=0 in 3-C https://t.co/fXSG4IdTFq\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Trying to understand S1P space and UC. But question: Why is Entyvio so popular if its clinical trial delta wasn't that great? Does it work better in real world or just + tolerability profile?\\n\\n4-Component Mayo is easier to hit vs. the 3-Component as I understand it bc RB=0 in 3-C https://t.co/fXSG4IdTFq\"}, {'verified': False, 'country': 'USA', 'id': '1441115152355635201', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Galera therapeutics is conducting a clinical trial investigating the effects of avasopasem manganese (GC4419) for the treatment of oral mucositis associated with chemoradiotherapy in patients with Head and Neck Cancer. https://t.co/oAdPhVFABk https://t.co/q8CdkKOxrG', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/oAdPhVFABk'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Galera therapeutics is conducting a clinical trial investigating the effects of avasopasem manganese (GC4419) for the treatment of oral mucositis associated with chemoradiotherapy in patients with Head and Neck Cancer.  https://t.co/q8CdkKOxrG'}, {'verified': False, 'country': 'USA', 'id': '1441115150078156801', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Satya Das, MD, MSCI, of @VUMC_Cancer is the national PI for a new #clinicaltrial to test a new targeted therapy in patients with advanced and difficult-to-treat #cancers. @nanudasmd @CureNETs @ccf @NANETS1 @jordanberlin5 @NCICTEP_ClinRes \\nhttps://t.co/6kWZMIoJjn', 'tweet_lang': 'en', 'hashtags': ['clinicaltrial', 'cancers'], 'mentions': ['VUMC_Cancer', 'nanudasmd', 'CureNETs', 'ccf', 'NANETS1', 'jordanberlin5', 'NCICTEP_ClinRes'], 'tweet_urls': ['https://t.co/6kWZMIoJjn'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Satya Das, MD, MSCI, of  is the national PI for a new  to test a new targeted therapy in patients with advanced and difficult-to-treat .       \\n'}, {'verified': False, 'country': 'USA', 'id': '1441115147922255884', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Galera therapeutics is conducting a clinical trial investigating the effects of avasopasem manganese (GC4419) for the treatment of oral mucositis associated with chemoradiotherapy in patients with Head and Neck Cancer. https://t.co/KJYZUsaPUG https://t.co/C9E0Bmpp6k', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/KJYZUsaPUG'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Galera therapeutics is conducting a clinical trial investigating the effects of avasopasem manganese (GC4419) for the treatment of oral mucositis associated with chemoradiotherapy in patients with Head and Neck Cancer.  https://t.co/C9E0Bmpp6k'}, {'verified': False, 'country': 'USA', 'id': '1441113635581939715', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB  Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 | BioSpace https://t.co/ISpetLIbJ3 #jobs', 'tweet_lang': 'en', 'hashtags': ['jobs'], 'mentions': [], 'tweet_urls': ['https://t.co/ISpetLIbJ3'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB  Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 | BioSpace  '}, {'verified': False, 'country': 'USA', 'id': '1441111384268296205', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#QPS has a partnership campaign with Clinical Leader! Information about QPS #clinical trial capabilities can now be found here https://t.co/6FyziFX7ig. Sign up on the Clinical Leader website to access all the content. #clinicaldevelopment https://t.co/46oU3hZvpv', 'tweet_lang': 'en', 'hashtags': ['QPS', 'clinical', 'clinicaldevelopment'], 'mentions': [], 'tweet_urls': ['https://t.co/6FyziFX7ig'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' has a partnership campaign with Clinical Leader! Information about QPS  trial capabilities can now be found here . Sign up on the Clinical Leader website to access all the content. development https://t.co/46oU3hZvpv'}, {'verified': False, 'country': 'USA', 'id': '1441110810823061508', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"The @WBJonline reports on Zalgen's contract with @CEPIvaccines to provide Lassa fever antibody testing kits for a three-year clinical trial in West Africa, with the goal of giving a more accurate assessment of the prevalence of Lassa fever: https://t.co/ssJcoUD9sH https://t.co/Oj2mTShDCG\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['WBJonline', 'CEPIvaccines'], 'tweet_urls': ['https://t.co/ssJcoUD9sH'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"The  reports on Zalgen's contract with  to provide Lassa fever antibody testing kits for a three-year clinical trial in West Africa, with the goal of giving a more accurate assessment of the prevalence of Lassa fever:  https://t.co/Oj2mTShDCG\"}, {'verified': False, 'country': 'USA', 'id': '1441109107943960582', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The stubborn lack of treatments for fragile X syndrome -- a leading cause of inherited intellectual disability and autism -- is spurring researchers to revise clinical trial techniques and revisit old drug candidates https://t.co/y354OjY2CO', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/y354OjY2CO'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The stubborn lack of treatments for fragile X syndrome -- a leading cause of inherited intellectual disability and autism -- is spurring researchers to revise clinical trial techniques and revisit old drug candidates '}, {'verified': False, 'country': 'USA', 'id': '1441108829828108294', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'SC hospital participating in ivermectin COVID-19 clinical trial #SmartNews  https://t.co/qKQDKiddQW', 'tweet_lang': 'en', 'hashtags': ['SmartNews'], 'mentions': [], 'tweet_urls': ['https://t.co/qKQDKiddQW'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'SC hospital participating in ivermectin COVID-19 clinical trial   '}, {'verified': False, 'country': 'USA', 'id': '1441107684246188034', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Notes on a Brazilian clinical trial testing whether MMR vaccines can reduce Covid-19 cases. https://t.co/GV76VngtsO', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/GV76VngtsO'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Notes on a Brazilian clinical trial testing whether MMR vaccines can reduce Covid-19 cases. '}, {'verified': True, 'country': 'USA', 'id': '1441106964860203015', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Meet Althea Black Madden, a Clay County 9-year-old, who decided to join a clinical  trial for the COVID vaccine for kids. \\nhttps://t.co/sx8TBmSs8e', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/sx8TBmSs8e'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Meet Althea Black Madden, a Clay County 9-year-old, who decided to join a clinical  trial for the COVID vaccine for kids. \\n'}, {'verified': False, 'country': 'USA', 'id': '1441104099991113739', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Adjusting fatty acid intake may help with mood variability in bipolar disorders - Can specific dietary guidelines help people living with bipolar disorders better manage their health? Clinical trial results showed that... - https://t.co/BwX9Kjspcl https://t.co/tmh72xTz8P', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/BwX9Kjspcl'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Adjusting fatty acid intake may help with mood variability in bipolar disorders - Can specific dietary guidelines help people living with bipolar disorders better manage their health? Clinical trial results showed that... -  https://t.co/tmh72xTz8P'}, {'verified': False, 'country': 'USA', 'id': '1441103742493888513', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Do you personally know anybody (including yourself) who has gotten a covid vaccine outside current protocols, such as for a child under age 12, or a third dose, or a second dose on top of JNJ, not including clinical trial participants?', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Do you personally know anybody (including yourself) who has gotten a covid vaccine outside current protocols, such as for a child under age 12, or a third dose, or a second dose on top of JNJ, not including clinical trial participants?'}, {'verified': False, 'country': 'USA', 'id': '1441102641530949647', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China - Neuro Central via BrainSights for iOS https://t.co/ouBkEqVxkR', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ouBkEqVxkR'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China - Neuro Central via BrainSights for iOS '}, {'verified': False, 'country': 'USA', 'id': '1441102074758918148', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T-Cure Bioscience has announced FDA regulatory approval for the initiation of a phase I clinical study to evaluate their KK-LC-1 TCR-T in targeting solid #tumors. TCR-T #celltherapy may be a promising new treatment for common epithelial #cancers. More:\\nhttps://t.co/5qIJ7NekrY', 'tweet_lang': 'en', 'hashtags': ['tumors', 'celltherapy', 'cancers'], 'mentions': [], 'tweet_urls': ['https://t.co/5qIJ7NekrY'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T-Cure Bioscience has announced FDA regulatory approval for the initiation of a phase I clinical study to evaluate their KK-LC-1 TCR-T in targeting solid . TCR-T  may be a promising new treatment for common epithelial . More:\\n'}, {'verified': True, 'country': 'USA', 'id': '1441102060871553032', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'It was March 2020. Scans showed that Jill Bailey\u2019s metastatic tumors, which had shrunk in response to #chemotherapy and another drug, were slowly starting to grow. A friend suggested Bailey go to Dana-Farber for a second opinion. #COVID  https://t.co/9bUhfgToaJ', 'tweet_lang': 'en', 'hashtags': ['chemotherapy', 'COVID'], 'mentions': [], 'tweet_urls': ['https://t.co/9bUhfgToaJ'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'It was March 2020. Scans showed that Jill Bailey\u2019s metastatic tumors, which had shrunk in response to  and another drug, were slowly starting to grow. A friend suggested Bailey go to Dana-Farber for a second opinion.   '}, {'verified': False, 'country': 'USA', 'id': '1441101558729482247', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Can you recommend anyone for this job in DC? https://t.co/dsSv8hYbeu #clinical', 'tweet_lang': 'en', 'hashtags': ['clinical'], 'mentions': [], 'tweet_urls': ['https://t.co/dsSv8hYbeu'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [38.9059849, -77.0334179]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Can you recommend anyone for this job in DC?  '}, {'verified': False, 'country': 'USA', 'id': '1441100880883818501', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'There\u2019s still time to upskill! Our October 2nd start date for Clinical Trial Management and Data Analytics programs is quickly approaching, don\u2019t miss out on your chance to get started. \\n\\nFind out more about our programs and partner universities here: https://t.co/TrdlKI7ta5 https://t.co/tBjE8ye4vC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/TrdlKI7ta5'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'There\u2019s still time to upskill! Our October 2nd start date for Clinical Trial Management and Data Analytics programs is quickly approaching, don\u2019t miss out on your chance to get started. \\n\\nFind out more about our programs and partner universities here:  https://t.co/tBjE8ye4vC'}, {'verified': True, 'country': 'USA', 'id': '1441100565946142720', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Graham came to @TheChristieNHS for a clinical trial to treat throat cancer, he\\'s now showing no signs of cancer.\\n\\n\"Thanks to The Christie I am able to look forward to the birth of my first grandchild\"\\n\\nRead why he\\'s supporting our Beacon of Hope appeal \ud83d\udc49 https://t.co/XsrLHIeDuv https://t.co/BWoDhvSkFT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['TheChristieNHS'], 'tweet_urls': ['https://t.co/XsrLHIeDuv'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Graham came to  for a clinical trial to treat throat cancer, he\\'s now showing no signs of cancer.\\n\\n\"Thanks to The Christie I am able to look forward to the birth of my first grandchild\"\\n\\nRead why he\\'s supporting our Beacon of Hope appeal \ud83d\udc49  https://t.co/BWoDhvSkFT'}, {'verified': False, 'country': 'USA', 'id': '1441100376502005764', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'For #AFibAwarenessMonth, we are excited to announce that the Erlanger Heart and Lung Institute is participating in a clinical trial that aims to reduce stroke in atrial fibrillation patients.\\n\\nhttps://t.co/Dul4ZazH6W', 'tweet_lang': 'en', 'hashtags': ['AFibAwarenessMonth'], 'mentions': [], 'tweet_urls': ['https://t.co/Dul4ZazH6W'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'For , we are excited to announce that the Erlanger Heart and Lung Institute is participating in a clinical trial that aims to reduce stroke in atrial fibrillation patients.\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441100128425701395', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Hey sponsors and CROs! Are you looking to manage your trials remotely? Read our blog to learn all about what RealTime Decentrial can do for you! Click the link below!\\nhttps://t.co/UgTnZxPKBe https://t.co/wBQ9GTo4dy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/UgTnZxPKBe'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Hey sponsors and CROs! Are you looking to manage your trials remotely? Read our blog to learn all about what RealTime Decentrial can do for you! Click the link below!\\n https://t.co/wBQ9GTo4dy'}, {'verified': False, 'country': 'USA', 'id': '1441100065548865540', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A clinical trial by the Queen Mary University of London has found #Ecigarettes to be more effective at achieving long-term smoking reduction than nicotine replacement therapies (NRTs) \ud83d\ude4c\\n\\n\ud83d\uddde\ufe0f Read and find out more here: https://t.co/ZulrezuTXw\\n\\n#VapeNews #Ecig https://t.co/C1KvjHJWdH', 'tweet_lang': 'en', 'hashtags': ['Ecigarettes', 'VapeNews', 'Ecig'], 'mentions': [], 'tweet_urls': ['https://t.co/ZulrezuTXw'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A clinical trial by the Queen Mary University of London has found  to be more effective at achieving long-term smoking reduction than nicotine replacement therapies (NRTs) \ud83d\ude4c\\n\\n\ud83d\uddde\ufe0f Read and find out more here: \\n\\n  https://t.co/C1KvjHJWdH'}, {'verified': False, 'country': 'USA', 'id': '1441100055730171904', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'In this session a Clinical Trials Specialist Nurse will go through what clinical trials are, the benefits &amp; drawbacks &amp; how to find out whether there is a suitable trial for you. Talk with Andrea, Clare or Mary when you drop in or ring us on 01865 751882 for more information https://t.co/XXX4SfwQ4t', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'In this session a Clinical Trials Specialist Nurse will go through what clinical trials are, the benefits &amp; drawbacks &amp; how to find out whether there is a suitable trial for you. Talk with Andrea, Clare or Mary when you drop in or ring us on 01865 751882 for more information https://t.co/XXX4SfwQ4t'}, {'verified': False, 'country': 'USA', 'id': '1441099058349699086', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The FAB-GT clinical trial is currently enrolling!  If you have classic #Fabry disease, you may be eligible to participate in a Phase 1/2 clinical trial of AVR-RD-01, an investigational lentiviral gene therapy. To learn more, contact 1-877-330-5216 or visit https://t.co/CO5YAl1N0C https://t.co/AkIPRU6xsV', 'tweet_lang': 'en', 'hashtags': ['Fabry'], 'mentions': [], 'tweet_urls': ['https://t.co/CO5YAl1N0C'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The FAB-GT clinical trial is currently enrolling!  If you have classic  disease, you may be eligible to participate in a Phase 1/2 clinical trial of AVR-RD-01, an investigational lentiviral gene therapy. To learn more, contact 1-877-330-5216 or visit  https://t.co/AkIPRU6xsV'}, {'verified': False, 'country': 'USA', 'id': '1441098059581050891', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties | BioSpace https://t.co/vR8IMc8xJt #jobs\", 'tweet_lang': 'en', 'hashtags': ['jobs'], 'mentions': [], 'tweet_urls': ['https://t.co/vR8IMc8xJt'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties | BioSpace  \"}, {'verified': False, 'country': 'USA', 'id': '1441097238583787522', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Check out the 5 reasons to use #ePRO in your next #clinicalstudy.                                                                        \\nhttps://t.co/yHPCXQ2Mlx https://t.co/KspxJcjGsW', 'tweet_lang': 'en', 'hashtags': ['ePRO', 'clinicalstudy'], 'mentions': [], 'tweet_urls': ['https://t.co/yHPCXQ2Mlx'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Check out the 5 reasons to use  in your next .                                                                        \\n https://t.co/KspxJcjGsW'}, {'verified': False, 'country': 'USA', 'id': '1441095904396673028', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Adjusting fatty acid intake may help with mood variability in bipolar disorders: Can specific dietary guidelines help people living with bipolar disorders better manage their health? Clinical trial results showed that a diet designed to alter levels of\u2026 https://t.co/yPtomaGw7g', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/yPtomaGw7g'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Adjusting fatty acid intake may help with mood variability in bipolar disorders: Can specific dietary guidelines help people living with bipolar disorders better manage their health? Clinical trial results showed that a diet designed to alter levels of\u2026 '}, {'verified': False, 'country': 'USA', 'id': '1441095025484464133', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Our L. reuteri\\xa0is backed by clinical trial results published in 7 peer-reviewed scientific studies. Each capsule contains 3.5 billion CFU and starts acting only once it reaches your colon. No surprises, just science!\\n\\nShop now: https://t.co/ZhIelL0cSm https://t.co/sSqVeoGhur', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZhIelL0cSm'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Our L. reuteri\\xa0is backed by clinical trial results published in 7 peer-reviewed scientific studies. Each capsule contains 3.5 billion CFU and starts acting only once it reaches your colon. No surprises, just science!\\n\\nShop now:  https://t.co/sSqVeoGhur'}, {'verified': False, 'country': 'USA', 'id': '1441094515608088576', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '5 ways to deliver continuous product improvement in the highly regulated clinical trial industry: https://t.co/CQMrNSMrlg #clinicaltrials #teckrotheanswer #clinicaltrial #trials #protocol #mhealth #medtech #meded #pharma #ai #biotech https://t.co/7VzUA3jIaM', 'tweet_lang': 'en', 'hashtags': ['clinicaltrials', 'teckrotheanswer', 'clinicaltrial', 'trials', 'protocol', 'mhealth', 'medtech', 'meded', 'pharma', 'ai', 'biotech'], 'mentions': [], 'tweet_urls': ['https://t.co/CQMrNSMrlg'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '5 ways to deliver continuous product improvement in the highly regulated clinical trial industry:             https://t.co/7VzUA3jIaM'}, {'verified': False, 'country': 'USA', 'id': '1441093663518441485', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Coffee Increases Post-Exercise Muscle Glycogen Recovery in Endurance Athletes: A Randomized Clinical Trial \\n\\nhttps://t.co/2PhCpq0PIL', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2PhCpq0PIL'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Coffee Increases Post-Exercise Muscle Glycogen Recovery in Endurance Athletes: A Randomized Clinical Trial \\n\\n'}, {'verified': True, 'country': 'USA', 'id': '1441092568352129029', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Taking part in a clinical trial is a commitment. The Hendrick family must monitor the kids for a year, record any side effects and they must check in with researchers as well.  https://t.co/Weny1dsbVg', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Weny1dsbVg'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Taking part in a clinical trial is a commitment. The Hendrick family must monitor the kids for a year, record any side effects and they must check in with researchers as well.  '}, {'verified': True, 'country': 'USA', 'id': '1441092500349800458', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Researchers, use our new \u201cNatural Products Clinical Trials Resource\u201d to learn about @US_FDA requirements for a clinical trial that will use a natural product. https://t.co/DPFkUJRd3q', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['US_FDA'], 'tweet_urls': ['https://t.co/DPFkUJRd3q'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Researchers, use our new \u201cNatural Products Clinical Trials Resource\u201d to learn about  requirements for a clinical trial that will use a natural product. '}, {'verified': False, 'country': 'USA', 'id': '1441092497820684296', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of black rice extract on #obesity in obese postmenopausal women: a 12-week randomized, double-blind, placebo-controlled preliminary clinical trial https://t.co/tAhGjUNabF @MenopauseOrg @Lippincott #menopause', 'tweet_lang': 'en', 'hashtags': ['obesity', 'menopause'], 'mentions': ['MenopauseOrg', 'lippincott'], 'tweet_urls': ['https://t.co/tAhGjUNabF'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of black rice extract on  in obese postmenopausal women: a 12-week randomized, double-blind, placebo-controlled preliminary clinical trial   @Lippincott '}, {'verified': False, 'country': 'USA', 'id': '1441092433857576970', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Finding the RIGHT patients for clinical trials by harnessing #RWD: leaders from the #NIHR, #Parexel &amp; Clinerion on trial staff issues &amp; case studies in our next webinar, with #LongTaal and the #SCRS. Free for SCRS members\\nhttps://t.co/doHG6G2mLS\\n#reimagineresearch #clinicaltrials https://t.co/ZmgEOFQKLm', 'tweet_lang': 'en', 'hashtags': ['RWD', 'NIHR', 'Parexel', 'LongTaal', 'SCRS', 'reimagineresearch', 'clinicaltrials'], 'mentions': [], 'tweet_urls': ['https://t.co/doHG6G2mLS'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Finding the RIGHT patients for clinical trials by harnessing : leaders from the ,  &amp; Clinerion on trial staff issues &amp; case studies in our next webinar, with  and the . Free for SCRS members\\n\\n  https://t.co/ZmgEOFQKLm'}, {'verified': False, 'country': 'USA', 'id': '1441092052209467392', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A recent clinical trial in Barcelona tested the RGS system with alcoholic patients.\\n\u201c Rehabilitation Gaming System for Alcohol-Related Cognitive Impairment: A Pilot Usability Study\u201d https://t.co/EYUI0sS8m4', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/EYUI0sS8m4'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A recent clinical trial in Barcelona tested the RGS system with alcoholic patients.\\n\u201c Rehabilitation Gaming System for Alcohol-Related Cognitive Impairment: A Pilot Usability Study\u201d '}, {'verified': False, 'country': 'USA', 'id': '1441091992847486986', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A phase 3 clinical trial published in the New England Journal of Medicine found that an immunotherapy called tebentafusp is first systemic treatment to show significant, clinically meaningful improvement in overall survival for metastatic uveal melanoma. https://t.co/4lhDFX8V1a https://t.co/2MiiF175NP', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/4lhDFX8V1a'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A phase 3 clinical trial published in the New England Journal of Medicine found that an immunotherapy called tebentafusp is first systemic treatment to show significant, clinically meaningful improvement in overall survival for metastatic uveal melanoma.  https://t.co/2MiiF175NP'}, {'verified': False, 'country': 'USA', 'id': '1441090970758500373', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New diabetes clinical trial: Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children https://t.co/pZT5JRtPGs', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/pZT5JRtPGs'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New diabetes clinical trial: Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children '}, {'verified': False, 'country': 'USA', 'id': '1441090968271216652', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New diabetes clinical trial: Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus https://t.co/fupvAdLVsd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fupvAdLVsd'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New diabetes clinical trial: Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus '}, {'verified': False, 'country': 'USA', 'id': '1441090966190903301', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New diabetes clinical trial: Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes https://t.co/oxPl9e2e5z', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/oxPl9e2e5z'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New diabetes clinical trial: Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes '}, {'verified': False, 'country': 'USA', 'id': '1441090963288387598', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New diabetes clinical trial: Impact of Type 2 Diabetes on Outcomes Associated With Antiplatelet Drugs: A Retrospective Analysis https://t.co/yqnK8Sxgpb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/yqnK8Sxgpb'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New diabetes clinical trial: Impact of Type 2 Diabetes on Outcomes Associated With Antiplatelet Drugs: A Retrospective Analysis '}, {'verified': False, 'country': 'USA', 'id': '1441090959622639616', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New diabetes clinical trial: Baseline Blood Indices and Prolonged Length of Hospital Stay https://t.co/JWCtdKuKk6', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JWCtdKuKk6'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New diabetes clinical trial: Baseline Blood Indices and Prolonged Length of Hospital Stay '}, {'verified': False, 'country': 'USA', 'id': '1441090781259841545', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'See our latest #Charlotte, NC job and click to apply: Senior Clinical Trial Manager (CTL) - Oncology - https://t.co/MfKNCCfJ2g #clinical', 'tweet_lang': 'en', 'hashtags': ['Charlotte', 'clinical'], 'mentions': [], 'tweet_urls': ['https://t.co/MfKNCCfJ2g'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [35.2379014, -80.8419341]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'See our latest , NC job and click to apply: Senior Clinical Trial Manager (CTL) - Oncology -  '}, {'verified': False, 'country': 'USA', 'id': '1441090374445924361', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'AFCR is excited by this, another innovative @GCAResearch cancer clinical trial. Congratulations!\ud83c\udf89 #OvarianCanceRx https://t.co/O3PfQJtl98', 'tweet_lang': 'en', 'hashtags': ['OvarianCanceRx'], 'mentions': ['GCAResearch'], 'tweet_urls': ['https://t.co/O3PfQJtl98'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'AFCR is excited by this, another innovative  cancer clinical trial. Congratulations!\ud83c\udf89  '}, {'verified': False, 'country': 'USA', 'id': '1441089978566545412', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'From McKinsey &amp; Company : Vaccination rates,\\xa0vaccine hesitancy, herd immunity\u2014these have become topics that occupy our everyday thoughts. It can be jarring to remember that less than a year ago, nobody, outside of clinical-trial vo\u2026https://t.co/tCaBpbDu3s https://t.co/TqNTRWTc5q', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/tCaBpbDu3s', 'https://t.co/TqNTRWTc5q'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'From McKinsey &amp; Company : Vaccination rates,\\xa0vaccine hesitancy, herd immunity\u2014these have become topics that occupy our everyday thoughts. It can be jarring to remember that less than a year ago, nobody, outside of clinical-trial vo\u2026 '}, {'verified': False, 'country': 'USA', 'id': '1441089516085809158', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'SAN FRANCISCO, Sept. 23, 2021 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has named international IT and clinical trial veteran Katri Langel as senior director of program development for the European ma\u2026 https://t.co/q6c3AyePG5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/q6c3AyePG5'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'SAN FRANCISCO, Sept. 23, 2021 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has named international IT and clinical trial veteran Katri Langel as senior director of program development for the European ma\u2026 '}, {'verified': False, 'country': 'USA', 'id': '1441089487304466436', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Triall\u2019s first product \u2018Verial eTMF\u2019 is a blockchain-integrated clinical trial document management solution. Uniquely, Verial eTMF enables users to generate verifiable proof of the integrity and existence of their clinical trial data through blockchain timestamp. #TRIALL https://t.co/Pt8ZDffWLU', 'tweet_lang': 'en', 'hashtags': ['Triall', 'TRIALL'], 'mentions': [], 'tweet_urls': ['https://t.co/Pt8ZDffWLU'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u2019s first product \u2018Verial eTMF\u2019 is a blockchain-integrated clinical trial document management solution. Uniquely, Verial eTMF enables users to generate verifiable proof of the integrity and existence of their clinical trial data through blockchain timestamp.  '}, {'verified': False, 'country': 'USA', 'id': '1441089277778010119', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy. https://t.co/OkBl4bOjNy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/OkBl4bOjNy'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy. '}, {'verified': False, 'country': 'USA', 'id': '1441088960176922630', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial\\n\\nhttps://t.co/FkMAe1MVEk', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/FkMAe1MVEk'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441088957387730953', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Publication\ud83d\udea8 1/2:\\n\\nRAMPART's protocol paper has been published in Contemporary Clinical Trials!\\n\\nRAMPART is a MAMS platform trial in patients with resected locally advanced RCC.\\n\\n\ud83d\udd17: https://t.co/ACiKRk9OG3\\n\\n@MRCCTU \\n\\n#kidneycancer #clinicaltrials #MAMS #platformtrials\", 'tweet_lang': 'en', 'hashtags': ['kidneycancer', 'clinicaltrials', 'MAMS', 'platformtrials'], 'mentions': ['MRCCTU'], 'tweet_urls': ['https://t.co/ACiKRk9OG3'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Publication\ud83d\udea8 1/2:\\n\\nRAMPART's protocol paper has been published in Contemporary Clinical Trials!\\n\\nRAMPART is a MAMS platform trial in patients with resected locally advanced RCC.\\n\\n\ud83d\udd17: \\n\\n \\n\\n   \"}, {'verified': False, 'country': 'USA', 'id': '1441087502215892999', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'What is Clinical Trial Ancillary Supply Chain (or CTASC\u2122)?\\nhttps://t.co/fmpgAq4YX5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fmpgAq4YX5'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'What is Clinical Trial Ancillary Supply Chain (or CTASC\u2122)?\\n'}, {'verified': False, 'country': 'USA', 'id': '1441087405344247810', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$VXRT @Vaxart has already obtained the @US_FDA clearance to start clinical trials for\\xa0its #COVID19 oral vaccine candidate.\\xa0The mid-stage trial is expected to start in the 2nd half of 2021,  the company announced in August. https://t.co/6ArboH97aE', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': ['Vaxart', 'US_FDA'], 'tweet_urls': ['https://t.co/6ArboH97aE'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$VXRT  has already obtained the  clearance to start clinical trials for\\xa0its  oral vaccine candidate.\\xa0The mid-stage trial is expected to start in the 2nd half of 2021,  the company announced in August. '}, {'verified': False, 'country': 'USA', 'id': '1441086299306217480', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Researchers have advanced the age-old effort to overcome the blood-brain barrier with clinical trial data suggesting ultrasound can temporarily enable molecules past the blockade \ud83d\udc8a\\n\\nRead more here \ud83d\udc47\\nhttps://t.co/qx4Fj9cHcA https://t.co/wup0n2EDxF', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/qx4Fj9cHcA'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Researchers have advanced the age-old effort to overcome the blood-brain barrier with clinical trial data suggesting ultrasound can temporarily enable molecules past the blockade \ud83d\udc8a\\n\\nRead more here \ud83d\udc47\\n https://t.co/wup0n2EDxF'}, {'verified': False, 'country': 'USA', 'id': '1441085507660750849', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Increased survival with eye melanoma in clinical trial\\n\\nhttps://t.co/Yv4BGrvhcC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Yv4BGrvhcC'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Increased survival with eye melanoma in clinical trial\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441085448969809937', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study Scavenger Clinical Trial Platform\\nICON Early Phase Service Clinical Trial for for healthy non-smoking Adults ages 18-55 (BR 4585-0013 MAD) in San Antonio, TX. Compensation $15,015\\n\\nhttps://t.co/lvi3pxUGsJ\\n\\n#Studies #ClinicalTrials #Clinicalresearch  #Medicalresearch #phase1', 'tweet_lang': 'en', 'hashtags': ['Studies', 'ClinicalTrials', 'Clinicalresearch', 'Medicalresearch', 'phase1'], 'mentions': [], 'tweet_urls': ['https://t.co/lvi3pxUGsJ'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study Scavenger Clinical Trial Platform\\nICON Early Phase Service Clinical Trial for for healthy non-smoking Adults ages 18-55 (BR 4585-0013 MAD) in San Antonio, TX. Compensation $15,015\\n\\n\\n\\n     '}, {'verified': False, 'country': 'USA', 'id': '1441085434382020612', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows\\n\\nhttps://t.co/WJu741T4WC\\n\\nhttps://t.co/QcsgI5Yo7Z https://t.co/LbzWtCPID4', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/WJu741T4WC', 'https://t.co/QcsgI5Yo7Z'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows\\n\\n\\n\\n https://t.co/LbzWtCPID4'}, {'verified': False, 'country': 'USA', 'id': '1441085270770655234', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial.  https://t.co/sMuixpfiEs @JAMANetwork @PossinKate @WinstonChiong @HooperSarahM @DataCooker @AlissaLily https://t.co/gzwBcQqmPb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['JAMANetwork', 'PossinKate', 'WinstonChiong', 'HooperSarahM', 'DataCooker', 'AlissaLily'], 'tweet_urls': ['https://t.co/sMuixpfiEs'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial.         https://t.co/gzwBcQqmPb'}, {'verified': False, 'country': 'USA', 'id': '1441085117498224649', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/bB9nqYKHDF I think a vaccine should follow the typical timeline until full FDA approval and vaccine mandates especially on universal level, not typical, which means we at least have another year or more till this should be acceptable and we are in clinical trial 3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/bB9nqYKHDF'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' I think a vaccine should follow the typical timeline until full FDA approval and vaccine mandates especially on universal level, not typical, which means we at least have another year or more till this should be acceptable and we are in clinical trial 3'}, {'verified': False, 'country': 'USA', 'id': '1441083754353606662', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '4/7?! How absolutely dare u! \"PPL WILL DIE\" of course said the Melbourne marriage skeeze.\\n[ knowingly] \\n\\nRe lying about\\n HCQ &amp; lying...\\n\\n#TRUTH ON #GODSIDE \\nA Dr. Dena must watch see video.\\n\\nhttps://t.co/pbfQveJjyD https://t.co/YV0anVPHSP https://t.co/YgiMcAaml6', 'tweet_lang': 'en', 'hashtags': ['TRUTH', 'GODSIDE'], 'mentions': [], 'tweet_urls': ['https://t.co/pbfQveJjyD', 'https://t.co/YV0anVPHSP'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '4/7?! How absolutely dare u! \"PPL WILL DIE\" of course said the Melbourne marriage skeeze.\\n[ knowingly] \\n\\nRe lying about\\n HCQ &amp; lying...\\n\\n ON  \\nA Dr. Dena must watch see video.\\n\\n  https://t.co/YgiMcAaml6'}, {'verified': False, 'country': 'USA', 'id': '1441083312508833795', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We were honored to join the @GO2Foundation run/walk hybrid event last weekend to raise money for #lungcancer awareness and spread the word about our #SPARTA clinical trial. https://t.co/Z1Un9MJChJ', 'tweet_lang': 'en', 'hashtags': ['lungcancer', 'SPARTA'], 'mentions': ['GO2Foundation'], 'tweet_urls': [], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We were honored to join the  run/walk hybrid event last weekend to raise money for  awareness and spread the word about our  clinical trial. https://t.co/Z1Un9MJChJ'}, {'verified': False, 'country': 'USA', 'id': '1441082195486019586', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"We're hiring! Read about our latest job opening here: Senior Clinical Trial Manager (CTL) - Oncology - https://t.co/JY6IghPox1 #clinical #NorthWales, PA\", 'tweet_lang': 'en', 'hashtags': ['clinical', 'NorthWales'], 'mentions': [], 'tweet_urls': ['https://t.co/JY6IghPox1'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [40.2109404, -75.2782317]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"We're hiring! Read about our latest job opening here: Senior Clinical Trial Manager (CTL) - Oncology -   , PA\"}, {'verified': False, 'country': 'USA', 'id': '1441081817042497536', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Finally!!! As a clinical trial participant, looking forward to it!!! https://t.co/BXoRZLNn23', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/BXoRZLNn23'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Finally!!! As a clinical trial participant, looking forward to it!!! '}, {'verified': False, 'country': 'USA', 'id': '1441081684380856325', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Just signed up to be in a clinical trial where they give you synthetic psilocybin to treat depression!! Going \u2708\ufe0f Tranquillum girls \ud83d\ude0e', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Just signed up to be in a clinical trial where they give you synthetic psilocybin to treat depression!! Going \u2708\ufe0f Tranquillum girls \ud83d\ude0e'}, {'verified': False, 'country': 'USA', 'id': '1441081559050866688', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Congratulations to @DrEdKim! A true leader in the field and an integral part of our #eligibilitycriteria project, looking to modernize clinical trial eligibility criteria. Just one of many great reasons for this recognition! https://t.co/JFX03zvSDl', 'tweet_lang': 'en', 'hashtags': ['eligibilitycriteria'], 'mentions': ['DrEdKim'], 'tweet_urls': ['https://t.co/JFX03zvSDl'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Congratulations to ! A true leader in the field and an integral part of our  project, looking to modernize clinical trial eligibility criteria. Just one of many great reasons for this recognition! '}, {'verified': False, 'country': 'USA', 'id': '1441081387797336067', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Join us today at 5:00 PM ET for our oncology nursing webinar focusing on Hodgkin and non-Hodgkin lymphomas with Dr John Leonard and Amy Goodrich, CRNP, who will discuss cases and review recent clinical trial findings. \\n\\nRegister here: https://t.co/GUXrkOOA0L\\n\\n#oncology https://t.co/khsp05B7nk', 'tweet_lang': 'en', 'hashtags': ['oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/GUXrkOOA0L'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Join us today at 5:00 PM ET for our oncology nursing webinar focusing on Hodgkin and non-Hodgkin lymphomas with Dr John Leonard and Amy Goodrich, CRNP, who will discuss cases and review recent clinical trial findings. \\n\\nRegister here: \\n\\n https://t.co/khsp05B7nk'}, {'verified': False, 'country': 'USA', 'id': '1441079892808974350', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/TYOOpP8ti6 Clinical Trial Manager (CTM)', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/TYOOpP8ti6'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' Clinical Trial Manager (CTM)'}, {'verified': False, 'country': 'USA', 'id': '1441079826807332872', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation https://t.co/VetS8zSZDO #MMSM #MultipleMyeloma #hematology https://t.co/LshxBNTFzF', 'tweet_lang': 'en', 'hashtags': ['MMSM', 'MultipleMyeloma', 'hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/VetS8zSZDO'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation     https://t.co/LshxBNTFzF'}, {'verified': False, 'country': 'USA', 'id': '1441079817756024833', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma https://t.co/cqtTs4fW7I #MMSM #MultipleMyeloma #hematology https://t.co/cYhiRRQUSH', 'tweet_lang': 'en', 'hashtags': ['MMSM', 'MultipleMyeloma', 'hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/cqtTs4fW7I'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma     https://t.co/cYhiRRQUSH'}, {'verified': False, 'country': 'USA', 'id': '1441079809015046160', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas https://t.co/qO8o6TdHLt #TCL #lymsm #hematology', 'tweet_lang': 'en', 'hashtags': ['TCL', 'lymsm', 'hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/qO8o6TdHLt'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas    '}, {'verified': False, 'country': 'USA', 'id': '1441079801926721540', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"New clinical trial: CART19 Cells Effects in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma https://t.co/ZFMCB13IUC #TCL #lymsm #hematology\", 'tweet_lang': 'en', 'hashtags': ['TCL', 'lymsm', 'hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/ZFMCB13IUC'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"New clinical trial: CART19 Cells Effects in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma    \"}, {'verified': False, 'country': 'USA', 'id': '1441079596489740291', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women https://t.co/G14vB6c5HU #breastcancer #oncology https://t.co/wDA1hq7mDJ', 'tweet_lang': 'en', 'hashtags': ['breastcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/G14vB6c5HU'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women    https://t.co/wDA1hq7mDJ'}, {'verified': False, 'country': 'USA', 'id': '1441079587299946503', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer https://t.co/yHfu3U46Ze #breastcancer #oncology https://t.co/yBEd3CZ5ci', 'tweet_lang': 'en', 'hashtags': ['breastcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/yHfu3U46Ze'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer    https://t.co/yBEd3CZ5ci'}, {'verified': False, 'country': 'USA', 'id': '1441079578080907270', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort https://t.co/OcCTy5OQyi #breastcancer #oncology https://t.co/epRWe99fxH', 'tweet_lang': 'en', 'hashtags': ['breastcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/OcCTy5OQyi'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort    https://t.co/epRWe99fxH'}, {'verified': False, 'country': 'USA', 'id': '1441079568945725451', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer https://t.co/X8Pi9hb6lX #breastcancer #oncology https://t.co/NJyhefc5w6', 'tweet_lang': 'en', 'hashtags': ['breastcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/X8Pi9hb6lX'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer    https://t.co/NJyhefc5w6'}, {'verified': False, 'country': 'USA', 'id': '1441079559433064456', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study https://t.co/Ifw3kO7DhB #breastcancer #oncology https://t.co/w8epdzuYxO', 'tweet_lang': 'en', 'hashtags': ['breastcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/Ifw3kO7DhB'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study    https://t.co/w8epdzuYxO'}, {'verified': False, 'country': 'USA', 'id': '1441079550289465344', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants https://t.co/nbrcwjoOS9 #breastcancer #oncology https://t.co/aKd7mbLu5p', 'tweet_lang': 'en', 'hashtags': ['breastcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/nbrcwjoOS9'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants    https://t.co/aKd7mbLu5p'}, {'verified': True, 'country': 'USA', 'id': '1441079429984362500', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Makenna Lai joined a pediatric cancer treatment clinical trial because her mom wanted to find the best treatment for her, and for future kids to have better treatment options.  Learn more: https://t.co/hzeECMfb2h Nevada #NCORP https://t.co/lZv5d6jQB1', 'tweet_lang': 'en', 'hashtags': ['NCORP'], 'mentions': [], 'tweet_urls': ['https://t.co/hzeECMfb2h'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Makenna Lai joined a pediatric cancer treatment clinical trial because her mom wanted to find the best treatment for her, and for future kids to have better treatment options.  Learn more:  Nevada  https://t.co/lZv5d6jQB1'}, {'verified': False, 'country': 'USA', 'id': '1441078688309727234', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\ud83d\udce9It is time for #JEMjc: A phase I clinical trial shows BRAF inhibitor topical therapy could reduce skin toxicity from EGFR inhibitors in patients with metastatic colorectal cancer https://t.co/ByNuMmEtye', 'tweet_lang': 'en', 'hashtags': ['JEMjc'], 'mentions': [], 'tweet_urls': ['https://t.co/ByNuMmEtye'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\ud83d\udce9It is time for : A phase I clinical trial shows BRAF inhibitor topical therapy could reduce skin toxicity from EGFR inhibitors in patients with metastatic colorectal cancer '}, {'verified': False, 'country': 'USA', 'id': '1441078428145389571', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u201cI strongly believe that a clinical trial helps us answer those questions and offers possible treatment options in a safe and controlled manner,\u201d Zebian said.\\n\\nhttps://t.co/uikEP5MKJG', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/uikEP5MKJG'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u201cI strongly believe that a clinical trial helps us answer those questions and offers possible treatment options in a safe and controlled manner,\u201d Zebian said.\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441078300986597379', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas https://t.co/UnmUYGy5VJ #pancreaticcancer #oncology https://t.co/54Z4WUMyLK', 'tweet_lang': 'en', 'hashtags': ['pancreaticcancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/UnmUYGy5VJ'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas    https://t.co/54Z4WUMyLK'}, {'verified': False, 'country': 'USA', 'id': '1441078291650138115', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients https://t.co/XtHx0mgiGO #melanoma #oncology https://t.co/XH1t5R0lRp', 'tweet_lang': 'en', 'hashtags': ['melanoma', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/XtHx0mgiGO'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients    https://t.co/XH1t5R0lRp'}, {'verified': False, 'country': 'USA', 'id': '1441078289192263693', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML https://t.co/ucnwSM432J #AML #leusm #hematology', 'tweet_lang': 'en', 'hashtags': ['AML', 'leusm', 'hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/ucnwSM432J'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML    '}, {'verified': False, 'country': 'USA', 'id': '1441078049143803905', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method https://t.co/TizSCjnqDV #prostatecancer #oncology https://t.co/inOpgF3P47', 'tweet_lang': 'en', 'hashtags': ['prostatecancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/TizSCjnqDV'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method    https://t.co/inOpgF3P47'}, {'verified': False, 'country': 'USA', 'id': '1441078039845113858', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring https://t.co/swHzfqHofr #prostatecancer #oncology https://t.co/Uhuuk5veNf', 'tweet_lang': 'en', 'hashtags': ['prostatecancer', 'oncology'], 'mentions': [], 'tweet_urls': ['https://t.co/swHzfqHofr'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring    https://t.co/Uhuuk5veNf'}, {'verified': False, 'country': 'USA', 'id': '1441078037844348936', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL https://t.co/VULfchcv9q #DLBCL #lymsm #hematology https://t.co/JQclj9QA13', 'tweet_lang': 'en', 'hashtags': ['DLBCL', 'lymsm', 'hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/VULfchcv9q'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL     https://t.co/JQclj9QA13'}, {'verified': False, 'country': 'USA', 'id': '1441077928138194954', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis https://t.co/WsuWaoV854 #MS #multiplesclerosis #neurology', 'tweet_lang': 'en', 'hashtags': ['MS', 'multiplesclerosis', 'neurology'], 'mentions': [], 'tweet_urls': ['https://t.co/WsuWaoV854'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis    '}, {'verified': False, 'country': 'USA', 'id': '1441077922450739208', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial: Ultrasound-Guided Percutaneous Neuromodulation in Spasticity https://t.co/Vxm8ZQpGPw #MS #multiplesclerosis #neurology', 'tweet_lang': 'en', 'hashtags': ['MS', 'multiplesclerosis', 'neurology'], 'mentions': [], 'tweet_urls': ['https://t.co/Vxm8ZQpGPw'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial: Ultrasound-Guided Percutaneous Neuromodulation in Spasticity    '}, {'verified': False, 'country': 'USA', 'id': '1441077501472632840', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '***University of Glasgow Live Online CPD Course***\\n\\nMaximising the Value of Clinical Trial Data: [Advanced] Analysis for Economic Evaluation and Modelling is a new course from @HEHTAGlasgow running in November 2021!\\n\\nFind out more here: https://t.co/yjEKAmVpq5 https://t.co/WARnrCFgLJ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['HEHTAGlasgow'], 'tweet_urls': ['https://t.co/yjEKAmVpq5'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '***University of Glasgow Live Online CPD Course***\\n\\nMaximising the Value of Clinical Trial Data: [Advanced] Analysis for Economic Evaluation and Modelling is a new course from  running in November 2021!\\n\\nFind out more here:  https://t.co/WARnrCFgLJ'}, {'verified': False, 'country': 'USA', 'id': '1441077401828610053', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Currently, there are no treatments for Alopecia Areata. However, Pfizer reported positive top-line data on its clinical trial for Ritlecitinib with a 20% or less scalp hair loss: https://t.co/K5Di1aZrrG\\xa0\\n#alopecia #alopeciaareata #Pharmaindustry #clinicaltrials https://t.co/DelgvMrRst', 'tweet_lang': 'en', 'hashtags': ['alopecia', 'alopeciaareata', 'Pharmaindustry', 'clinicaltrials'], 'mentions': [], 'tweet_urls': ['https://t.co/K5Di1aZrrG'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Currently, there are no treatments for Alopecia Areata. However, Pfizer reported positive top-line data on its clinical trial for Ritlecitinib with a 20% or less scalp hair loss: \\xa0\\n areata   https://t.co/DelgvMrRst'}, {'verified': False, 'country': 'USA', 'id': '1441076231227645954', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'NCX 4251 fails to meet primary, secondary endpoints in phase 2b blepharitis trial - Back to Healio NCX 4251 did not meet the primary or secondary efficacy endpoints in a phase 2b clinical trial investigating the... - https://t.co/mSfsRJk0pW https://t.co/ryD2xqThmU', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/mSfsRJk0pW'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'NCX 4251 fails to meet primary, secondary endpoints in phase 2b blepharitis trial - Back to Healio NCX 4251 did not meet the primary or secondary efficacy endpoints in a phase 2b clinical trial investigating the... -  https://t.co/ryD2xqThmU'}, {'verified': False, 'country': 'USA', 'id': '1441076182770933762', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'What does #healthtech in a post-COVID world look like? Download this eBook, in partnership with @MedTechDive, to learn how top companies like @bostonsci and @AbbottGlobal leverage digital solutions to overcome challenges in #medicaldevice #clinicaltrials: https://t.co/mVUDovnNEW https://t.co/hZ8ZBIVC24', 'tweet_lang': 'en', 'hashtags': ['healthtech', 'medicaldevice', 'clinicaltrials'], 'mentions': ['MedTechDive', 'bostonsci', 'AbbottGlobal'], 'tweet_urls': ['https://t.co/mVUDovnNEW'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'What does  in a post-COVID world look like? Download this eBook, in partnership with , to learn how top companies like  and  leverage digital solutions to overcome challenges in  :  https://t.co/hZ8ZBIVC24'}, {'verified': False, 'country': 'USA', 'id': '1441075989094690830', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Bahahahaha!! Run a clinical trial in my free time! Bahahahaha!!!!! They just won the Internet! \ud83e\udd23\ud83e\udd23\ud83e\udd23\ud83d\udc80 https://t.co/KBQJXXa867', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/KBQJXXa867'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Bahahahaha!! Run a clinical trial in my free time! Bahahahaha!!!!! They just won the Internet! \ud83e\udd23\ud83e\udd23\ud83e\udd23\ud83d\udc80 '}, {'verified': False, 'country': 'USA', 'id': '1441075848258494464', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Challenges Identified With Low Clinical Trial Accrual for AYA Patients With Sarcoma\\n\\nMore medical news at https://t.co/Z2xEnRpr3X\\n#Oncology #MedTwitter #MedEd\\nhttps://t.co/jBBknmeMD9', 'tweet_lang': 'en', 'hashtags': ['Oncology', 'MedTwitter', 'MedEd'], 'mentions': [], 'tweet_urls': ['https://t.co/Z2xEnRpr3X', 'https://t.co/jBBknmeMD9'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Challenges Identified With Low Clinical Trial Accrual for AYA Patients With Sarcoma\\n\\nMore medical news at \\n  \\n'}, {'verified': True, 'country': 'USA', 'id': '1441074933719703556', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The Novavax COVID-19 shot is a protein-based vaccine, shown to be more than 90 per cent effective against a variety of coronavirus variants in a U.S.-based clinical trial.\\nhttps://t.co/ZwmHoIvsbT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZwmHoIvsbT'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The Novavax COVID-19 shot is a protein-based vaccine, shown to be more than 90 per cent effective against a variety of coronavirus variants in a U.S.-based clinical trial.\\n'}, {'verified': False, 'country': 'USA', 'id': '1441074797992050691', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dr Bonnie Henry announced that BC will offer vaccines to children 5-12 once clinical trials are complete. Pfizer was the first company to announce initial positive clinical trial results for kids aged 5-11 and apply for approval to administer the vaccine to those age 5 and over.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dr Bonnie Henry announced that BC will offer vaccines to children 5-12 once clinical trials are complete. Pfizer was the first company to announce initial positive clinical trial results for kids aged 5-11 and apply for approval to administer the vaccine to those age 5 and over.'}, {'verified': True, 'country': 'USA', 'id': '1441074632983908361', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Challenges Identified With Low Clinical Trial Accrual for AYA Patients With Sarcoma @RLRandallMD @ucdavis #scmsm https://t.co/pjgGwXPZgk', 'tweet_lang': 'en', 'hashtags': ['scmsm'], 'mentions': ['RLRandallMD', 'ucdavis'], 'tweet_urls': ['https://t.co/pjgGwXPZgk'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Challenges Identified With Low Clinical Trial Accrual for AYA Patients With Sarcoma    '}, {'verified': False, 'country': 'USA', 'id': '1441074236915806215', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Join the AtriCure team! See our latest job opening here: https://t.co/6xQOltLI21 #MedDevice #AtriCureCareers', 'tweet_lang': 'en', 'hashtags': ['MedDevice', 'AtriCureCareers'], 'mentions': [], 'tweet_urls': ['https://t.co/6xQOltLI21'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Join the AtriCure team! See our latest job opening here:   '}, {'verified': False, 'country': 'USA', 'id': '1441073534164369408', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation GlobeNewswire https://t.co/N6KXkGyVyr #smallcapsdaily #smallcaps #microcap #stocks #trading #profits', 'tweet_lang': 'en', 'hashtags': ['smallcapsdaily', 'smallcaps', 'microcap', 'stocks', 'trading', 'profits'], 'mentions': [], 'tweet_urls': ['https://t.co/N6KXkGyVyr'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation GlobeNewswire       '}, {'verified': True, 'country': 'USA', 'id': '1441073336079974402', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"NantWorks' #COVID19vaccine has been in clinical research in South Africa since earlier this year. The vaccine is slightly different from current jabs &amp; is being tested as an injection, oral drops, nasal spray and room-temperature tablet. #COVID19SA https://t.co/gwZ890Hn7K https://t.co/OKZSGem1g4\", 'tweet_lang': 'en', 'hashtags': ['COVID19vaccine', 'COVID19SA'], 'mentions': [], 'tweet_urls': ['https://t.co/gwZ890Hn7K', 'https://t.co/OKZSGem1g4'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"NantWorks'  has been in clinical research in South Africa since earlier this year. The vaccine is slightly different from current jabs &amp; is being tested as an injection, oral drops, nasal spray and room-temperature tablet.   \"}, {'verified': False, 'country': 'USA', 'id': '1441073112976543746', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'At 11, Emily was diagnosed with #bonecancer. Despite multiple treatments, her #cancer was aggressive. Thanks to a partnership between her oncologist &amp; #FlintAnimalCancerCenter, Emily was one of the 1st human patients to enroll in the MTP-PE clinical trial. #OneCancerOneCure https://t.co/UR5uFSSqmP', 'tweet_lang': 'en', 'hashtags': ['bonecancer', 'cancer', 'FlintAnimalCancerCenter', 'OneCancerOneCure'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'At 11, Emily was diagnosed with . Despite multiple treatments, her  was aggressive. Thanks to a partnership between her oncologist &amp; , Emily was one of the 1st human patients to enroll in the MTP-PE clinical trial.  https://t.co/UR5uFSSqmP'}, {'verified': False, 'country': 'USA', 'id': '1441072807857774592', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Question #cardiotwitter @CardioNerdsJC , about the RIVER trial (abstract below)\\n\\nIts conclusion was that in patients with afib and bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to major clinical events.\\n\\n1/3 https://t.co/X9jjCWaTvt', 'tweet_lang': 'en', 'hashtags': ['cardiotwitter'], 'mentions': ['CardioNerdsJC'], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Question   , about the RIVER trial (abstract below)\\n\\nIts conclusion was that in patients with afib and bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to major clinical events.\\n\\n1/3 https://t.co/X9jjCWaTvt'}, {'verified': False, 'country': 'USA', 'id': '1441072685644140544', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Chinese clinical-stage company Clover Biopharmaceuticals has announced that its protein-based Covid-19 vaccine candidate, SCB-2019, was 67% effective against coronavirus infection in a large trial. https://t.co/nSNfixhP9j', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/nSNfixhP9j'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Chinese clinical-stage company Clover Biopharmaceuticals has announced that its protein-based Covid-19 vaccine candidate, SCB-2019, was 67% effective against coronavirus infection in a large trial. '}, {'verified': False, 'country': 'USA', 'id': '1441072268973543436', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 GlobeNewswire https://t.co/CQzOS8PpYX #smallcapsdaily #smallcaps #microcap #stocks #trading #profits', 'tweet_lang': 'en', 'hashtags': ['smallcapsdaily', 'smallcaps', 'microcap', 'stocks', 'trading', 'profits'], 'mentions': [], 'tweet_urls': ['https://t.co/CQzOS8PpYX'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 GlobeNewswire       '}, {'verified': False, 'country': 'USA', 'id': '1441072036911136769', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'FDA approves first trial investigating CRISPR gene editing as HIV cure https://t.co/5eI3KIVtOz via @Clinical Trials Arena,', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['clinical'], 'tweet_urls': ['https://t.co/5eI3KIVtOz'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'FDA approves first trial investigating CRISPR gene editing as HIV cure  via @Clinical Trials Arena,'}, {'verified': False, 'country': 'USA', 'id': '1441071670354194443', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Top5PublicUF #Florida #AAUMember #TheEveryThingSchool #UF #WeAreFlorida #FloridaForever https://t.co/SwVvyyr2Em', 'tweet_lang': 'en', 'hashtags': ['Top5PublicUF', 'Florida', 'AAUMember', 'TheEveryThingSchool', 'UF', 'WeAreFlorida', 'FloridaForever'], 'mentions': [], 'tweet_urls': ['https://t.co/SwVvyyr2Em'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '      Forever '}, {'verified': False, 'country': 'USA', 'id': '1441071614129364995', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'FDA approves first trial investigating CRISPR gene editing as HIV cure https://t.co/tRagusSiJ5 v\u00eda @Clinical Trials Arena', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['clinical'], 'tweet_urls': ['https://t.co/tRagusSiJ5'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'FDA approves first trial investigating CRISPR gene editing as HIV cure  v\u00eda @Clinical Trials Arena'}, {'verified': False, 'country': 'USA', 'id': '1441071340593709060', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical trial recruitment is one such area where recruiters can\u2019t mess up. It requires equal attention to detail and diligence. #recruitment #recruiter #recruiters', 'tweet_lang': 'en', 'hashtags': ['recruitment', 'recruiter', 'recruiters'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical trial recruitment is one such area where recruiters can\u2019t mess up. It requires equal attention to detail and diligence.   s'}, {'verified': True, 'country': 'USA', 'id': '1441070731672973314', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#PTVNewsTonight | Results of VCO clinical trial out end-September\\n\\nhttps://t.co/GWEsUPfriy', 'tweet_lang': 'en', 'hashtags': ['PTVNewsTonight'], 'mentions': [], 'tweet_urls': ['https://t.co/GWEsUPfriy'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' | Results of VCO clinical trial out end-September\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441070729638789129', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial\u2013Eligible Populations\\n\\n\ud83d\udd13 Open Access\\n\ud83d\udd17 https://t.co/YSZMe3aaVr https://t.co/hg4xsS0HE8', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/YSZMe3aaVr'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial\u2013Eligible Populations\\n\\n\ud83d\udd13 Open Access\\n\ud83d\udd17  https://t.co/hg4xsS0HE8'}, {'verified': False, 'country': 'USA', 'id': '1441069984524931081', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'At long last.  #ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial  https://t.co/Rdf8BOVoq9', 'tweet_lang': 'en', 'hashtags': ['ACTIVATION'], 'mentions': [], 'tweet_urls': ['https://t.co/Rdf8BOVoq9'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'At long last.   (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial  '}, {'verified': True, 'country': 'USA', 'id': '1441069971262615561', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Janice Krieger has received a $2.1 million grant to use the virtual health assistant ALEX to recruit older minorities for clinical trials. The project will focus on underserved populations at risk for developing chronic diseases and health conditions.\\nhttps://t.co/dfyPbCSAkK https://t.co/dWi1UGni6s', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/dfyPbCSAkK'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Janice Krieger has received a $2.1 million grant to use the virtual health assistant ALEX to recruit older minorities for clinical trials. The project will focus on underserved populations at risk for developing chronic diseases and health conditions.\\n https://t.co/dWi1UGni6s'}, {'verified': True, 'country': 'USA', 'id': '1441069898021711877', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '78% of respondents thought their clinical trial experience met or exceeded their expectations. Learn more about participating in clinical trials here: https://t.co/W1SeyTd3vh https://t.co/MVaJPhx9vN', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/W1SeyTd3vh'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '78% of respondents thought their clinical trial experience met or exceeded their expectations. Learn more about participating in clinical trials here:  https://t.co/MVaJPhx9vN'}, {'verified': False, 'country': 'USA', 'id': '1441069849208401929', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'An open-label clinical trial on patients with generalized anxiety disorder found that supplementing with chamomile led to reported improvement in anxiety symptoms. \\n\\nhttps://t.co/oMBYNDQx3k\\n\\n#chamomile #stress #anxiety #GAD #integrativehealth #holistic #designsforhealth https://t.co/cRwPRg66xg', 'tweet_lang': 'en', 'hashtags': ['chamomile', 'stress', 'anxiety', 'GAD', 'integrativehealth', 'holistic', 'designsforhealth'], 'mentions': [], 'tweet_urls': ['https://t.co/oMBYNDQx3k'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'An open-label clinical trial on patients with generalized anxiety disorder found that supplementing with chamomile led to reported improvement in anxiety symptoms. \\n\\n\\n\\n       https://t.co/cRwPRg66xg'}, {'verified': False, 'country': 'USA', 'id': '1441069845337067528', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We\u2019re honored to be chosen as one of the region\u2019s most promising technology companies and as a 2021 showcase company by @VentureAtlanta 2021! #VA2021\\nhttps://t.co/0eZnu2NTCf', 'tweet_lang': 'en', 'hashtags': ['VA2021'], 'mentions': ['VentureAtlanta'], 'tweet_urls': ['https://t.co/0eZnu2NTCf'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We\u2019re honored to be chosen as one of the region\u2019s most promising technology companies and as a 2021 showcase company by  2021! \\n'}, {'verified': False, 'country': 'USA', 'id': '1441069631746289666', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Traveling \ud83e\uddf3 to a clinical trial appointment. However it\u2019s raining \u2614\ufe0f cats \ud83d\udc31 and dogs\ud83d\udc15. The weather is horrible. I left home at 8 am this morning. Still have another 60 miles to go.We need to bring clinical trials closer to the patients. #clinicaltrials #clinicalresearch #RVA', 'tweet_lang': 'en', 'hashtags': ['clinicaltrials', 'clinicalresearch', 'RVA'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Traveling \ud83e\uddf3 to a clinical trial appointment. However it\u2019s raining \u2614\ufe0f cats \ud83d\udc31 and dogs\ud83d\udc15. The weather is horrible. I left home at 8 am this morning. Still have another 60 miles to go.We need to bring clinical trials closer to the patients.   '}, {'verified': False, 'country': 'USA', 'id': '1441069225045479428', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Taiwan vaccine maker plans to conduct Phase 3 clinical trial in Europe - Focus Taiwan https://t.co/a2HSIVtJO1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/a2HSIVtJO1'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Taiwan vaccine maker plans to conduct Phase 3 clinical trial in Europe - Focus Taiwan '}, {'verified': False, 'country': 'USA', 'id': '1441068931217825792', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Looks like I may have been in a behavioral clinical trial by my employer.. fantastic.\\n\\nAlmost 10,000 employees. Inclusion Criteria:\\n\\n\"Employees at (such &amp; such) Health System who have not gotten a COVID-19 vaccination\"', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Looks like I may have been in a behavioral clinical trial by my employer.. fantastic.\\n\\nAlmost 10,000 employees. Inclusion Criteria:\\n\\n\"Employees at (such &amp; such) Health System who have not gotten a COVID-19 vaccination\"'}, {'verified': True, 'country': 'USA', 'id': '1441068640174968841', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A clinical trial on #HeartDisease prevention in people living with #HIV found that nearly 50% of study participants considered low risk of future heart disease had atherosclerotic plaque in their arteries. https://t.co/w2soaZDaaS https://t.co/p3tFLMiemD', 'tweet_lang': 'en', 'hashtags': ['HeartDisease', 'HIV'], 'mentions': [], 'tweet_urls': ['https://t.co/w2soaZDaaS'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A clinical trial on  prevention in people living with  found that nearly 50% of study participants considered low risk of future heart disease had atherosclerotic plaque in their arteries.  https://t.co/p3tFLMiemD'}, {'verified': False, 'country': 'USA', 'id': '1441068454040252420', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Emerging data on flow diverter technologies are \"welcome and exciting\", according to @meyerspm. Positive trial results have recently been reported on FRED (@MV_Terumo) in the @JNIS_BMJ and on Surpass (@Stryker_NV) at @SNISinfo 2021 by @DrAlexanderCoon \\nhttps://t.co/AB5r4mwZwf', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['meyerspm', 'MV_Terumo', 'JNIS_BMJ', 'Stryker_NV', 'SNISinfo', 'DrAlexanderCoon'], 'tweet_urls': ['https://t.co/AB5r4mwZwf'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Emerging data on flow diverter technologies are \"welcome and exciting\", according to . Positive trial results have recently been reported on FRED () in the  and on Surpass () at  2021 by  \\n'}, {'verified': False, 'country': 'USA', 'id': '1441068091127910410', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Would you volunteer for a clinical trial that compensates you for your time and body? \u2014 I don't know. Probably not. https://t.co/VPrPwxZvSQ\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VPrPwxZvSQ'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Would you volunteer for a clinical trial that compensates you for your time and body? \u2014 I don't know. Probably not. \"}, {'verified': False, 'country': 'USA', 'id': '1441068087428612098', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Optimise your clinical supply chain, expedite trial timelines, control costs and champion quality. Does this sound like your study objectives? Download our recent brochure to discover what makes Almac the ideal partner of choice for your clincial studies. :https://t.co/PwujBzJOd0 https://t.co/ExYbsM2Nxd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/PwujBzJOd0'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Optimise your clinical supply chain, expedite trial timelines, control costs and champion quality. Does this sound like your study objectives? Download our recent brochure to discover what makes Almac the ideal partner of choice for your clincial studies. : https://t.co/ExYbsM2Nxd'}, {'verified': False, 'country': 'USA', 'id': '1441068086782795779', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Fucking cramps...pain makes me so bad at thinking. I'm currently struggling to read an extremely basic table detailing the results of a clinical trial.\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Fucking cramps...pain makes me so bad at thinking. I'm currently struggling to read an extremely basic table detailing the results of a clinical trial.\"}, {'verified': False, 'country': 'USA', 'id': '1441067203680358411', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'OCRA is partnering with @GCAResearch on a new clinical trial initiative, #OvarianCanceRx, which is designed to test multiple drugs simultaneously against the standard of care treatments for #ovca patients: https://t.co/jeHdMFzUv8', 'tweet_lang': 'en', 'hashtags': ['OvarianCanceRx', 'ovca'], 'mentions': ['GCAResearch'], 'tweet_urls': ['https://t.co/jeHdMFzUv8'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'OCRA is partnering with  on a new clinical trial initiative, , which is designed to test multiple drugs simultaneously against the standard of care treatments for  patients: '}, {'verified': False, 'country': 'USA', 'id': '1441067104619302917', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not\\xa0Allowed) https://t.co/FJh9S6vHCi', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/FJh9S6vHCi'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not\\xa0Allowed) '}, {'verified': False, 'country': 'USA', 'id': '1441067007957417990', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Irish medtech Icon gets \u20ac4m State funding for hybrid trial research | Silicon Republic. https://t.co/80Xw13k6A7', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/80Xw13k6A7'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Irish medtech Icon gets \u20ac4m State funding for hybrid trial research | Silicon Republic. '}, {'verified': False, 'country': 'USA', 'id': '1441066755531497483', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Irish medtech Icon gets \u20ac4m State funding for hybrid trial research\\nhttps://t.co/MaxumSp5KT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/MaxumSp5KT'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Irish medtech Icon gets \u20ac4m State funding for hybrid trial research\\n'}, {'verified': False, 'country': 'USA', 'id': '1441066120740577286', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A clinical trial is enrolling people with mild #COVID19 to see if any of three existing drugs work against the disease.\\n\\nLearn more:\\nhttps://t.co/7HVLSr7tva', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': [], 'tweet_urls': ['https://t.co/7HVLSr7tva'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A clinical trial is enrolling people with mild  to see if any of three existing drugs work against the disease.\\n\\nLearn more:\\n'}, {'verified': False, 'country': 'USA', 'id': '1441065433600184325', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'googling how to become a clinical trial patient at johns hopkins https://t.co/NkmO2VcGIO', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NkmO2VcGIO'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'googling how to become a clinical trial patient at johns hopkins '}, {'verified': False, 'country': 'USA', 'id': '1441064220527763457', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This job might be a great fit for you: Senior Clinical Trial Manager (CTL) - Oncology - https://t.co/9FBUrhaba8 #clinical #KansasCity, MO', 'tweet_lang': 'en', 'hashtags': ['clinical', 'KansasCity'], 'mentions': [], 'tweet_urls': ['https://t.co/9FBUrhaba8'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [39.1041725, -94.5998517]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This job might be a great fit for you: Senior Clinical Trial Manager (CTL) - Oncology -   , MO'}, {'verified': False, 'country': 'USA', 'id': '1441064184070901771', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'In the Q&amp;A, Dr @KristenCiombor mentions the important ECOG trial for #rectal cancer patients at @VUMC_Cancer \\n\\nhttps://t.co/79JkII7AAj\\n\\n #GDUGI2021', 'tweet_lang': 'en', 'hashtags': ['rectal', 'GDUGI2021'], 'mentions': ['KristenCiombor', 'VUMC_Cancer'], 'tweet_urls': ['https://t.co/79JkII7AAj'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'In the Q&amp;A, Dr  mentions the important ECOG trial for  cancer patients at  \\n\\n\\n\\n '}, {'verified': False, 'country': 'USA', 'id': '1441062829394567169', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Loved being part of @marcusevans evolution summit  discussing translational medicine and clinical trial considerations. First face-to-face meeting after a long time! https://t.co/1jqxpUUHti', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['marcusevans'], 'tweet_urls': ['https://t.co/1jqxpUUHti'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Loved being part of  evolution summit  discussing translational medicine and clinical trial considerations. First face-to-face meeting after a long time! '}, {'verified': True, 'country': 'USA', 'id': '1441062490708733952', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Irish medtech Icon gets \u20ac4m State funding for hybrid trial research https://t.co/dDVOnVb8YK', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/dDVOnVb8YK'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Irish medtech Icon gets \u20ac4m State funding for hybrid trial research '}, {'verified': False, 'country': 'USA', 'id': '1441062300518019077', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Are you ready to explore the role of #type2inflammation in dermatologic diseases?\\nJoin our live symposium today from 6:30pm CEST, to hear our expert faculty discuss #type2inflammation in #atopicdermatitis, other pruritic dermatoses, clinical trial outcomes and more. #ESDR2021 https://t.co/vc1HZDWZQj', 'tweet_lang': 'en', 'hashtags': ['type2inflammation', 'type2inflammation', 'atopicdermatitis', 'ESDR2021'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Are you ready to explore the role of  in dermatologic diseases?\\nJoin our live symposium today from 6:30pm CEST, to hear our expert faculty discuss  in , other pruritic dermatoses, clinical trial outcomes and more.  https://t.co/vc1HZDWZQj'}, {'verified': True, 'country': 'USA', 'id': '1441062123157721090', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'No single nation can respond to the challenges of Covid-19 alone. Collaboration based on #IP licensing, technology transfer and the sharing of know-how and clinical trial information is vital for innovation and manufacturing. (Photo: Getty Images/Tetra Images) https://t.co/wowP5658ty', 'tweet_lang': 'en', 'hashtags': ['IP'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'No single nation can respond to the challenges of Covid-19 alone. Collaboration based on  licensing, technology transfer and the sharing of know-how and clinical trial information is vital for innovation and manufacturing. (Photo: Getty Images/Tetra Images) https://t.co/wowP5658ty'}, {'verified': False, 'country': 'USA', 'id': '1441062091381620740', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical/medical trial or study participants would give details of existing medical conditions and treatments they may be on or have received recently before being allowed. This report is NOT scientific if it excludes a full medical history. @BBCNews https://t.co/PEyQIQxpdm', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['BBCNews'], 'tweet_urls': ['https://t.co/PEyQIQxpdm'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical/medical trial or study participants would give details of existing medical conditions and treatments they may be on or have received recently before being allowed. This report is NOT scientific if it excludes a full medical history.  '}, {'verified': False, 'country': 'USA', 'id': '1441060341836705793', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Interested in a job in #Kingston, Ontario? This could be a great fit: https://t.co/8iCvyvPhTo', 'tweet_lang': 'en', 'hashtags': ['Kingston'], 'mentions': [], 'tweet_urls': ['https://t.co/8iCvyvPhTo'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [44.224351, -76.492686]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Interested in a job in , Ontario? This could be a great fit: '}, {'verified': False, 'country': 'USA', 'id': '1441060110692864000', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Small (n=648) industry-sponsored double-blind RCT among high-risk HCWs in \ud83c\uddee\ud83c\uddf3 suggests that a nasal spray containing \"Vita Raphael\" &amp; natural virucides may be a good prophylactic tool against #SARSCoV2. https://t.co/xWonfihJvP 1/4', 'tweet_lang': 'en', 'hashtags': ['SARSCoV2'], 'mentions': [], 'tweet_urls': ['https://t.co/xWonfihJvP'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Small (n=648) industry-sponsored double-blind RCT among high-risk HCWs in \ud83c\uddee\ud83c\uddf3 suggests that a nasal spray containing \"Vita Raphael\" &amp; natural virucides may be a good prophylactic tool against .  1/4'}, {'verified': False, 'country': 'USA', 'id': '1441059805456650240', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Appili Therapeutics Announces Agreement with FUJIFILM and Funding Support for Clinical Trial Program Evaluating Avigan\u00ae/Reeqonus\u2122 for COVID-19 Patients https://t.co/xki8HViIwK via @Yahoo', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['Yahoo'], 'tweet_urls': ['https://t.co/xki8HViIwK'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Appili Therapeutics Announces Agreement with FUJIFILM and Funding Support for Clinical Trial Program Evaluating Avigan\u00ae/Reeqonus\u2122 for COVID-19 Patients  via '}, {'verified': False, 'country': 'USA', 'id': '1441059661223022592', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"The people getting vaxxed are in the early stage of world's largest clinical trial and don't know they are still being lied to about safety and efficacy! https://t.co/16Bl2EQluP\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/16Bl2EQluP'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"The people getting vaxxed are in the early stage of world's largest clinical trial and don't know they are still being lied to about safety and efficacy! \"}, {'verified': False, 'country': 'USA', 'id': '1441059408952193027', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#ICYMI: Earlier this week, we presented new clinical data at #ESMO21 on our CDK7 inhibitor, SY-5609. CDK7 plays a central role in two important processes that cancer cells use to survive and thrive. Find our latest data here: https://t.co/4ZkkLnF2Cl https://t.co/fc92wP5YpZ', 'tweet_lang': 'en', 'hashtags': ['ICYMI', 'ESMO21'], 'mentions': [], 'tweet_urls': ['https://t.co/4ZkkLnF2Cl'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ': Earlier this week, we presented new clinical data at  on our CDK7 inhibitor, SY-5609. CDK7 plays a central role in two important processes that cancer cells use to survive and thrive. Find our latest data here:  https://t.co/fc92wP5YpZ'}, {'verified': False, 'country': 'USA', 'id': '1441057570731577346', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Maybe, just maybe cancer rates should be followed state by state with regard to legalization of Cannabis Oil, commonly known as RSO.\\nhttps://t.co/Z1jJHyXVQb https://t.co/rfrfb5BLkn', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Z1jJHyXVQb'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Maybe, just maybe cancer rates should be followed state by state with regard to legalization of Cannabis Oil, commonly known as RSO.\\n https://t.co/rfrfb5BLkn'}, {'verified': False, 'country': 'USA', 'id': '1441057505279369216', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder.\\n\\nRead more...\\nhttps://t.co/AqyL2tajMy https://t.co/sHK9GgoYr1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/AqyL2tajMy'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder.\\n\\nRead more...\\n https://t.co/sHK9GgoYr1'}, {'verified': False, 'country': 'USA', 'id': '1441057103012147203', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Alpine\u2019s phase 2 trial for ALPN-101 is ongoing. https://t.co/fH57jpY3xk via @geekwire', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['geekwire'], 'tweet_urls': ['https://t.co/fH57jpY3xk'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Alpine\u2019s phase 2 trial for ALPN-101 is ongoing.  via '}, {'verified': False, 'country': 'USA', 'id': '1441056863018180611', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"It's important to understand the costs you'll be responsible for when participating in a trial, but don't feel overwhelmed; the trial team is there to help. Here's what you need to know: https://t.co/ZmTIXHrduL\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZmTIXHrduL'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"It's important to understand the costs you'll be responsible for when participating in a trial, but don't feel overwhelmed; the trial team is there to help. Here's what you need to know: \"}, {'verified': False, 'country': 'USA', 'id': '1441056803220033539', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Still experiencing celiac disease symptoms despite your gluten-free diet? This phase 2 clinical trial is testing the investigational medication PRV-015 in combination with a gluten-free diet for ongoing celiac disease symptoms. https://t.co/BPiroBYuGD https://t.co/5UiVgpsciB', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/BPiroBYuGD'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Still experiencing celiac disease symptoms despite your gluten-free diet? This phase 2 clinical trial is testing the investigational medication PRV-015 in combination with a gluten-free diet for ongoing celiac disease symptoms.  https://t.co/5UiVgpsciB'}, {'verified': True, 'country': 'USA', 'id': '1441056771557130243', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed) https://t.co/vbESqZZhxI', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/vbESqZZhxI'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed) '}, {'verified': False, 'country': 'USA', 'id': '1441056348007923723', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'ClinEdge is now combined with Elligo Health Research\u00ae, furthering our mission to create innovative solutions that connect and empower the clinical trial ecosystem. Learn more: https://t.co/g25vJts8s9 https://t.co/X4J6bfWFcr', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/g25vJts8s9'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'ClinEdge is now combined with Elligo Health Research\u00ae, furthering our mission to create innovative solutions that connect and empower the clinical trial ecosystem. Learn more:  https://t.co/X4J6bfWFcr'}, {'verified': False, 'country': 'USA', 'id': '1441056152490549250', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"AstraZeneca's new breast cancer drug yields 'groundbreaking' results in clinical trial #REPUBLIC @republic https://t.co/QvbIlQmLFM\", 'tweet_lang': 'en', 'hashtags': ['REPUBLIC'], 'mentions': ['republic'], 'tweet_urls': ['https://t.co/QvbIlQmLFM'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"AstraZeneca's new breast cancer drug yields 'groundbreaking' results in clinical trial   \"}, {'verified': False, 'country': 'USA', 'id': '1441056028905324545', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical trials will lead to the development of treatments and a cure for ALS. Learn more about the ALS Association research program and find a clinical trial near you here: https://t.co/9raXp7mpue. https://t.co/7bGqNffcp3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/9raXp7mpue'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical trials will lead to the development of treatments and a cure for ALS. Learn more about the ALS Association research program and find a clinical trial near you here: . https://t.co/7bGqNffcp3'}, {'verified': False, 'country': 'USA', 'id': '1441055881047670791', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'As Mesothelioma Awareness Day approaches (September 26), our guest blogger Katie Heller, MA, tells us about a promising clinical trial going on. Learn more about the PrE0506/DREAM3R clinical trial here! #mesotheliomaawareness https://t.co/CcEv4cPMkO', 'tweet_lang': 'en', 'hashtags': ['mesotheliomaawareness'], 'mentions': [], 'tweet_urls': ['https://t.co/CcEv4cPMkO'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'As Mesothelioma Awareness Day approaches (September 26), our guest blogger Katie Heller, MA, tells us about a promising clinical trial going on. Learn more about the PrE0506/DREAM3R clinical trial here!  '}, {'verified': False, 'country': 'USA', 'id': '1441055820125515779', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. https://t.co/ANtCfxVfh2', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ANtCfxVfh2'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. '}, {'verified': False, 'country': 'USA', 'id': '1441055498325872641', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. https://t.co/7BIaVz8M6T', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/7BIaVz8M6T'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. '}, {'verified': False, 'country': 'USA', 'id': '1441055279936856064', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study Scavenger Clinical Trial Platform\\nCelerion clinical trial study to investigate medication used to treat a rare condition affecting the nervous system in Lincoln, NE. Compensation $4,779\\n\\nhttps://t.co/kbMo7RoVyI\\n\\n#Volunteers #Studies #ClinicalTrials #Medicalresearch #phase1', 'tweet_lang': 'en', 'hashtags': ['Volunteers', 'Studies', 'ClinicalTrials', 'Medicalresearch', 'phase1'], 'mentions': [], 'tweet_urls': ['https://t.co/kbMo7RoVyI'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study Scavenger Clinical Trial Platform\\nCelerion clinical trial study to investigate medication used to treat a rare condition affecting the nervous system in Lincoln, NE. Compensation $4,779\\n\\n\\n\\n    '}, {'verified': False, 'country': 'USA', 'id': '1441054803451318272', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'From streamlining data build to managing remote #datasources, here\u2019s how #CROs are enabling faster, nimbler trial execution. https://t.co/OQB1CHvJPd\\n@Clin_Trials https://t.co/aiJw2vYIwU', 'tweet_lang': 'en', 'hashtags': ['datasources', 'CROs'], 'mentions': ['Clin_Trials'], 'tweet_urls': ['https://t.co/OQB1CHvJPd'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'From streamlining data build to managing remote , here\u2019s how  are enabling faster, nimbler trial execution. \\n https://t.co/aiJw2vYIwU'}, {'verified': False, 'country': 'USA', 'id': '1441054760187174914', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Volunteers who join in @NIH_NHLBI #SickleCell disease clinical #research make advancement possible. Clinical trial participant contributions have been essential for understanding sickle cell disease and developing better care &amp; new treatments.  #SickleCellAwarenesMonth https://t.co/EwV41Wy8Qr', 'tweet_lang': 'en', 'hashtags': ['SickleCell', 'research', 'SickleCellAwarenesMonth'], 'mentions': ['nih_nhlbi'], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Volunteers who join in @NIH_NHLBI  disease clinical  make advancement possible. Clinical trial participant contributions have been essential for understanding sickle cell disease and developing better care &amp; new treatments.  AwarenesMonth https://t.co/EwV41Wy8Qr'}, {'verified': False, 'country': 'USA', 'id': '1441054691056656387', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. https://t.co/wQ9KLuERC7', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/wQ9KLuERC7'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. '}, {'verified': False, 'country': 'USA', 'id': '1441054589931835405', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We are thrilled to to open this study nationally [ NCT04514497] and hope to make an impact on outcomes for pts with high grade NEC, SCLC and pancreatic cancer @CureNETs @ccf @NANETS1 @VUMC_Cancer @jordanberlin5 @NCICTEP_ClinRes \\n\\nhttps://t.co/ouzeTaCxO9', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['CureNETs', 'ccf', 'NANETS1', 'VUMC_Cancer', 'jordanberlin5', 'NCICTEP_ClinRes'], 'tweet_urls': ['https://t.co/ouzeTaCxO9'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We are thrilled to to open this study nationally [ NCT04514497] and hope to make an impact on outcomes for pts with high grade NEC, SCLC and pancreatic cancer       \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441053997364822020', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. https://t.co/1H4l4PAv5l', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1H4l4PAv5l'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. '}, {'verified': False, 'country': 'USA', 'id': '1441053763020623886', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical trial, with control group in biblical Book of Daniel\\n\\n\"Prove thy servants...and let them give us pulse to eat, and water to drink.\\n\\nThen let our countenances be looked upon before thee, and the countenance of the children that eat of the portion of the king\\'s meat\" https://t.co/JLP6fHFLM0', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JLP6fHFLM0'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical trial, with control group in biblical Book of Daniel\\n\\n\"Prove thy servants...and let them give us pulse to eat, and water to drink.\\n\\nThen let our countenances be looked upon before thee, and the countenance of the children that eat of the portion of the king\\'s meat\" '}, {'verified': False, 'country': 'USA', 'id': '1441053097720270849', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Fantastic to see so over 100 delegates join the #WMS2021 Clinical Trial Highlights breakout session to carry on the conversations and ask lots more questions https://t.co/dwHa6IOlBr', 'tweet_lang': 'en', 'hashtags': ['WMS2021'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Fantastic to see so over 100 delegates join the  Clinical Trial Highlights breakout session to carry on the conversations and ask lots more questions https://t.co/dwHa6IOlBr'}, {'verified': False, 'country': 'USA', 'id': '1441052992212398084', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '.@SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections https://t.co/OLA7CC5lZD $SCYX', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['scynexis'], 'tweet_urls': ['https://t.co/OLA7CC5lZD'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '.@SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections  $SCYX'}, {'verified': False, 'country': 'USA', 'id': '1441052661776715788', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'While we all know that NET cancer is rare, in adolescents it has been found to be rarer. @adacap_news has opened a clinical trial to evaluate the safety and dosimetry of Lutathera in adolescent patients with Pheochromocytoma and Paragangliomas (PPGL). https://t.co/U9WP9dDyRv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['adacap_news'], 'tweet_urls': ['https://t.co/U9WP9dDyRv'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'While we all know that NET cancer is rare, in adolescents it has been found to be rarer.  has opened a clinical trial to evaluate the safety and dosimetry of Lutathera in adolescent patients with Pheochromocytoma and Paragangliomas (PPGL). '}, {'verified': False, 'country': 'USA', 'id': '1441052627693887489', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"#CARTCell #tcellrx #immunotherapy aficionados, I'm crowdsourcing worldwide # of pts treated w commercial and clinical trial products, which I estimate as well north of 10,000. Refine my estimates and add on. Go!\\ncc @bradloncar &amp; his fan club https://t.co/mmntfe6WfA\", 'tweet_lang': 'en', 'hashtags': ['CARTCell', 'tcellrx', 'immunotherapy'], 'mentions': ['bradloncar'], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"   aficionados, I'm crowdsourcing worldwide # of pts treated w commercial and clinical trial products, which I estimate as well north of 10,000. Refine my estimates and add on. Go!\\ncc  &amp; his fan club https://t.co/mmntfe6WfA\"}, {'verified': False, 'country': 'USA', 'id': '1441052112939520001', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'panNF antibodies (IgG1) might define a subclass of extremely severe + rapidly progressive autoimmune neuropathy. #Rituximab might help (clinical trial needed!). \\nInteresting findings by Janev Fehmi et al. from @SimonRinaldi78 group, published in @JNNP_BMJ \\nhttps://t.co/i5vzgOSZmb https://t.co/ei3EdMThUY', 'tweet_lang': 'en', 'hashtags': ['Rituximab'], 'mentions': ['SimonRinaldi78', 'JNNP_BMJ'], 'tweet_urls': ['https://t.co/i5vzgOSZmb', 'https://t.co/ei3EdMThUY'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'panNF antibodies (IgG1) might define a subclass of extremely severe + rapidly progressive autoimmune neuropathy.  might help (clinical trial needed!). \\nInteresting findings by Janev Fehmi et al. from  group, published in  \\n '}, {'verified': False, 'country': 'USA', 'id': '1441051949403680772', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. https://t.co/8cAlyU0bdL', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/8cAlyU0bdL'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Myonex, a leading global clinical trial supply company, celebrated the opening of its worldwide headquarters in Horsham Wednesday. '}, {'verified': False, 'country': 'USA', 'id': '1441051009640448004', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Call for late-breaking oral abstracts |  We encourage submissions related to COVID-19 incl. clinical trial results, evidence-based policy recommendations, and public health measures implemented to control COVID-19 and improve public confidence in vaccines. https://t.co/DRSnL9Ua9X https://t.co/jfsvzhUmGH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/DRSnL9Ua9X'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Call for late-breaking oral abstracts |  We encourage submissions related to COVID-19 incl. clinical trial results, evidence-based policy recommendations, and public health measures implemented to control COVID-19 and improve public confidence in vaccines.  https://t.co/jfsvzhUmGH'}, {'verified': False, 'country': 'USA', 'id': '1441050524925693958', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Phase 3 Clinical Trial:\\nLength of Study: 1 to 4 years\\nApproximately 25-30% of drugs move to the next phase', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Phase 3 Clinical Trial:\\nLength of Study: 1 to 4 years\\nApproximately 25-30% of drugs move to the next phase'}, {'verified': True, 'country': 'USA', 'id': '1441050146016567300', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Another lawsuit has been filed over Williamson County\\'s school mask mandate \u2014 this time by a group of anti-mask parents who are arguing that the district is \"engaging in what amounts to a whole school clinical experimental trial.\" \\n\\nhttps://t.co/6yVH7WkyEd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6yVH7WkyEd'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Another lawsuit has been filed over Williamson County\\'s school mask mandate \u2014 this time by a group of anti-mask parents who are arguing that the district is \"engaging in what amounts to a whole school clinical experimental trial.\" \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441048484224938004', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Virtual clinical trials are one way study volunteers participants are protected during emergencies. Watch the full video on \u2018Basics of Clinical Trial Participation\u2019 at https://t.co/1c6sq9xZNq https://t.co/JXq2mQqRZd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1c6sq9xZNq'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Virtual clinical trials are one way study volunteers participants are protected during emergencies. Watch the full video on \u2018Basics of Clinical Trial Participation\u2019 at  https://t.co/JXq2mQqRZd'}, {'verified': False, 'country': 'USA', 'id': '1441048049338421250', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Very honored to be invited by @berlinnovation the 8 October for an on-line lecture: \"Maximizing the Impact of Medical Journal Requirements for Clinical Trial Data-Sharing\". Thanks @questbih and @dirnagl. \\n\\nhttps://t.co/23iIlnk3Hw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['berlinnovation', 'questbih', 'dirnagl'], 'tweet_urls': ['https://t.co/23iIlnk3Hw'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Very honored to be invited by  the 8 October for an on-line lecture: \"Maximizing the Impact of Medical Journal Requirements for Clinical Trial Data-Sharing\". Thanks  and . \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441047824075010049', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'U of M leads groundbreaking clinical trial of opioid vaccine https://t.co/2u6dlO90pT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2u6dlO90pT'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'U of M leads groundbreaking clinical trial of opioid vaccine '}, {'verified': False, 'country': 'USA', 'id': '1441047352693886977', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We believe a well-planned Clinical Trial Ancillary Supply Chain (CTASC) is essential to on-time, on-budget trials.  Put Ancillare\u2019s Time-Saving Approach to the Test. Schedule a 15-minute consultation today.  https://t.co/3jnwFga2BT https://t.co/lyJHOpbH0Q', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/3jnwFga2BT'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We believe a well-planned Clinical Trial Ancillary Supply Chain (CTASC) is essential to on-time, on-budget trials.  Put Ancillare\u2019s Time-Saving Approach to the Test. Schedule a 15-minute consultation today.   https://t.co/lyJHOpbH0Q'}, {'verified': False, 'country': 'USA', 'id': '1441047274344300548', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A #Phase0 #ClinicalTrial is designed to quickly identify how a drug works in patients &amp; whether it should be fast-tracked for further development. Learn about the trial of #SonodynamicTherapy for patients with recurrent high-grade glioma. https://t.co/tlppvDWoDU #braincancer', 'tweet_lang': 'en', 'hashtags': ['Phase0', 'ClinicalTrial', 'SonodynamicTherapy', 'braincancer'], 'mentions': [], 'tweet_urls': ['https://t.co/tlppvDWoDU'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A   is designed to quickly identify how a drug works in patients &amp; whether it should be fast-tracked for further development. Learn about the trial of  for patients with recurrent high-grade glioma.  '}, {'verified': False, 'country': 'USA', 'id': '1441047221760311300', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Bioinformatics and #datascience are crucial aspects of our company in clinical R&amp;D. Our team is seeking a proficient leader for Head of #Biometrics to improve our patient clinical trial recruitment, #RWE, &amp; statistical programming. Read more: https://t.co/LZNsVX7tZV https://t.co/9CpT5qAwAr', 'tweet_lang': 'en', 'hashtags': ['Bioinformatics', 'datascience', 'Biometrics', 'RWE'], 'mentions': [], 'tweet_urls': ['https://t.co/LZNsVX7tZV'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' and  are crucial aspects of our company in clinical R&amp;D. Our team is seeking a proficient leader for Head of  to improve our patient clinical trial recruitment, , &amp; statistical programming. Read more:  https://t.co/9CpT5qAwAr'}, {'verified': False, 'country': 'USA', 'id': '1441047199354400773', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Effect of Preemptive Intervention on Developmental Outcomes Among Infants Showing Early Signs of Autism: A Randomized Clinical Trial of Outcomes to Diagnosis.\\nhttps://t.co/8p9TDZafMk\\nhttps://t.co/Q2lnpi59Ei #LocalAuthorThursday https://t.co/x5TmPe2UTk', 'tweet_lang': 'en', 'hashtags': ['LocalAuthorThursday'], 'mentions': [], 'tweet_urls': ['https://t.co/8p9TDZafMk', 'https://t.co/Q2lnpi59Ei'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Effect of Preemptive Intervention on Developmental Outcomes Among Infants Showing Early Signs of Autism: A Randomized Clinical Trial of Outcomes to Diagnosis.\\n\\n  https://t.co/x5TmPe2UTk'}, {'verified': False, 'country': 'USA', 'id': '1441046873918291968', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Join #Agilent and our esteemed panelists at World CB&amp;CDx as we discuss how to build a Best-in-Class Model for Global CDx Clinical Trial Deployment. Learn more: https://t.co/9ZWGIk0g30 \\n#WorldCDx #precisionmedicine #clinicaltrialsmore https://t.co/ljlpMdsD8Q', 'tweet_lang': 'en', 'hashtags': ['Agilent', 'WorldCDx', 'precisionmedicine', 'clinicaltrialsmore'], 'mentions': [], 'tweet_urls': ['https://t.co/9ZWGIk0g30'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Join  and our esteemed panelists at World CB&amp;CDx as we discuss how to build a Best-in-Class Model for Global CDx Clinical Trial Deployment. Learn more:  \\n   https://t.co/ljlpMdsD8Q'}, {'verified': False, 'country': 'USA', 'id': '1441046572473720832', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Notice of Correction to PAR-21-166 \u201cAcademic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 \u2013 Clinical Trial Not\\xa0Allowed)\u201d https://t.co/SI0PXx1uXV', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/SI0PXx1uXV'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Notice of Correction to PAR-21-166 \u201cAcademic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 \u2013 Clinical Trial Not\\xa0Allowed)\u201d '}, {'verified': False, 'country': 'USA', 'id': '1441046111540563969', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'FDA approval?\\nClinical Trial update? \\nNew license agreements?\\nBuyout? \\n\\nThe list of catalysts for $RGBP are solid!  \\nand keep in mind, 2021 8ks make these catalysts clear as day... FACT BASED https://t.co/QH6YRyUQtH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/QH6YRyUQtH'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'FDA approval?\\nClinical Trial update? \\nNew license agreements?\\nBuyout? \\n\\nThe list of catalysts for $RGBP are solid!  \\nand keep in mind, 2021 8ks make these catalysts clear as day... FACT BASED '}, {'verified': False, 'country': 'USA', 'id': '1441045263691309056', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Project Manager position available at CATALIS!\\nAre you interested in collaborating on projects and activities related to the #Quebec Accelerated Clinical Trial Evaluation Service? Look no further and click here: https://t.co/5ZBSBeXK60\\n#ClinicalTrials #TheSmartChoice https://t.co/tbbR37OlQf', 'tweet_lang': 'en', 'hashtags': ['Quebec', 'ClinicalTrials', 'TheSmartChoice'], 'mentions': [], 'tweet_urls': ['https://t.co/5ZBSBeXK60'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Project Manager position available at CATALIS!\\nAre you interested in collaborating on projects and activities related to the  Accelerated Clinical Trial Evaluation Service? Look no further and click here: \\n  https://t.co/tbbR37OlQf'}, {'verified': False, 'country': 'USA', 'id': '1441044713965031425', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#NIH #funding opportunity \ud83d\udce2 application deadline (10/5) - New Directions in #Hematology Research (SHINE-II) (R01 Clinical Trial Optional) https://t.co/pfwgLqE8mi https://t.co/d1Uy7Hfi6v', 'tweet_lang': 'en', 'hashtags': ['NIH', 'funding', 'Hematology'], 'mentions': [], 'tweet_urls': ['https://t.co/pfwgLqE8mi'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '  opportunity \ud83d\udce2 application deadline (10/5) - New Directions in  Research (SHINE-II) (R01 Clinical Trial Optional)  https://t.co/d1Uy7Hfi6v'}, {'verified': False, 'country': 'USA', 'id': '1441044309046824973', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Had to stop taking my melatonin bc I lost my prescription and I don't wanna ask my GP for a new one bc she keeps asking me to take CBD instead and join a clinical trial but I don't wanna quit recreational use for the trial but if I tell her that she might confiscate my ritalin!!\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Had to stop taking my melatonin bc I lost my prescription and I don't wanna ask my GP for a new one bc she keeps asking me to take CBD instead and join a clinical trial but I don't wanna quit recreational use for the trial but if I tell her that she might confiscate my ritalin!!\"}, {'verified': False, 'country': 'USA', 'id': '1441044194479382533', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New Trial Posted:  Traumatic Brain Injury - Springfield MA https://t.co/54lzFQTbAH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/54lzFQTbAH'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New Trial Posted:  Traumatic Brain Injury - Springfield MA '}, {'verified': False, 'country': 'USA', 'id': '1441043806455959558', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Most kids don\u2019t know how to use their inhalers, but a new clinical trial is exploring if more screen time may be a solution. If your child has #asthma, you can learn more about studies like this one on @bethenewnorm \u2014 https://t.co/HJI3cMQ6gM https://t.co/iBGBpmJnT2', 'tweet_lang': 'en', 'hashtags': ['asthma'], 'mentions': ['bethenewnorm'], 'tweet_urls': ['https://t.co/HJI3cMQ6gM'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Most kids don\u2019t know how to use their inhalers, but a new clinical trial is exploring if more screen time may be a solution. If your child has , you can learn more about studies like this one on  \u2014  https://t.co/iBGBpmJnT2'}, {'verified': False, 'country': 'USA', 'id': '1441043527723470853', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties https://t.co/NzprqznyhB\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NzprqznyhB'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties \"}, {'verified': False, 'country': 'USA', 'id': '1441043074575212548', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Unique role for a PhD here locally in Colorado.\\n\\nLooking for a Manager Clinical Affairs who will specifically be working in the #vaccine space and collaborate with many other companies and academic institutions. \\n\\nClinical trial background needed.\\n\\nDM for deets!', 'tweet_lang': 'en', 'hashtags': ['vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Unique role for a PhD here locally in Colorado.\\n\\nLooking for a Manager Clinical Affairs who will specifically be working in the  space and collaborate with many other companies and academic institutions. \\n\\nClinical trial background needed.\\n\\nDM for deets!'}, {'verified': False, 'country': 'USA', 'id': '1441042176729759747', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation https://t.co/DTAg3dOfZ4', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/DTAg3dOfZ4'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation '}, {'verified': False, 'country': 'USA', 'id': '1441041820457181198', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP: TFF Pharmaceuticals reports topline results from Phase 1 clinical trial of inhaled tacrolimus powder https://t.co/Jrxpfm6Uk2', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Jrxpfm6Uk2'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP: TFF Pharmaceuticals reports topline results from Phase 1 clinical trial of inhaled tacrolimus powder '}, {'verified': False, 'country': 'USA', 'id': '1441040452078145543', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Great update from @dtrip2015 highlighting key clinical trials in #portalhypertension in the UK! @BoppPtrial @CalibreTrial @ASEPTIC_TRIAL #BASL2021 https://t.co/Gzk0XjxPME', 'tweet_lang': 'en', 'hashtags': ['portalhypertension', 'BASL2021'], 'mentions': ['dtrip2015', 'BoppPtrial', 'CalibreTrial', 'ASEPTIC_TRIAL'], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Great update from  highlighting key clinical trials in  in the UK!     https://t.co/Gzk0XjxPME'}, {'verified': False, 'country': 'USA', 'id': '1441040412991315980', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"CLIN covers trial data from conferences big and small. Request a demo of CLIN and explore clinical trial data from this year's #AUA21 https://t.co/R1tfzaDwAz\\n\\n@AmerUrological #MedTwitter #ClinicalData https://t.co/LYbxYFus0r\", 'tweet_lang': 'en', 'hashtags': ['AUA21', 'MedTwitter', 'ClinicalData'], 'mentions': ['AmerUrological'], 'tweet_urls': ['https://t.co/R1tfzaDwAz'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"CLIN covers trial data from conferences big and small. Request a demo of CLIN and explore clinical trial data from this year's  \\n\\n   https://t.co/LYbxYFus0r\"}, {'verified': False, 'country': 'USA', 'id': '1441040404409843713', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical Trial: CBD Administration Associated with Short-Term Improvements in Verbal Recall https://t.co/86nj4CvxrA', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/86nj4CvxrA'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical Trial: CBD Administration Associated with Short-Term Improvements in Verbal Recall '}, {'verified': False, 'country': 'USA', 'id': '1441040152608923661', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Inside Korea's pharma industry: SK Bioscience filed an IND application to South Korea\u2019s MFDS for Phase 3 clinical trial of its COVID-19 vaccine GBP510. This is the first instance of a locally-made COVID-19 vaccine being submitted for a Phase 3 IND.\\nhttps://t.co/fFeL6IFdGA\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fFeL6IFdGA'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Inside Korea's pharma industry: SK Bioscience filed an IND application to South Korea\u2019s MFDS for Phase 3 clinical trial of its COVID-19 vaccine GBP510. This is the first instance of a locally-made COVID-19 vaccine being submitted for a Phase 3 IND.\\n\"}, {'verified': False, 'country': 'USA', 'id': '1441040105574076429', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical Trial Supplies Market worth $ 2.9 billion by 2026 - Exclusive Report by MarketsandMarkets\u2122 - https://t.co/IppLsdiJcu', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/IppLsdiJcu'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical Trial Supplies Market worth $ 2.9 billion by 2026 - Exclusive Report by MarketsandMarkets\u2122 - '}, {'verified': False, 'country': 'USA', 'id': '1441039548478222340', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This job might be a great fit for you: Senior Clinical Trial Manager (CTL) - Oncology - https://t.co/xjYwdwN26h #clinical #Gaithersburg, MD', 'tweet_lang': 'en', 'hashtags': ['clinical', 'Gaithersburg'], 'mentions': [], 'tweet_urls': ['https://t.co/xjYwdwN26h'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [39.17, -77.19]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This job might be a great fit for you: Senior Clinical Trial Manager (CTL) - Oncology -   , MD'}, {'verified': False, 'country': 'USA', 'id': '1441039021094834185', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$CHNC Did you know Alpha Research allows CHNC to conduct in house clinical trial phases 1-4. This will greatly speed product development! https://t.co/D2DfjTRySl', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/D2DfjTRySl'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$CHNC Did you know Alpha Research allows CHNC to conduct in house clinical trial phases 1-4. This will greatly speed product development! '}, {'verified': False, 'country': 'USA', 'id': '1441038391093735427', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e27\u0e31\u0e14\u0e2d\u0e38\u0e13\u0e2b\u0e20\u0e39\u0e21\u0e34\u0e2d\u0e34\u0e19\u0e1f\u0e23\u0e32\u0e40\u0e23\u0e14\u0e14\u0e34\u0e08\u0e34\u0e15\u0e2d\u0e25\u0e41\u0e1a\u0e1a\u0e44\u0e21\u0e48\u0e2a\u0e31\u0e21\u0e1c\u0e31\u0e2a \u0e1c\u0e48\u0e32\u0e19\u0e01\u0e32\u0e23\u0e27\u0e34\u0e08\u0e31\u0e22\u0e17\u0e32\u0e07\u0e04\u0e25\u0e34\u0e19\u0e34\u0e01 Clinical Trial \u0e02\u0e2d\u0e07\u0e41\u0e17\u0e49 \u0e1e\u0e23\u0e49\u0e2d\u0e21\u0e2a\u0e48\u0e07\u0e08\u0e32\u0e01\u0e44\u0e17\u0e22 FLASH SALE \u0e25\u0e14 49% \u0e27\u0e31\u0e19\u0e19\u0e35\u0e49\u0e15\u0e2d\u0e19\u0e19\u0e35\u0e49\u0e40\u0e17\u0e48\u0e32\u0e19\u0e31\u0e49\u0e19 \u0e2a\u0e31\u0e48\u0e07\u0e40\u0e25\u0e22\u0e1e\u0e23\u0e49\u0e2d\u0e21\u0e2a\u0e48\u0e07 https://t.co/uBRdGhRuBr https://t.co/8NuezmQCGj', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/uBRdGhRuBr'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e27\u0e31\u0e14\u0e2d\u0e38\u0e13\u0e2b\u0e20\u0e39\u0e21\u0e34\u0e2d\u0e34\u0e19\u0e1f\u0e23\u0e32\u0e40\u0e23\u0e14\u0e14\u0e34\u0e08\u0e34\u0e15\u0e2d\u0e25\u0e41\u0e1a\u0e1a\u0e44\u0e21\u0e48\u0e2a\u0e31\u0e21\u0e1c\u0e31\u0e2a \u0e1c\u0e48\u0e32\u0e19\u0e01\u0e32\u0e23\u0e27\u0e34\u0e08\u0e31\u0e22\u0e17\u0e32\u0e07\u0e04\u0e25\u0e34\u0e19\u0e34\u0e01 Clinical Trial \u0e02\u0e2d\u0e07\u0e41\u0e17\u0e49 \u0e1e\u0e23\u0e49\u0e2d\u0e21\u0e2a\u0e48\u0e07\u0e08\u0e32\u0e01\u0e44\u0e17\u0e22 FLASH SALE \u0e25\u0e14 49% \u0e27\u0e31\u0e19\u0e19\u0e35\u0e49\u0e15\u0e2d\u0e19\u0e19\u0e35\u0e49\u0e40\u0e17\u0e48\u0e32\u0e19\u0e31\u0e49\u0e19 \u0e2a\u0e31\u0e48\u0e07\u0e40\u0e25\u0e22\u0e1e\u0e23\u0e49\u0e2d\u0e21\u0e2a\u0e48\u0e07  https://t.co/8NuezmQCGj'}, {'verified': False, 'country': 'USA', 'id': '1441038296407289861', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines https://t.co/S6fnAqFyvj', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/S6fnAqFyvj'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines '}, {'verified': True, 'country': 'USA', 'id': '1441038019385978882', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Notice of Correction to PAR-21-166 \"Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)\" https://t.co/tfNFC5f7Nx', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/tfNFC5f7Nx'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Notice of Correction to PAR-21-166 \"Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)\" '}, {'verified': False, 'country': 'USA', 'id': '1441037889480138754', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Is your clinical trial compliant? Only 29.16% of completed studies in the US have a properly maintained study protocol registered with https://t.co/Ac8SPOu6eu. TrialCompliance can help: https://t.co/zXK42uSVj7 #Compliance', 'tweet_lang': 'en', 'hashtags': ['Compliance'], 'mentions': [], 'tweet_urls': ['https://t.co/Ac8SPOu6eu', 'https://t.co/zXK42uSVj7'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Is your clinical trial compliant? Only 29.16% of completed studies in the US have a properly maintained study protocol registered with . TrialCompliance can help:  '}, {'verified': False, 'country': 'USA', 'id': '1441036706510217220', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\nhttps://t.co/WmwHJPlXlt\\n#stockmarket  #stocks #invest #investor #daytrading #trading #money #investment #business', 'tweet_lang': 'en', 'hashtags': ['stockmarket', 'stocks', 'invest', 'investor', 'daytrading', 'trading', 'money', 'investment', 'business'], 'mentions': [], 'tweet_urls': ['https://t.co/WmwHJPlXlt'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n\\n    or    ment '}, {'verified': False, 'country': 'USA', 'id': '1441036316544835584', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n - Barrington James\\n - United States\\nFind Out More! https://t.co/VHVjfBBahx https://t.co/rVHHn6rsAl', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VHVjfBBahx'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n - Barrington James\\n - United States\\nFind Out More!  https://t.co/rVHHn6rsAl'}, {'verified': False, 'country': 'USA', 'id': '1441036307413803008', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical Trial Management System Market worth $1,590 Million by 2025 - Exclusive Report by MarketsandMarkets\u2122 - https://t.co/C1HvL5038c', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/C1HvL5038c'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical Trial Management System Market worth $1,590 Million by 2025 - Exclusive Report by MarketsandMarkets\u2122 - '}, {'verified': False, 'country': 'USA', 'id': '1441035850725404672', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Inc. (NASDAQ:SLDB) will present at the World Muscle Society Congress with\\xa0long-term data from patients ages 4-6 in the ongoing IGNITE DMD Phase 1/2 clinical trial of SGT-001 in patients with Duchenne muscular dystrophy. $sldb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Inc. (NASDAQ:SLDB) will present at the World Muscle Society Congress with\\xa0long-term data from patients ages 4-6 in the ongoing IGNITE DMD Phase 1/2 clinical trial of SGT-001 in patients with Duchenne muscular dystrophy. $sldb'}, {'verified': False, 'country': 'USA', 'id': '1441033901741416448', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$ATHX \u201ccompetition\u201d will catch up at the pace of the current clinical trial: https://t.co/FYlt4VYu3h https://t.co/RnLJzQU3Yz', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/FYlt4VYu3h', 'https://t.co/RnLJzQU3Yz'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$ATHX \u201ccompetition\u201d will catch up at the pace of the current clinical trial:  '}, {'verified': True, 'country': 'USA', 'id': '1441033598044229643', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#UlatBayan | Resulta ng Clinical Trial sa VCO vs. COVID-19, ilalabas na sa katapusan ng Setyembre; Lagundi, nakatutulong maibsan ang sintomas ng COVID-19 ayon sa DOST\\n\\nhttps://t.co/zzI34RJVFz', 'tweet_lang': 'en', 'hashtags': ['UlatBayan'], 'mentions': [], 'tweet_urls': ['https://t.co/zzI34RJVFz'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' | Resulta ng Clinical Trial sa VCO vs. COVID-19, ilalabas na sa katapusan ng Setyembre; Lagundi, nakatutulong maibsan ang sintomas ng COVID-19 ayon sa DOST\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441033432134393857', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'ICYMI: German universities have uploaded 131 missing clinical trial results this summer alone. \\n\\nRapid and sustained progress. This is a one-way street.\\n\\nhttps://t.co/D9n3aA0um6 @uaem https://t.co/pRIfdczMkt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['uaem'], 'tweet_urls': ['https://t.co/D9n3aA0um6'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'ICYMI: German universities have uploaded 131 missing clinical trial results this summer alone. \\n\\nRapid and sustained progress. This is a one-way street.\\n\\n  https://t.co/pRIfdczMkt'}, {'verified': False, 'country': 'USA', 'id': '1441033411276247040', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"The first publication from the Finding My Way UK study is out now! Check it out to read more about our team's adaptation of the Finding My Way programme and our ongoing clinical trial \\n@NorthWestCancer @rosiependrous @TimCartwright11 https://t.co/NscCDO2kh8\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['NorthWestCancer', 'rosiependrous', 'TimCartwright11'], 'tweet_urls': ['https://t.co/NscCDO2kh8'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"The first publication from the Finding My Way UK study is out now! Check it out to read more about our team's adaptation of the Finding My Way programme and our ongoing clinical trial \\n   \"}, {'verified': False, 'country': 'USA', 'id': '1441033281365966854', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/z2rWsDPxUT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/z2rWsDPxUT'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1441033138273067021', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Q BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022\\n\\nhttps://t.co/QvqPdPagYS\\n.\\n.\\n. \\n#investing\\xa0#stockmarket\\xa0#finance\\xa0#stocks\\xa0#wealth\\xa0#wallstreet\\xa0\\n#investments #passiveincome https://t.co/8O3L5qo5V1', 'tweet_lang': 'en', 'hashtags': ['investing', 'stockmarket', 'finance', 'stocks', 'wealth', 'wallstreet', 'investments', 'passiveincome'], 'mentions': [], 'tweet_urls': ['https://t.co/QvqPdPagYS'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Q BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022\\n\\n\\n.\\n.\\n. \\n\\xa0\\xa0\\xa0\\xa0\\xa0\\xa0\\n  https://t.co/8O3L5qo5V1'}, {'verified': False, 'country': 'USA', 'id': '1441032751508041732', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clinical trial shows planned breaks in cancer treatment to be beneficial https://t.co/WN552c3ExH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/WN552c3ExH'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clinical trial shows planned breaks in cancer treatment to be beneficial '}, {'verified': False, 'country': 'USA', 'id': '1441032287651573762', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n - Barrington James\\n - United States\\nFind Out More! https://t.co/IsOOsWYAYo https://t.co/l0756Xj24S', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/IsOOsWYAYo'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n - Barrington James\\n - United States\\nFind Out More!  https://t.co/l0756Xj24S'}, {'verified': False, 'country': 'USA', 'id': '1441032236132810754', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SCYX SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections https://t.co/3ac5a7eg9D', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/3ac5a7eg9D'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SCYX SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections '}, {'verified': False, 'country': 'USA', 'id': '1441032176309608452', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"As a life sciences translator, I didn't hesitate to get the COVID-19 vaccine when it became available. If you work in this area, you know it takes a village to run a clinical trial: PIs, regulatory departments, ethics committees, and more. The process is sound. #getvaccinated https://t.co/IHNfRpeeNF\", 'tweet_lang': 'en', 'hashtags': ['getvaccinated'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"As a life sciences translator, I didn't hesitate to get the COVID-19 vaccine when it became available. If you work in this area, you know it takes a village to run a clinical trial: PIs, regulatory departments, ethics committees, and more. The process is sound.  https://t.co/IHNfRpeeNF\"}, {'verified': False, 'country': 'USA', 'id': '1441032102716133383', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'With COPD, it can feel like life revolves around symptoms. Sound familiar? Consider taking part in a clinical trial researching an investigational treatment option for moderate-to-severe COPD. Learn more through @antidote_me  to see if you may qualify: https://t.co/8r7t4wrjh9 https://t.co/eaJlpGuHir', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['antidote_me'], 'tweet_urls': ['https://t.co/8r7t4wrjh9'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'With COPD, it can feel like life revolves around symptoms. Sound familiar? Consider taking part in a clinical trial researching an investigational treatment option for moderate-to-severe COPD. Learn more through   to see if you may qualify:  https://t.co/eaJlpGuHir'}, {'verified': True, 'country': 'USA', 'id': '1441031070611349509', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T\u00e1naiste @LeoVaradkar announced today that @ICONplc has been awarded \u20ac4m in R&amp;D support administered by Enterprise Ireland to further enhance its data solutions and decentralised clinical trial technology. https://t.co/bBYbwYH6uZ https://t.co/oXbi2aNoFy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['LeoVaradkar', 'ICONplc'], 'tweet_urls': ['https://t.co/bBYbwYH6uZ'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T\u00e1naiste  announced today that  has been awarded \u20ac4m in R&amp;D support administered by Enterprise Ireland to further enhance its data solutions and decentralised clinical trial technology.  https://t.co/oXbi2aNoFy'}, {'verified': False, 'country': 'USA', 'id': '1441030710983159816', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"We're hiring! Click to apply: Clinical Trial Leader - UK Wide - https://t.co/z6T4AuVgp1 #clinical #LittlewickGreen, England\", 'tweet_lang': 'en', 'hashtags': ['clinical', 'LittlewickGreen'], 'mentions': [], 'tweet_urls': ['https://t.co/z6T4AuVgp1'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [51.5006047, -0.7785527]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"We're hiring! Click to apply: Clinical Trial Leader - UK Wide -   , England\"}, {'verified': False, 'country': 'USA', 'id': '1441030061373591555', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Are too many Phase III #Cancer clinical trials set up to fail? \\nhttps://t.co/scGO5sbtqM\\n#ClinicalTrials #Effect #Harvard #Innovation #Oncology #Participants #Pipeline #Professor #Research #School #Testing #Therapeutics #Treatment #Trial #Visit https://t.co/m5vNbkHTnF', 'tweet_lang': 'en', 'hashtags': ['Cancer', 'ClinicalTrials', 'Effect', 'Harvard', 'Innovation', 'Oncology', 'Participants', 'Pipeline', 'Professor', 'Research', 'School', 'Testing', 'Therapeutics', 'Treatment', 'Trial', 'Visit'], 'mentions': [], 'tweet_urls': ['https://t.co/scGO5sbtqM'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Are too many Phase III  clinical trials set up to fail? \\n\\n               https://t.co/m5vNbkHTnF'}, {'verified': False, 'country': 'USA', 'id': '1441029919606202369', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'As clinical studies evolve to incorporate in-home nursing visits and direct-to-patient shipments of study medications, SMi Trial(D) has launched specialized training specifically for home healthcare providers. https://t.co/LxbW03WMQK', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/LxbW03WMQK'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'As clinical studies evolve to incorporate in-home nursing visits and direct-to-patient shipments of study medications, SMi Trial(D) has launched specialized training specifically for home healthcare providers. '}, {'verified': False, 'country': 'USA', 'id': '1441029103671398402', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Under a new research collaboration with J&amp;J\u2019s Lung #Cancer Initiative, Mauna Kea is launching a single-arm #clinical trial of the technology to further validate Cellvizio\u2019s ability to improve needle placement during biopsies of peripheral #lung nodules. https://t.co/2qdLLljou9', 'tweet_lang': 'en', 'hashtags': ['Cancer', 'clinical', 'lung'], 'mentions': [], 'tweet_urls': ['https://t.co/2qdLLljou9'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Under a new research collaboration with J&amp;J\u2019s Lung  Initiative, Mauna Kea is launching a single-arm  trial of the technology to further validate Cellvizio\u2019s ability to improve needle placement during biopsies of peripheral  nodules. '}, {'verified': True, 'country': 'USA', 'id': '1441028336155758592', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Diagnosed with colorectal cancer? A clinical trial is looking for volunteers in your area. See if you may qualify: #ColorectalCancer #HER2PositiveCRC #MetastaticCRC (sponsored)\\nhttps://t.co/ibEqagkqEW https://t.co/OMdml2PxGY', 'tweet_lang': 'en', 'hashtags': ['ColorectalCancer', 'HER2PositiveCRC', 'MetastaticCRC'], 'mentions': [], 'tweet_urls': ['https://t.co/ibEqagkqEW'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Diagnosed with colorectal cancer? A clinical trial is looking for volunteers in your area. See if you may qualify:    (sponsored)\\n https://t.co/OMdml2PxGY'}, {'verified': False, 'country': 'USA', 'id': '1441028316719427592', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"One of our first @UHCW_Pharmacy #Phzazz award winners. Ayesha was nominated by her colleagues for all her work on supporting a trial through committee processes to deliver the world's first treatment of a clinical trial drug. https://t.co/4MHGT9SiVZ\", 'tweet_lang': 'en', 'hashtags': ['Phzazz'], 'mentions': ['UHCW_Pharmacy'], 'tweet_urls': [], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"One of our first   award winners. Ayesha was nominated by her colleagues for all her work on supporting a trial through committee processes to deliver the world's first treatment of a clinical trial drug. https://t.co/4MHGT9SiVZ\"}, {'verified': False, 'country': 'USA', 'id': '1441028200566562818', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'De president van Kroati\u00eb zegt dat ze klaar zijn met vaccineren. Ze gaan er niet mee door!\\n\\nAlle covid synthetische mRNA gen therapie, aka \"vaccins\" op de markt zijn nog steeds in de testfase (clinical trial).\\nhttps://t.co/16jFBF1hqC\\nhttps://t.co/I4un1GBcgx\\nhttps://t.co/Sl8vV3qMoc https://t.co/mvPPmVbPz6', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/16jFBF1hqC', 'https://t.co/I4un1GBcgx', 'https://t.co/Sl8vV3qMoc', 'https://t.co/mvPPmVbPz6'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'De president van Kroati\u00eb zegt dat ze klaar zijn met vaccineren. Ze gaan er niet mee door!\\n\\nAlle covid synthetische mRNA gen therapie, aka \"vaccins\" op de markt zijn nog steeds in de testfase (clinical trial).\\n\\n\\n '}, {'verified': False, 'country': 'USA', 'id': '1441027584792293380', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB - Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB - Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001'}, {'verified': False, 'country': 'USA', 'id': '1441027345276604416', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#WMS2021 Oral presentations with teams from @Inst_Myologie this afternoon at @WorldMuscleSoc virtual congress. Check out 0.1 presentation in clinical trial highlights &amp; 0.7 &amp; 0.8 in clinical research presentations @researchmyology @BiotherapiesIns @Telethon_France @AfmPresse https://t.co/FC4kABBeEf', 'tweet_lang': 'en', 'hashtags': ['WMS2021'], 'mentions': ['Inst_Myologie', 'WorldMuscleSoc', 'researchmyology', 'BiotherapiesIns', 'Telethon_France', 'AfmPresse'], 'tweet_urls': ['https://t.co/FC4kABBeEf'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' Oral presentations with teams from  this afternoon at  virtual congress. Check out 0.1 presentation in clinical trial highlights &amp; 0.7 &amp; 0.8 in clinical research presentations     '}, {'verified': False, 'country': 'USA', 'id': '1441027158672089091', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP - TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP - TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation'}, {'verified': False, 'country': 'USA', 'id': '1441027072336568320', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Researchers from the University of Basel have developed an #AR app to help people reduce their fear of spiders. \\n\\nShown to be effective in a clinical trial, what other fears could #augmentedreality help the public face? Find out more @TheIET: https://t.co/sv3vmL2vHR\\n\\n#ARNews', 'tweet_lang': 'en', 'hashtags': ['AR', 'augmentedreality', 'ARNews'], 'mentions': ['TheIET'], 'tweet_urls': ['https://t.co/sv3vmL2vHR'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Researchers from the University of Basel have developed an  app to help people reduce their fear of spiders. \\n\\nShown to be effective in a clinical trial, what other fears could  help the public face? Find out more : \\n\\nNews'}, {'verified': False, 'country': 'USA', 'id': '1441026676721393673', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease https://t.co/Z2TvYqHqJQ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Z2TvYqHqJQ'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease '}, {'verified': False, 'country': 'USA', 'id': '1441025882638983170', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Preferred Research Partners is currently enrolling children with ADHD for a clinical trial. Learn more today to see if your child may qualify. https://t.co/8jvVNX6zOj https://t.co/VPrAYIFxqP', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/8jvVNX6zOj'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Preferred Research Partners is currently enrolling children with ADHD for a clinical trial. Learn more today to see if your child may qualify.  https://t.co/VPrAYIFxqP'}, {'verified': False, 'country': 'USA', 'id': '1441025874661298176', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Lead\\n - AL2S3 LTD\\n - United States, East Coast\\nFind Out More! https://t.co/a12o2BHvQg https://t.co/3okVD5DOwT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/a12o2BHvQg'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Lead\\n - AL2S3 LTD\\n - United States, East Coast\\nFind Out More!  https://t.co/3okVD5DOwT'}, {'verified': False, 'country': 'USA', 'id': '1441025482816819211', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dar\u00e9 Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy - https://t.co/Fgy5mBnqzO therapy for women who cannot, or should not, take supplemental estrogen    Potential to be the first treatment for ... https://t.co/Nl9qg6f3kB', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Fgy5mBnqzO'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dar\u00e9 Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy -  therapy for women who cannot, or should not, take supplemental estrogen    Potential to be the first treatment for ... https://t.co/Nl9qg6f3kB'}, {'verified': False, 'country': 'USA', 'id': '1441025451548315651', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation - https://t.co/ffLcUHFmiy Tacrolimus Shows Dose-Dependent PK that Achieves Desired Therapeutic Plasma Concent... https://t.co/w9XhJ0PvQB', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ffLcUHFmiy'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation -  Tacrolimus Shows Dose-Dependent PK that Achieves Desired Therapeutic Plasma Concent... https://t.co/w9XhJ0PvQB'}, {'verified': False, 'country': 'USA', 'id': '1441025055127965701', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study Scavenger Clinical Trial Platform\\nPAREXEL Paid Clinical Trial Study for Healthy Males in Baltimore, MD. Compensation $3,350\\n\\nhttps://t.co/yxilXvHNlv\\n\\n#Healthy #Volunteers #Studies #ClinicalTrials #Clinicalresearch  #Medicalresearch #phase1 #Opportunities #ResearchStudies', 'tweet_lang': 'en', 'hashtags': ['Healthy', 'Volunteers', 'Studies', 'ClinicalTrials', 'Clinicalresearch', 'Medicalresearch', 'phase1', 'Opportunities', 'ResearchStudies'], 'mentions': [], 'tweet_urls': ['https://t.co/yxilXvHNlv'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study Scavenger Clinical Trial Platform\\nPAREXEL Paid Clinical Trial Study for Healthy Males in Baltimore, MD. Compensation $3,350\\n\\n\\n\\n         '}, {'verified': False, 'country': 'USA', 'id': '1441024894557376513', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Lead\\n - AL2S3 LTD\\n - United Kingdom, homebased\\nFind Out More! https://t.co/QM95cREStO https://t.co/aJad5khODH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/QM95cREStO'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Lead\\n - AL2S3 LTD\\n - United Kingdom, homebased\\nFind Out More!  https://t.co/aJad5khODH'}, {'verified': False, 'country': 'USA', 'id': '1441024430847627276', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Beautiful integrative study of #crohnsdisease by NYSCF\u2014Robertson Investigator @ordovas_phd combining single-cell RNA-Seq &amp; clinical trial data https://t.co/rSJqkq0ZmE', 'tweet_lang': 'en', 'hashtags': ['crohnsdisease'], 'mentions': ['ordovas_phd'], 'tweet_urls': ['https://t.co/rSJqkq0ZmE'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Beautiful integrative study of  by NYSCF\u2014Robertson Investigator  combining single-cell RNA-Seq &amp; clinical trial data '}, {'verified': False, 'country': 'USA', 'id': '1441023578879655939', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Effect of Low-dose Methotrexate on Estimated Glomerular Filtration Rate and Kidney Adverse Events: A Randomized Clinical Trial https://t.co/MvuqAjPhWO https://t.co/VMq3YDDkdG', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/MvuqAjPhWO'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Effect of Low-dose Methotrexate on Estimated Glomerular Filtration Rate and Kidney Adverse Events: A Randomized Clinical Trial  https://t.co/VMq3YDDkdG'}, {'verified': False, 'country': 'USA', 'id': '1441022728081915905', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#FDA #ODAC to hold another #AdComm to discuss status of confirmatory clinical studies for Accelerated Approval products and whether indications should remain on the market while additional trial(s) are conducted - https://t.co/zWBIRkldcC', 'tweet_lang': 'en', 'hashtags': ['FDA', 'ODAC', 'AdComm'], 'mentions': [], 'tweet_urls': ['https://t.co/zWBIRkldcC'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '  to hold another  to discuss status of confirmatory clinical studies for Accelerated Approval products and whether indications should remain on the market while additional trial(s) are conducted - '}, {'verified': False, 'country': 'USA', 'id': '1441022063263641607', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'good IDO!\\n\u2018World\u2019s First Clinical Trial on Blockchain\u2019\\nThis is my favourite feature of Triall.\\n$TRL, $PROT, #Prostarter, https://t.co/wgHQlJo0x5', 'tweet_lang': 'en', 'hashtags': ['Prostarter'], 'mentions': [], 'tweet_urls': ['https://t.co/wgHQlJo0x5'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'good IDO!\\n\u2018World\u2019s First Clinical Trial on Blockchain\u2019\\nThis is my favourite feature of Triall.\\n$TRL, $PROT, , '}, {'verified': False, 'country': 'USA', 'id': '1441021419526053892', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'With the proliferation of clinical data sources, managing clinical trial data must factor in the type of data, its source, format, and other attributes. Learn more: https://t.co/ZOCXA9N5V4 https://t.co/HceIFdR0H2', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZOCXA9N5V4'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'With the proliferation of clinical data sources, managing clinical trial data must factor in the type of data, its source, format, and other attributes. Learn more:  https://t.co/HceIFdR0H2'}, {'verified': False, 'country': 'USA', 'id': '1441021399297150976', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP Very positive data on Tacrolimus. This will eventually be a billion dollar drug. The valuation of TFF can be justified by this one product, much less the promising pipeline of many other drugs. @TFFPharma \\n\\nhttps://t.co/NQb5s85spZ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['TFFPharma'], 'tweet_urls': ['https://t.co/NQb5s85spZ'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP Very positive data on Tacrolimus. This will eventually be a billion dollar drug. The valuation of TFF can be justified by this one product, much less the promising pipeline of many other drugs.  \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441021318854479878', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Barrington James: Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\nhttps://t.co/6flqj07BfW\\n\\n#USPharmaJobs #USLifeSciences #USClinicalResearch #PharmiwebUS https://t.co/kg962bYbBh', 'tweet_lang': 'en', 'hashtags': ['USPharmaJobs', 'USLifeSciences', 'USClinicalResearch', 'PharmiwebUS'], 'mentions': [], 'tweet_urls': ['https://t.co/6flqj07BfW'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Barrington James: Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n\\n\\n    https://t.co/kg962bYbBh'}, {'verified': False, 'country': 'USA', 'id': '1441021183990931456', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB  \ud83d\ude80\ud83d\ude80\ud83d\ude80\ud83d\ude80\\n\\nSolid Biosciences (SLDB) Present Encouraging 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/hIgladB0HO', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/hIgladB0HO'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB  \ud83d\ude80\ud83d\ude80\ud83d\ude80\ud83d\ude80\\n\\nSolid Biosciences (SLDB) Present Encouraging 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1441020615532683271', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\ud83d\udce2CDDF Webinar on \"How to Analyse Clinical Trial Data Collected during the Pandemic\" will be held today at 6PM (CEST). To join us for the insightful lecture and discussion, register now at https://t.co/H81FxywMsA\\n\\n#CDDFwebinar #oncology #ClinicalTrials #cancerdrug https://t.co/CIVq7f6rDs', 'tweet_lang': 'en', 'hashtags': ['CDDFwebinar', 'oncology', 'ClinicalTrials', 'cancerdrug'], 'mentions': [], 'tweet_urls': ['https://t.co/H81FxywMsA'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\ud83d\udce2CDDF Webinar on \"How to Analyse Clinical Trial Data Collected during the Pandemic\" will be held today at 6PM (CEST). To join us for the insightful lecture and discussion, register now at \\n\\n    https://t.co/CIVq7f6rDs'}, {'verified': False, 'country': 'USA', 'id': '1441018995847671814', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Research at the @umnmedschool has the potential to change entirely the way we think about and treat #opioid use disorder, as told by @KSTP's @CallanGrayNews. https://t.co/PODhn7RObg\", 'tweet_lang': 'en', 'hashtags': ['opioid'], 'mentions': ['umnmedschool', 'KSTP', 'CallanGrayNews'], 'tweet_urls': ['https://t.co/PODhn7RObg'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Research at the  has the potential to change entirely the way we think about and treat  use disorder, as told by 's . \"}, {'verified': False, 'country': 'USA', 'id': '1441018663113428997', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"How many Singaporeans have been killed by the side effects of Comirnaty, the vaccine funded by Singapore government in the government's clinical trial? https://t.co/r8WhyzUVNT\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/r8WhyzUVNT'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"How many Singaporeans have been killed by the side effects of Comirnaty, the vaccine funded by Singapore government in the government's clinical trial? \"}, {'verified': False, 'country': 'USA', 'id': '1441018291967827969', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial S https://t.co/B01bhqqJsI', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/B01bhqqJsI'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial S '}, {'verified': False, 'country': 'USA', 'id': '1441017888916258820', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'SCYNEXIS To Present Data On Oral Ibrexafungerp At IDWeek 2021 From Interim Analyses Of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates In Patents With Mucocutaneous And Invasive Fungal Infections | $SCYX', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'SCYNEXIS To Present Data On Oral Ibrexafungerp At IDWeek 2021 From Interim Analyses Of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates In Patents With Mucocutaneous And Invasive Fungal Infections | $SCYX'}, {'verified': False, 'country': 'USA', 'id': '1441017549274206210', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SCYX Scynexis To Present Data On Oral Ibrexafungerp At Idweek 2021 From Interim Analyses Of Phase 3 Furi Clinical Trial Showing Therapeutic Response Rates In Patients With Mucocutaneous And Invasive Fungal Infections https://t.co/5UH8vi8Sp4', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/5UH8vi8Sp4'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SCYX Scynexis To Present Data On Oral Ibrexafungerp At Idweek 2021 From Interim Analyses Of Phase 3 Furi Clinical Trial Showing Therapeutic Response Rates In Patients With Mucocutaneous And Invasive Fungal Infections '}, {'verified': False, 'country': 'USA', 'id': '1441017546552000514', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SCYX SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SCYX SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections'}, {'verified': False, 'country': 'USA', 'id': '1441017208369471492', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Ulrike Schara-Schmidt and Giovanni Baranello are the moderators for the first #WMS2021 session on Day 4 today ' Clinical trial highlights \u2013 Selected oral presentations 1 (O.1-4)' with Live Q&amp;A.  Join via the Lobby 'Scientific Sessions' at 14:00 BST https://t.co/kJKeH0qsVI https://t.co/nDtgWAjVM2\", 'tweet_lang': 'en', 'hashtags': ['WMS2021'], 'mentions': [], 'tweet_urls': ['https://t.co/kJKeH0qsVI'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Ulrike Schara-Schmidt and Giovanni Baranello are the moderators for the first  session on Day 4 today ' Clinical trial highlights \u2013 Selected oral presentations 1 (O.1-4)' with Live Q&amp;A.  Join via the Lobby 'Scientific Sessions' at 14:00 BST  https://t.co/nDtgWAjVM2\"}, {'verified': False, 'country': 'USA', 'id': '1441017063804391430', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SCYX SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infection\\nhttps://t.co/5trjlYcBqF\\n\\n#clinicaltrial', 'tweet_lang': 'en', 'hashtags': ['clinicaltrial'], 'mentions': [], 'tweet_urls': ['https://t.co/5trjlYcBqF'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SCYX SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infection\\n\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441016999799410694', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'By reusing patient\u2019s clinical trial data, we have the potential to speed up discoveries for diseases like Dementia, Diabetes and Cancer. That\u2019s where Vivli comes in. Learn more https://t.co/dNZ7K4nmdt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/dNZ7K4nmdt'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'By reusing patient\u2019s clinical trial data, we have the potential to speed up discoveries for diseases like Dementia, Diabetes and Cancer. That\u2019s where Vivli comes in. Learn more '}, {'verified': False, 'country': 'USA', 'id': '1441016401225977858', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"It's vital that any medical device organisation putting together a clinical investigation understands the logical steps in the clinical trial process... and where the EDC vendor fits into that. \\nhttps://t.co/soQxyJ28e6 https://t.co/b9nYmhsxjS\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/soQxyJ28e6'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"It's vital that any medical device organisation putting together a clinical investigation understands the logical steps in the clinical trial process... and where the EDC vendor fits into that. \\n https://t.co/b9nYmhsxjS\"}, {'verified': False, 'country': 'USA', 'id': '1441014916144578563', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We are sharing our first preprint from PREDICT; a clinical trial led by our close friends and colleagues from the Kean Lab. Together, we set out to ask how the baseline cell states in Crohn\u2019s disease influence disease severity and treatment outcome https://t.co/xCatxIWpJb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xCatxIWpJb'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We are sharing our first preprint from PREDICT; a clinical trial led by our close friends and colleagues from the Kean Lab. Together, we set out to ask how the baseline cell states in Crohn\u2019s disease influence disease severity and treatment outcome '}, {'verified': False, 'country': 'USA', 'id': '1441013837629693952', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Children, Vol. 8, Pages 835: Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) https://t.co/6yyidjROm0 #science #feedly', 'tweet_lang': 'en', 'hashtags': ['science', 'feedly'], 'mentions': [], 'tweet_urls': ['https://t.co/6yyidjROm0'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Children, Vol. 8, Pages 835: Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)   '}, {'verified': False, 'country': 'USA', 'id': '1441013470875602945', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP News out TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation\\n\\nhttps://t.co/vCJzei2584', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/vCJzei2584'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP News out TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441012741154607115', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin\u2019s Broad-Spectrum Antiviral Properties https://t.co/jgeK4060gx', 'tweet_lang': 'en', 'hashtags': ['OTCQB'], 'mentions': [], 'tweet_urls': ['https://t.co/jgeK4060gx'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$IPIX  Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin\u2019s Broad-Spectrum Antiviral Properties '}, {'verified': False, 'country': 'USA', 'id': '1441012267907174401', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We\u2019re proud to be working with Lanman Neurosurgery in Beverley Hills, led by @todd_lanman and @cuellarspine as part of the Synergy Disc US IDE clinical trial.\\n \\nFor more information on the trial, head to https://t.co/NHwHpYF5Gg\\n \\n#spine #orthopaedic #synergydisc #clinicaltrial https://t.co/ECt34CO05S', 'tweet_lang': 'en', 'hashtags': ['spine', 'orthopaedic', 'synergydisc', 'clinicaltrial'], 'mentions': ['todd_lanman', 'cuellarspine'], 'tweet_urls': ['https://t.co/NHwHpYF5Gg'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We\u2019re proud to be working with Lanman Neurosurgery in Beverley Hills, led by  and  as part of the Synergy Disc US IDE clinical trial.\\n \\nFor more information on the trial, head to \\n \\n    https://t.co/ECt34CO05S'}, {'verified': False, 'country': 'USA', 'id': '1441012209518317570', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$IPIX\\nInnovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties\\nhttps://t.co/UgBOOjpRBX\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/UgBOOjpRBX'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$IPIX\\nInnovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties\\n\"}, {'verified': False, 'country': 'USA', 'id': '1441011920316809216', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Barrington James: Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\nhttps://t.co/J1s43MosB0\\n\\ncompetetive:\\n\\nBarrington James:\\n\\nClinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n\\nUnited States...\\n\\n#USPharmaJo https://t.co/NpD78KUnxd', 'tweet_lang': 'en', 'hashtags': ['USPharmaJo'], 'mentions': [], 'tweet_urls': ['https://t.co/J1s43MosB0'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Barrington James: Clinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n\\n\\ncompetetive:\\n\\nBarrington James:\\n\\nClinical Study Manager (Clinical Trial Manager) (fully remote) small decentralized CRO\\n\\nUnited States...\\n\\n https://t.co/NpD78KUnxd'}, {'verified': False, 'country': 'USA', 'id': '1441011294522515459', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Our CEO, Sarah Howell recently spoke with @proactive_UK to discuss our latest results and current development pipeline, including the recently announced positive headline data from our Phase I clinical trial for AT278. Watch the full interview here: https://t.co/xa7VNDNdkC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['proactive_UK'], 'tweet_urls': ['https://t.co/xa7VNDNdkC'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Our CEO, Sarah Howell recently spoke with  to discuss our latest results and current development pipeline, including the recently announced positive headline data from our Phase I clinical trial for AT278. Watch the full interview here: '}, {'verified': False, 'country': 'USA', 'id': '1441011095951626243', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties $IPIX https://t.co/UClOe9ON5M\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/UClOe9ON5M'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties $IPIX \"}, {'verified': False, 'country': 'USA', 'id': '1441010843567730690', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin\u2019s Broad-Spectrum Antiviral Properties\\n\\n$PFE $JNJ $GILD $AZN $MRNA $INO $VIR $AMGN $GSK $NVAX\\n$NWBO $HGEN\\n\\nhttps://t.co/WJEsYuoSiu', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/WJEsYuoSiu'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin\u2019s Broad-Spectrum Antiviral Properties\\n\\n$PFE $JNJ $GILD $AZN $MRNA $INO $VIR $AMGN $GSK $NVAX\\n$NWBO $HGEN\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441010526155378691', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP Tff Pharmaceuticals Announces Promising Topline Results From Phase 1 Clinical Trial Of Inhaled Tacrolimus Powder And Progression Toward Phase 2 In Lung Transplantation https://t.co/MiLzoFkINP', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/MiLzoFkINP'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP Tff Pharmaceuticals Announces Promising Topline Results From Phase 1 Clinical Trial Of Inhaled Tacrolimus Powder And Progression Toward Phase 2 In Lung Transplantation '}, {'verified': False, 'country': 'USA', 'id': '1441010437127028737', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines https://t.co/I5Y9Xrja2N', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/I5Y9Xrja2N'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines '}, {'verified': False, 'country': 'USA', 'id': '1441010381976080386', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into  https://t.co/1mYuMFSoul', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1mYuMFSoul'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into  '}, {'verified': False, 'country': 'USA', 'id': '1441010358836031489', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB: Solid Biosciences reports 1.5-year data from patients in the ongoing IGNITE DMD Phase I/II clinical trial of... https://t.co/iZHBMNZONW', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/iZHBMNZONW'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB: Solid Biosciences reports 1.5-year data from patients in the ongoing IGNITE DMD Phase I/II clinical trial of... '}, {'verified': False, 'country': 'USA', 'id': '1441010154506530819', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$IPIX Innovation Pharmaceuticals Provides Update on ##covid19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties\\nhttps://t.co/TIX0tIA0ZK\", 'tweet_lang': 'en', 'hashtags': ['covid19'], 'mentions': [], 'tweet_urls': ['https://t.co/TIX0tIA0ZK'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$IPIX Innovation Pharmaceuticals Provides Update on # Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties\\n\"}, {'verified': False, 'country': 'USA', 'id': '1441009960368934912', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties\\nhttps://t.co/XuBUUUQCCR\\n\\n#covid19 #clinicaltrial\", 'tweet_lang': 'en', 'hashtags': ['covid19', 'clinicaltrial'], 'mentions': [], 'tweet_urls': ['https://t.co/XuBUUUQCCR'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin's Broad-Spectrum Antiviral Properties\\n\\n\\n \"}, {'verified': False, 'country': 'USA', 'id': '1441009896523288576', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research ... https://t.co/0MBy7ZOv6T', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/0MBy7ZOv6T'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$IPIX Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research ... '}, {'verified': False, 'country': 'USA', 'id': '1441009515026165761', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$TFFP TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation\\nhttps://t.co/iQXvQ9GLLb\\n\\n#clinicaltrial', 'tweet_lang': 'en', 'hashtags': ['clinicaltrial'], 'mentions': [], 'tweet_urls': ['https://t.co/iQXvQ9GLLb'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$TFFP TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation\\n\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441009450794487812', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The ISN-ACT Global Trials Focus (GTF) team has collected and published a new list of randomized research from nephrologists around the world for September. Each trial is reviewed in context and the risk of bias in seven key areas is assessed \u27a1 https://t.co/ot6lBVtH3g', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ot6lBVtH3g'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The ISN-ACT Global Trials Focus (GTF) team has collected and published a new list of randomized research from nephrologists around the world for September. Each trial is reviewed in context and the risk of bias in seven key areas is assessed \u27a1 '}, {'verified': False, 'country': 'USA', 'id': '1441009450131787778', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A clinical trial by Queen Mary University of London proved that vaping is a more effective approach for dependent smokers in achieving long term smoking reduction &amp; cessation. \\nRead more: https://t.co/91lcm4Pfzv\\n#RightToVape \\n#RightToChoice \\n#RightToBetterHealth https://t.co/ajYwxY32Iv', 'tweet_lang': 'en', 'hashtags': ['RightToVape', 'RightToChoice', 'RightToBetterHealth'], 'mentions': [], 'tweet_urls': ['https://t.co/91lcm4Pfzv'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A clinical trial by Queen Mary University of London proved that vaping is a more effective approach for dependent smokers in achieving long term smoking reduction &amp; cessation. \\nRead more: \\n \\n \\n https://t.co/ajYwxY32Iv'}, {'verified': False, 'country': 'USA', 'id': '1441008833736945672', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This result highlights the growing significance of #AI in healthcare and spotlights many opportunities for its execution in the future of #healthcare. \ud83e\ude7a\ud83c\udfe5\\n\\nhttps://t.co/43wDFcf1p2\\n\\n#Lunit #ESMO #ESMOcongress2021 #oncology #Immunotherapy #pharmascroll #machinelearning #pharma https://t.co/wBvrcU5hF5', 'tweet_lang': 'en', 'hashtags': ['AI', 'healthcare', 'Lunit', 'ESMO', 'ESMOcongress2021', 'oncology', 'Immunotherapy', 'pharmascroll', 'machinelearning', 'pharma'], 'mentions': [], 'tweet_urls': ['https://t.co/43wDFcf1p2'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This result highlights the growing significance of  in healthcare and spotlights many opportunities for its execution in the future of . \ud83e\ude7a\ud83c\udfe5\\n\\n\\n\\n  congress2021      https://t.co/wBvrcU5hF5'}, {'verified': False, 'country': 'USA', 'id': '1441007557200515077', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"\u2018Brain training\u2019 may help treat post-traumatic stress, clinical trial finds\" With Ruth Lanius, MD, PhD, speaker in our \"The Trauma Series\" \\n\\nTrauma Series: https://t.co/EqaxECT5XQ\\n\\nArticle: https://t.co/VzQeX6mSIM https://t.co/DPfOgFbkTN', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/EqaxECT5XQ', 'https://t.co/VzQeX6mSIM'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"\u2018Brain training\u2019 may help treat post-traumatic stress, clinical trial finds\" With Ruth Lanius, MD, PhD, speaker in our \"The Trauma Series\" \\n\\nTrauma Series: \\n\\nArticle:  https://t.co/DPfOgFbkTN'}, {'verified': False, 'country': 'USA', 'id': '1441005823963054087', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/6BU49ogXWU', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6BU49ogXWU'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1441005580982890496', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"\u2018Brain training\u2019 may help treat post-traumatic stress, clinical trial finds;\" With Ruth Lanius, MD, PhD, speaker in our \"The Trauma Series\" \\n\\nFind the webinar: https://t.co/olwxdXSqPz\\n\\nRead the article: https://t.co/GtGaBQYaeP\\n\\n#trauma #ptsd #psychotherapy https://t.co/NIu9XMojQl', 'tweet_lang': 'en', 'hashtags': ['trauma', 'ptsd', 'psychotherapy'], 'mentions': [], 'tweet_urls': ['https://t.co/olwxdXSqPz', 'https://t.co/GtGaBQYaeP'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"\u2018Brain training\u2019 may help treat post-traumatic stress, clinical trial finds;\" With Ruth Lanius, MD, PhD, speaker in our \"The Trauma Series\" \\n\\nFind the webinar: \\n\\nRead the article: \\n\\n   https://t.co/NIu9XMojQl'}, {'verified': False, 'country': 'USA', 'id': '1441005261335011329', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Manager Associate - Late Phase\\n - i-Pharm Consulting\\n - West London, England, London\\nFind Out More! https://t.co/dBGCXN0vg0 https://t.co/5m5Ookhfsn', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/dBGCXN0vg0'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Manager Associate - Late Phase\\n - i-Pharm Consulting\\n - West London, England, London\\nFind Out More!  https://t.co/5m5Ookhfsn'}, {'verified': False, 'country': 'USA', 'id': '1441005103083888640', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Check out our latest paper reporting how we have adapted the Finding My Way online intervention for UK cancer survivors. Our clinical trial is now underway! @UoCPsych @monica__leslie @drleehw @Lisa_Beatty @bogda_koczwara @ProfCoulson @Dr_Laura_Ashley @PeterHall001 https://t.co/lr8WByIBgQ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['UoCPsych', 'monica__leslie', 'drleehw', 'Lisa_Beatty', 'bogda_koczwara', 'ProfCoulson', 'Dr_Laura_Ashley', 'PeterHall001'], 'tweet_urls': ['https://t.co/lr8WByIBgQ'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Check out our latest paper reporting how we have adapted the Finding My Way online intervention for UK cancer survivors. Our clinical trial is now underway!         '}, {'verified': False, 'country': 'USA', 'id': '1441003915223441410', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Learn how a Top 10 sponsor improved compliance, reduced protocol deviations and doubled the rate of randomized participants: https://t.co/xvB15XD1yp #ExperienceTeckro  #clinicaltrials #teckrotheanswer #clinicaltrial #trials #protocol #mhealth #medtech #meded #pharma #ai #biotech https://t.co/Eq3Oii1OEx', 'tweet_lang': 'en', 'hashtags': ['ExperienceTeckro', 'clinicaltrials', 'teckrotheanswer', 'clinicaltrial', 'trials', 'protocol', 'mhealth', 'medtech', 'meded', 'pharma', 'ai', 'biotech'], 'mentions': [], 'tweet_urls': ['https://t.co/xvB15XD1yp'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Learn how a Top 10 sponsor improved compliance, reduced protocol deviations and doubled the rate of randomized participants:               https://t.co/Eq3Oii1OEx'}, {'verified': False, 'country': 'USA', 'id': '1441002907235663877', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Our virtual delegates, speakers and sponsors are getting ready for Day 4 of #WMS2021 - the programme commences at 14:00 BST with Clinical Trial Highlights - Selected Oral Presentations 1 (0.1-4) https://t.co/9FKWdqz09J', 'tweet_lang': 'en', 'hashtags': ['WMS2021'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Our virtual delegates, speakers and sponsors are getting ready for Day 4 of  - the programme commences at 14:00 BST with Clinical Trial Highlights - Selected Oral Presentations 1 (0.1-4) https://t.co/9FKWdqz09J'}, {'verified': False, 'country': 'USA', 'id': '1441002845583691779', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This is the trial I had the most contact with when I arrived at Princess Margaret 2 years ago. Glad for have been in the clinical battlefield while this knowledge was being generated. https://t.co/avT6bqHAHK', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/avT6bqHAHK'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This is the trial I had the most contact with when I arrived at Princess Margaret 2 years ago. Glad for have been in the clinical battlefield while this knowledge was being generated. '}, {'verified': True, 'country': 'USA', 'id': '1441002838537146372', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'What it\u2019s like to be a part of a clinical trial https://t.co/VU7zz7Om8A', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VU7zz7Om8A'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'What it\u2019s like to be a part of a clinical trial '}, {'verified': False, 'country': 'USA', 'id': '1441000934906241030', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Medicine development is a complex process that may take about 10-15 years. It requires technologically sophisticated equipment and the expertise of glorious minds. The process is made up of several stages that go from R&amp;D to clinical trial and then approvals.\\n.\\n.\\n#galpha #pharma https://t.co/YLV37qyAhw', 'tweet_lang': 'en', 'hashtags': ['galpha', 'pharma'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Medicine development is a complex process that may take about 10-15 years. It requires technologically sophisticated equipment and the expertise of glorious minds. The process is made up of several stages that go from R&amp;D to clinical trial and then approvals.\\n.\\n.\\n  https://t.co/YLV37qyAhw'}, {'verified': False, 'country': 'USA', 'id': '1440999369726177282', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#FoxKillsAmerica @FoxNews lets convert that to #FoxSavesAmerica an interview with us to discuss our successful clinical trial can shed light on the reason why vaccines should be optional.  We have proof behind us that we can overcome Covid19 naturally https://t.co/k7JnNxoybI', 'tweet_lang': 'en', 'hashtags': ['FoxKillsAmerica', 'FoxSavesAmerica'], 'mentions': ['FoxNews'], 'tweet_urls': ['https://t.co/k7JnNxoybI'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '  lets convert that to  an interview with us to discuss our successful clinical trial can shed light on the reason why vaccines should be optional.  We have proof behind us that we can overcome Covid19 naturally '}, {'verified': False, 'country': 'USA', 'id': '1440998445226004482', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Veeva Vault CDMS to manage clinical data for trial in detection of infections in complex wounds https://t.co/fDUgpEIdgb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fDUgpEIdgb'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Veeva Vault CDMS to manage clinical data for trial in detection of infections in complex wounds '}, {'verified': False, 'country': 'USA', 'id': '1440995686116380676', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'AL2S3 LTD: Clinical Trial Lead\\nhttps://t.co/ukqbFezjIJ\\n\\n$120,000 - $135,000:\\n\\nAL2S3 LTD:\\n\\nClinical Trial Lead opportunity with an emerging global CRO who specialise in rare disease studies for their small biotech partners. Remote East coast\\n\\nUnited States, East Coast...\\n\\n#USPharm https://t.co/KYGXHDsvY8', 'tweet_lang': 'en', 'hashtags': ['USPharm'], 'mentions': [], 'tweet_urls': ['https://t.co/ukqbFezjIJ'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'AL2S3 LTD: Clinical Trial Lead\\n\\n\\n$120,000 - $135,000:\\n\\nAL2S3 LTD:\\n\\nClinical Trial Lead opportunity with an emerging global CRO who specialise in rare disease studies for their small biotech partners. Remote East coast\\n\\nUnited States, East Coast...\\n\\n https://t.co/KYGXHDsvY8'}, {'verified': False, 'country': 'USA', 'id': '1440994648579846150', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study Scavenger\\nUniversity of Maryland School of Medicine Paid Clinical Trial Study for  Cigarette smoking in smokers with and without schizophrenia in Catonsville,MD. Compensation $350\\n\\nhttps://t.co/rvxSsjPWNW\\n\\n#Studies #ClinicalTrials #Clinicalresearch  #Medicalresearch #phase1', 'tweet_lang': 'en', 'hashtags': ['Studies', 'ClinicalTrials', 'Clinicalresearch', 'Medicalresearch', 'phase1'], 'mentions': [], 'tweet_urls': ['https://t.co/rvxSsjPWNW'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study Scavenger\\nUniversity of Maryland School of Medicine Paid Clinical Trial Study for  Cigarette smoking in smokers with and without schizophrenia in Catonsville,MD. Compensation $350\\n\\n\\n\\n     '}, {'verified': False, 'country': 'USA', 'id': '1440994352835149828', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Taiwan-based vaccine maker #Medigen will conduct a Phase 3 clinical trial for its #COVID19 vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets.\\nhttps://t.co/WLW7Nle2hL', 'tweet_lang': 'en', 'hashtags': ['Medigen', 'COVID19'], 'mentions': [], 'tweet_urls': ['https://t.co/WLW7Nle2hL'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Taiwan-based vaccine maker  will conduct a Phase 3 clinical trial for its  vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets.\\n'}, {'verified': False, 'country': 'USA', 'id': '1440993256960049154', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Remote in Belgium, Clinical Trial manager - Belgium, Antwerp - NonStop Consulting https://t.co/SOtP1GWRQW', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/SOtP1GWRQW'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Remote in Belgium, Clinical Trial manager - Belgium, Antwerp - NonStop Consulting '}, {'verified': False, 'country': 'USA', 'id': '1440992650522501121', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/2mtLcaxQHp', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2mtLcaxQHp'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1440992503692464132', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\ud83d\udce2 Speaking to @HolyroodDaily Dr Tom Russ, Clinical Lead for @NRS_NDN, discusses the #ClinicalResearch supported by the Network across Scotland, the landmark MND-SMART trial with @MNDoddie5 and other partners, #Alzheimers drug Aducanumab, and much more.\\n\\nRead now \ud83d\udc47 https://t.co/8AS9tcDlOs', 'tweet_lang': 'en', 'hashtags': ['ClinicalResearch', 'Alzheimers'], 'mentions': ['HolyroodDaily', 'NRS_NDN', 'MNDoddie5'], 'tweet_urls': ['https://t.co/8AS9tcDlOs'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\ud83d\udce2 Speaking to  Dr Tom Russ, Clinical Lead for , discusses the  supported by the Network across Scotland, the landmark MND-SMART trial with  and other partners,  drug Aducanumab, and much more.\\n\\nRead now \ud83d\udc47 '}, {'verified': False, 'country': 'USA', 'id': '1440992270895955969', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Clinical Trial #Manager - Medical Device needed in #Irvine at #KellyServices. Apply now! #job https://t.co/YzSugjc8OS https://t.co/w8AvkdqFlk', 'tweet_lang': 'en', 'hashtags': ['Clinical', 'Manager', 'Irvine', 'KellyServices', 'job'], 'mentions': [], 'tweet_urls': ['https://t.co/YzSugjc8OS'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' Trial  - Medical Device needed in  at . Apply now!   https://t.co/w8AvkdqFlk'}, {'verified': False, 'country': 'USA', 'id': '1440991347066818561', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Early Intervention to Reduce #Autism Symptoms Shows Promise in Clinical Trial\\nhttps://t.co/pszWmK5C6i', 'tweet_lang': 'en', 'hashtags': ['Autism'], 'mentions': [], 'tweet_urls': ['https://t.co/pszWmK5C6i'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Early Intervention to Reduce  Symptoms Shows Promise in Clinical Trial\\n'}, {'verified': False, 'country': 'USA', 'id': '1440991123900612609', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Startup scaling up clinical trial of #HIV #therapy tested with mice, monkeys https://t.co/PEldsBRk8s', 'tweet_lang': 'en', 'hashtags': ['HIV', 'therapy'], 'mentions': [], 'tweet_urls': ['https://t.co/PEldsBRk8s'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Startup scaling up clinical trial of   tested with mice, monkeys '}, {'verified': False, 'country': 'USA', 'id': '1440990176067534848', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#CGOncology and #Roche to Collaborate on Clinical Trial of #OncolyticImmunotherapy #CG0070 as Part of Novel Combination for Various #SolidTumor Indications https://t.co/8sxbnsYjxR', 'tweet_lang': 'en', 'hashtags': ['CGOncology', 'Roche', 'OncolyticImmunotherapy', 'CG0070', 'SolidTumor'], 'mentions': [], 'tweet_urls': ['https://t.co/8sxbnsYjxR'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' and  to Collaborate on Clinical Trial of   as Part of Novel Combination for Various  Indications '}, {'verified': False, 'country': 'USA', 'id': '1440988598258515970', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Here are the clinical trial end dates for the experiment your the carbon they want rid \\n\\n\u25aaPfizer mRNA BNT162b1: 31 Jan. 2023\\nhttps://t.co/DVZGtBBj3B \\n\\n\u25aaModerna mRNA-1273: 27 Oct. 2022\\nhttps://t.co/t92wDHdRlQ \\n\\n\u25aaOxford AstraZeneca AZD1222: 14 Feb. 2023\\nhttps://t.co/TVs8Uyk17P', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/DVZGtBBj3B', 'https://t.co/t92wDHdRlQ', 'https://t.co/TVs8Uyk17P'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Here are the clinical trial end dates for the experiment your the carbon they want rid \\n\\n\u25aaPfizer mRNA BNT162b1: 31 Jan. 2023\\n \\n\\n\u25aaModerna mRNA-1273: 27 Oct. 2022\\n \\n\\n\u25aaOxford AstraZeneca AZD1222: 14 Feb. 2023\\n'}, {'verified': False, 'country': 'USA', 'id': '1440988031654273025', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Manager\\n - i-Pharm Consulting\\n - England, West London, London\\nFind Out More! https://t.co/in24hNN8LW https://t.co/9I4d6NITow', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/in24hNN8LW'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Manager\\n - i-Pharm Consulting\\n - England, West London, London\\nFind Out More!  https://t.co/9I4d6NITow'}, {'verified': False, 'country': 'USA', 'id': '1440987845909430277', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'STUDY:  Remdesivir (DisCoVeRy trial)\\n\\nDoes Remdesivir treatment significantly affect mortality, clinical outcomes, or time to improvement in patients hospitalised with severe COVID-19?\\n\\nSummary:  No, it does not.\\n\\nA short \ud83e\uddf5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'STUDY:  Remdesivir (DisCoVeRy trial)\\n\\nDoes Remdesivir treatment significantly affect mortality, clinical outcomes, or time to improvement in patients hospitalised with severe COVID-19?\\n\\nSummary:  No, it does not.\\n\\nA short \ud83e\uddf5'}, {'verified': False, 'country': 'USA', 'id': '1440986937746018309', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A new non vaccine treatment has been approved by the TGA (based on just one clinical trial). Sobrovimad mono-clonal. It has  the same measured effectiveness as Ivermectin.\\nBut Ivermectin had 63 clinical trials.\\nThey will probably force you to have $$vaccines to have access to it. https://t.co/T0F15CDkuV', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A new non vaccine treatment has been approved by the TGA (based on just one clinical trial). Sobrovimad mono-clonal. It has  the same measured effectiveness as Ivermectin.\\nBut Ivermectin had 63 clinical trials.\\nThey will probably force you to have $$vaccines to have access to it. https://t.co/T0F15CDkuV'}, {'verified': False, 'country': 'USA', 'id': '1440986840157282307', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Thank you to Platinum Sponsor @thermosci for hosting the Technical Sessions -  the first one ' Adaptive Design &amp; Alternative Flexibility Levers for Clinical Trial Supply Chain Optimisation' presented by Helen Underwood\\n#bioforward #lifesciences  #innovation #networking #startups https://t.co/FlNiSL3nwe\", 'tweet_lang': 'en', 'hashtags': ['bioforward', 'lifesciences', 'innovation', 'networking', 'startups'], 'mentions': ['thermosci'], 'tweet_urls': [], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Thank you to Platinum Sponsor  for hosting the Technical Sessions -  the first one ' Adaptive Design &amp; Alternative Flexibility Levers for Clinical Trial Supply Chain Optimisation' presented by Helen Underwood\\n      https://t.co/FlNiSL3nwe\"}, {'verified': False, 'country': 'USA', 'id': '1440986838693523458', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial\\n\\nhttps://t.co/1eisfeutmb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1eisfeutmb'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440986000600174593', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial\\nhttps://t.co/lIVojEQemv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lIVojEQemv'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial\\n'}, {'verified': False, 'country': 'USA', 'id': '1440985731531513859', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB\\nSolid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB\\nSolid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001'}, {'verified': False, 'country': 'USA', 'id': '1440985711444852744', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A new non vaccine treatment has been approved by the TGA (based on just one clinical trial). Sobrovimad mono-clonal. It has  the same measured effectiveness as Ivermectin.\\nBut Ivermectin had 63 clinical trials.\\nThey will probably force you to have $$vaccines to have access to it.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A new non vaccine treatment has been approved by the TGA (based on just one clinical trial). Sobrovimad mono-clonal. It has  the same measured effectiveness as Ivermectin.\\nBut Ivermectin had 63 clinical trials.\\nThey will probably force you to have $$vaccines to have access to it.'}, {'verified': False, 'country': 'USA', 'id': '1440985310058323968', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/U1DckHDd1E #StockMarket', 'tweet_lang': 'en', 'hashtags': ['StockMarket'], 'mentions': [], 'tweet_urls': ['https://t.co/U1DckHDd1E'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001  '}, {'verified': True, 'country': 'USA', 'id': '1440985016583008258', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New clinical trial buoys hope for treating rare brain cancer in children https://t.co/K4yCi8Mrc8', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/K4yCi8Mrc8'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New clinical trial buoys hope for treating rare brain cancer in children '}, {'verified': False, 'country': 'USA', 'id': '1440984680216420353', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/Rz2m9hyqjm #StockMarket', 'tweet_lang': 'en', 'hashtags': ['StockMarket'], 'mentions': [], 'tweet_urls': ['https://t.co/Rz2m9hyqjm'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001  '}, {'verified': False, 'country': 'USA', 'id': '1440984342923206660', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'At first glance and to be fair from a long, the $SLDB data doesn\u2019t look great, it\u2019s ok.  It is great there are no safety concerns, which sort of was a given after all the clinical holds and changes to trial design, but the data itself is just ok.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'At first glance and to be fair from a long, the $SLDB data doesn\u2019t look great, it\u2019s ok.  It is great there are no safety concerns, which sort of was a given after all the clinical holds and changes to trial design, but the data itself is just ok.'}, {'verified': False, 'country': 'USA', 'id': '1440982969011908608', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Clinical trial shows planned breaks in #cancer treatment to be beneficial in cases of advanced #kidney cancer\\n\\n@NIHRresearch \\n\\nhttps://t.co/nJ4S7I5UR5 https://t.co/j6Adra8hNc', 'tweet_lang': 'en', 'hashtags': ['Clinical', 'cancer', 'kidney'], 'mentions': ['NIHRresearch'], 'tweet_urls': ['https://t.co/nJ4S7I5UR5'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' trial shows planned breaks in  treatment to be beneficial in cases of advanced  cancer\\n\\n \\n\\n https://t.co/j6Adra8hNc'}, {'verified': False, 'country': 'USA', 'id': '1440982632142098432', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dr. Vamshi Rao will present IGNITE DMD data, Sept. 23, 9 a.m. ET, at the @WorldMuscleSoc 2021 Virtual Congress. To read more about the data, visit: https://t.co/G7f1UXFCdo  \\n#TogetherWeAreSolid', 'tweet_lang': 'en', 'hashtags': ['TogetherWeAreSolid'], 'mentions': ['WorldMuscleSoc'], 'tweet_urls': ['https://t.co/G7f1UXFCdo'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dr. Vamshi Rao will present IGNITE DMD data, Sept. 23, 9 a.m. ET, at the  2021 Virtual Congress. To read more about the data, visit:   \\n'}, {'verified': False, 'country': 'USA', 'id': '1440982041114263556', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China https://t.co/e35MlTwREv https://t.co/hl050lFiHP', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/e35MlTwREv'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China  https://t.co/hl050lFiHP'}, {'verified': False, 'country': 'USA', 'id': '1440981338031464457', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports ++ 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n\\nNSAA 6MWT &amp; FVC all stable - vs historic control\\n\\n1.5 year safety - no new AE https://t.co/VksJ7sZqzz', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports ++ 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n\\nNSAA 6MWT &amp; FVC all stable - vs historic control\\n\\n1.5 year safety - no new AE https://t.co/VksJ7sZqzz'}, {'verified': False, 'country': 'USA', 'id': '1440981261326159875', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '74% of respondents found decentralised trials to be better for patient retention, a CTM study has found. \\n\\nWe work with you to enable home visits, to make your trial accessible to a more diverse population of patients. Read the rest of the study here: https://t.co/kX9zdBGKcA', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/kX9zdBGKcA'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '74% of respondents found decentralised trials to be better for patient retention, a CTM study has found. \\n\\nWe work with you to enable home visits, to make your trial accessible to a more diverse population of patients. Read the rest of the study here: '}, {'verified': False, 'country': 'USA', 'id': '1440980852528205825', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Stock_market_news NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China https://t.co/ViVMMt9sWu https://t.co/HhkKr6EmNW https://t.co/InEYqzKZja', 'tweet_lang': 'en', 'hashtags': ['Stock_market_news'], 'mentions': [], 'tweet_urls': ['https://t.co/ViVMMt9sWu', 'https://t.co/HhkKr6EmNW'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China   https://t.co/InEYqzKZja'}, {'verified': False, 'country': 'USA', 'id': '1440980803157061635', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China https://t.co/JhLV3p4mzx https://t.co/Aa8zytLnHQ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JhLV3p4mzx'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'NeuroVasc Announces First Patient Enrolled in ENVI\u2122-SR Mechanical Thrombectomy System Clinical Trial in China  https://t.co/Aa8zytLnHQ'}, {'verified': False, 'country': 'USA', 'id': '1440980575280672769', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/ecuz0n2akg', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ecuz0n2akg'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1440980537326194695', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/0sbbcwcT7K', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/0sbbcwcT7K'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1440980458087620611', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 $SLDB https://t.co/wdhH09lzLy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/wdhH09lzLy'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 $SLDB '}, {'verified': False, 'country': 'USA', 'id': '1440980414856790020', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n@MohanaBasu reports\\n\\n#ThePrintTracksCovid\\n\\nhttps://t.co/yoSABdmJ5J', 'tweet_lang': 'en', 'hashtags': ['ThePrintTracksCovid'], 'mentions': ['MohanaBasu'], 'tweet_urls': ['https://t.co/yoSABdmJ5J'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n reports\\n\\n\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440980057468678147', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB NEW ARTICLE : Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/l9e6IecXve Get all the latest $SLDB related news here : https://t.co/KgTAmdMfqw https://t.co/L0BcmLyP5a', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/l9e6IecXve', 'https://t.co/KgTAmdMfqw'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB NEW ARTICLE : Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001  Get all the latest $SLDB related news here :  https://t.co/L0BcmLyP5a'}, {'verified': False, 'country': 'USA', 'id': '1440979997896892419', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Read how trial execution is being accelerated by #CROs adopting agile study design and #AI. \\nhttps://t.co/MG6rWHY1dk', 'tweet_lang': 'en', 'hashtags': ['CROs', 'AI'], 'mentions': [], 'tweet_urls': ['https://t.co/MG6rWHY1dk'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Read how trial execution is being accelerated by  adopting agile study design and . \\n'}, {'verified': False, 'country': 'USA', 'id': '1440979821815812097', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB [15s. delayed]: Issued Press Release on September 23, 06:00:00: Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 https://t.co/8Qioiuy1Ej', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/8Qioiuy1Ej'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB [15s. delayed]: Issued Press Release on September 23, 06:00:00: Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 '}, {'verified': False, 'country': 'USA', 'id': '1440979817902616580', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n\\nhttps://t.co/5zIKdpuodf $SRPT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/5zIKdpuodf'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n\\n $SRPT'}, {'verified': False, 'country': 'USA', 'id': '1440979801796489216', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"I'm excited to share that @LabcorpDrugDev selected @Medidata\u2019s Sensor Cloud to expand decentralized #clinicaltrial capabilities, enabling a first-in-kind industry partnership for digital #biomarker discovery. Learn more: https://t.co/Sx0MvxKsq7 https://t.co/PWySU6U6H2\", 'tweet_lang': 'en', 'hashtags': ['clinicaltrial', 'biomarker'], 'mentions': ['LabcorpDrugDev', 'Medidata'], 'tweet_urls': ['https://t.co/Sx0MvxKsq7'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"I'm excited to share that  selected \u2019s Sensor Cloud to expand decentralized  capabilities, enabling a first-in-kind industry partnership for digital  discovery. Learn more:  https://t.co/PWySU6U6H2\"}, {'verified': False, 'country': 'USA', 'id': '1440979798000558080', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data From Patients In The Ongoing Ignite Dmd Phase I/Ii Clinical Trial Of Sgt-001 https://t.co/nncp6N3V6N', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/nncp6N3V6N'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data From Patients In The Ongoing Ignite Dmd Phase I/Ii Clinical Trial Of Sgt-001 '}, {'verified': False, 'country': 'USA', 'id': '1440979505401798659', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$QH Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\nhttps://t.co/7bGJQ6yE8r', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/7bGJQ6yE8r'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$QH Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n'}, {'verified': False, 'country': 'USA', 'id': '1440979505397501954', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\nhttps://t.co/Qi2m733Ao3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Qi2m733Ao3'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n'}, {'verified': False, 'country': 'USA', 'id': '1440979505389178881', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$HPK Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\nhttps://t.co/xdeUtrrcjb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xdeUtrrcjb'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$HPK Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n'}, {'verified': False, 'country': 'USA', 'id': '1440979313558446080', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\nhttps://t.co/p4aobEfjgl\\n\\n#clinicaltrial #clinicaltrial', 'tweet_lang': 'en', 'hashtags': ['clinicaltrial', 'clinicaltrial'], 'mentions': [], 'tweet_urls': ['https://t.co/p4aobEfjgl'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$SLDB Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001\\n\\n\\n '}, {'verified': False, 'country': 'USA', 'id': '1440979286828146689', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Ross Jackson, VP #Patient #Recruitment Services, discusses 'Clinical Trial Patient Recruitment Targeting in Facebook Advertising\u2019 in his article published in the Journal Of Clinical Research Best Practices. Click here to read all about it! https://t.co/K9tgVYxIU3 #MedComms\", 'tweet_lang': 'en', 'hashtags': ['Patient', 'Recruitment', 'MedComms'], 'mentions': [], 'tweet_urls': ['https://t.co/K9tgVYxIU3'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Ross Jackson, VP   Services, discusses 'Clinical Trial Patient Recruitment Targeting in Facebook Advertising\u2019 in his article published in the Journal Of Clinical Research Best Practices. Click here to read all about it!  \"}, {'verified': False, 'country': 'USA', 'id': '1440979259195936771', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'ICYMI: \"Bod Australia enters an agreement with the Woolcock Institute to undertake a phase IIb clinical trial for the development of a new cannabidiol product\" (@themarketherald)\\n\\nFull story: https://t.co/EK4AiTdCAl #CBD #cannabis #ausbiz $BDA #ASX', 'tweet_lang': 'en', 'hashtags': ['CBD', 'cannabis', 'ausbiz', 'ASX'], 'mentions': ['themarketherald'], 'tweet_urls': ['https://t.co/EK4AiTdCAl'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'ICYMI: \"Bod Australia enters an agreement with the Woolcock Institute to undertake a phase IIb clinical trial for the development of a new cannabidiol product\" ()\\n\\nFull story:     $BDA '}, {'verified': False, 'country': 'USA', 'id': '1440976755217604612', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$AREC Arecor Therapeutics: Rapid insulin promise in early-stage clinical trial and cash for pipeline https://t.co/basSA8Er3s @arecor_ltd #AREC #Katie_Proactive', 'tweet_lang': 'en', 'hashtags': ['AREC', 'Katie_Proactive'], 'mentions': ['arecor_ltd'], 'tweet_urls': ['https://t.co/basSA8Er3s'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$AREC Arecor Therapeutics: Rapid insulin promise in early-stage clinical trial and cash for pipeline    '}, {'verified': False, 'country': 'USA', 'id': '1440976586744893447', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Adults using ketamine without a doctor\u2019s oversight may qualify for a clinical trial. Earn up to $15,500 for study-related time &amp; travel. \\n\\nhttps://t.co/FCckVcphrp\\n\\n#studyscavenger #healthyvolunteers #earnmoney #KitKatdrug #Ketamine #Arkansas #VenmoItForward #mha327 #thursdayvibes https://t.co/k36uwaSsuB', 'tweet_lang': 'en', 'hashtags': ['studyscavenger', 'healthyvolunteers', 'earnmoney', 'KitKatdrug', 'Ketamine', 'Arkansas', 'VenmoItForward', 'mha327', 'thursdayvibes'], 'mentions': [], 'tweet_urls': ['https://t.co/FCckVcphrp'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Adults using ketamine without a doctor\u2019s oversight may qualify for a clinical trial. Earn up to $15,500 for study-related time &amp; travel. \\n\\n\\n\\n         https://t.co/k36uwaSsuB'}, {'verified': False, 'country': 'USA', 'id': '1440975676207734786', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"HealthVerity partners with J&amp;J's Janssen to provide real-world data for clinical trial, R&amp;D work | FierceBiotech https://t.co/4iUZq0gMNk\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/4iUZq0gMNk'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"HealthVerity partners with J&amp;J's Janssen to provide real-world data for clinical trial, R&amp;D work | FierceBiotech \"}, {'verified': True, 'country': 'USA', 'id': '1440974628088811529', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n@MohanaBasu reports\\n\\n#ThePrintTracksCovid\\n\\nhttps://t.co/md8EnabDpK', 'tweet_lang': 'en', 'hashtags': ['ThePrintTracksCovid'], 'mentions': ['MohanaBasu'], 'tweet_urls': ['https://t.co/md8EnabDpK'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n reports\\n\\n\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440974466872446978', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'While clinical studies continue to evolve with greater complexity\\n\u2013 CDISC standards evolve across multiple disease areas over the next 5 years\\n\u2013 Given FDA guidance, sponsors must submit trial data that conforms to\\nthese standards\\n\u2013 Controlled terminology is released every quarter', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'While clinical studies continue to evolve with greater complexity\\n\u2013 CDISC standards evolve across multiple disease areas over the next 5 years\\n\u2013 Given FDA guidance, sponsors must submit trial data that conforms to\\nthese standards\\n\u2013 Controlled terminology is released every quarter'}, {'verified': False, 'country': 'USA', 'id': '1440973828516106240', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Senior Clinical Trial Manager - Home based / office based\\n - DOCS Global\\n - Belgium\\nFind Out More! https://t.co/iGtsdqIIet https://t.co/o86pe6jhbb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/iGtsdqIIet'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Senior Clinical Trial Manager - Home based / office based\\n - DOCS Global\\n - Belgium\\nFind Out More!  https://t.co/o86pe6jhbb'}, {'verified': False, 'country': 'USA', 'id': '1440972643285409795', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"We're hiring! Click to apply: Clinical Trial Manager (CTL) - https://t.co/UKBxa8DuBr #clinical #Newark, NJ\", 'tweet_lang': 'en', 'hashtags': ['clinical', 'Newark'], 'mentions': [], 'tweet_urls': ['https://t.co/UKBxa8DuBr'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': {'type': 'Point', 'coordinates': [40.74, -74.17]}, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"We're hiring! Click to apply: Clinical Trial Manager (CTL) -   , NJ\"}, {'verified': False, 'country': 'USA', 'id': '1440972205597335554', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Assistant MAO (Global CTA) Office based Madrid\\n - DOCS Global\\n - Spain\\nFind Out More! https://t.co/Ad9i8tbd9L https://t.co/jlMt6YCZw4', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Ad9i8tbd9L'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Assistant MAO (Global CTA) Office based Madrid\\n - DOCS Global\\n - Spain\\nFind Out More!  https://t.co/jlMt6YCZw4'}, {'verified': False, 'country': 'USA', 'id': '1440971461007716356', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'U of M leads groundbreaking clinical trial of opioid vaccine | https://t.co/vLRuCYYbI7. So how does this work? This is so far off of what needs to happen.  https://t.co/zmw9VgAHsi', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/vLRuCYYbI7', 'https://t.co/zmw9VgAHsi'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'U of M leads groundbreaking clinical trial of opioid vaccine | . So how does this work? This is so far off of what needs to happen.  '}, {'verified': False, 'country': 'USA', 'id': '1440970201726586880', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Now Hiring: Clinical Trial Manager - IVD Devices | Kelly Science &amp; Clinical: San Jose, California | https://t.co/eXrHWdZtux #jobs', 'tweet_lang': 'en', 'hashtags': ['jobs'], 'mentions': [], 'tweet_urls': ['https://t.co/eXrHWdZtux'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Now Hiring: Clinical Trial Manager - IVD Devices | Kelly Science &amp; Clinical: San Jose, California |  '}, {'verified': False, 'country': 'USA', 'id': '1440969197891334148', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Increasingly savvy patients continue to push for a total shift in clinical trial approaches https://t.co/wEYs8P4lIX', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/wEYs8P4lIX'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Increasingly savvy patients continue to push for a total shift in clinical trial approaches '}, {'verified': False, 'country': 'USA', 'id': '1440968572696731648', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Hyv\u00e4 uutinen,jos lasten rokotusohjelmassa jo saama rokote ehk\u00e4isee heill\u00e4 my\u00f6s vaikeaa Koronamuotoa!\\nEFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL https://t.co/Fc0xIfHE6q', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Fc0xIfHE6q'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Hyv\u00e4 uutinen,jos lasten rokotusohjelmassa jo saama rokote ehk\u00e4isee heill\u00e4 my\u00f6s vaikeaa Koronamuotoa!\\nEFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL '}, {'verified': False, 'country': 'USA', 'id': '1440968463447691265', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Pixium Vision announces the successful first #implantation of a patient in Germany in the #PRIMAvera pivotal trial.\\nhttps://t.co/Nebp8WHpxN\\n#PRIMAvera #implant  #bionic #eye #pivotal #study #pivotalstudy #clinical #Germany #Bonn #Sulzbach #Hamburg #Munich #Ludwigshafen #Tuebingen', 'tweet_lang': 'en', 'hashtags': ['implantation', 'PRIMAvera', 'PRIMAvera', 'implant', 'bionic', 'eye', 'pivotal', 'study', 'pivotalstudy', 'clinical', 'Germany', 'Bonn', 'Sulzbach', 'Hamburg', 'Munich', 'Ludwigshafen', 'Tuebingen'], 'mentions': [], 'tweet_urls': ['https://t.co/Nebp8WHpxN'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Pixium Vision announces the successful first  of a patient in Germany in the  pivotal trial.\\n\\n       study        '}, {'verified': False, 'country': 'USA', 'id': '1440968138556903427', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"\ud83d\udc4f Impressive news on @pHOXBIO's clinical trial results on a prophylactic nasal spray preventing SARS-Cov-2 infection. Congratulations to the team under Rakesh Uppal, Professor of Cardiovascular Surgery at @QMUL and Director of @ls_barts https://t.co/6MBVg4qFHp\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['pHOXBIO', 'QMUL', 'ls_barts'], 'tweet_urls': ['https://t.co/6MBVg4qFHp'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"\ud83d\udc4f Impressive news on 's clinical trial results on a prophylactic nasal spray preventing SARS-Cov-2 infection. Congratulations to the team under Rakesh Uppal, Professor of Cardiovascular Surgery at  and Director of  \"}, {'verified': False, 'country': 'USA', 'id': '1440966525763170305', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dzi\u0119kuj\u0119 Dr @m_krzyzynski za wnikliw\u0105 analiz\u0119 cytowanej przeze mnie publikacji: https://t.co/seS4QtmJwj \\nZwolennik\u00f3w, sceptyk\u00f3w czy przeciwnik\u00f3w \ud83d\udc89 p-ko C19 zach\u0119cam do zapoznania si\u0119 z tym w\u0105tkiem. Odnios\u0119 si\u0119 do postawionych zarzut\u00f3w i sygnalizuje problem zw z bezpiecz \ud83d\udc89\\n1/ https://t.co/Zo9dijWTn3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['m_krzyzynski'], 'tweet_urls': ['https://t.co/seS4QtmJwj', 'https://t.co/Zo9dijWTn3'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dzi\u0119kuj\u0119 Dr  za wnikliw\u0105 analiz\u0119 cytowanej przeze mnie publikacji:  \\nZwolennik\u00f3w, sceptyk\u00f3w czy przeciwnik\u00f3w \ud83d\udc89 p-ko C19 zach\u0119cam do zapoznania si\u0119 z tym w\u0105tkiem. Odnios\u0119 si\u0119 do postawionych zarzut\u00f3w i sygnalizuje problem zw z bezpiecz \ud83d\udc89\\n1/ '}, {'verified': True, 'country': 'USA', 'id': '1440966172871168001', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Having more clinical trial participants from a community where a particular disease is prevalent is 1 of 5 transformative strategies that can help #biopharmaceuticals improve drug development processes. \ud83d\udc8a @Deloitte shares more: https://t.co/HG80q0C5so https://t.co/Zl8gfEbUmM', 'tweet_lang': 'en', 'hashtags': ['biopharmaceuticals'], 'mentions': ['Deloitte'], 'tweet_urls': ['https://t.co/HG80q0C5so'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Having more clinical trial participants from a community where a particular disease is prevalent is 1 of 5 transformative strategies that can help  improve drug development processes. \ud83d\udc8a  shares more:  https://t.co/Zl8gfEbUmM'}, {'verified': False, 'country': 'USA', 'id': '1440965993153581056', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'CLINICAL TRIAL REPORT Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study https://t.co/RicDQGmLdW', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RicDQGmLdW'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'CLINICAL TRIAL REPORT Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study '}, {'verified': False, 'country': 'USA', 'id': '1440965322924830722', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Looking for a secure way to manage clinical trial information?\\n\\n#Rgrid #NewEra #ClinicalTrials #cyber #cyberseciurity #dataprotection #access #information #seciurity https://t.co/lIYnQcou6m', 'tweet_lang': 'en', 'hashtags': ['Rgrid', 'NewEra', 'ClinicalTrials', 'cyber', 'cyberseciurity', 'dataprotection', 'access', 'information', 'seciurity'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Looking for a secure way to manage clinical trial information?\\n\\n    seciurity     https://t.co/lIYnQcou6m'}, {'verified': False, 'country': 'USA', 'id': '1440965035279405057', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Scioccante l'86% dei bambini ha subito una reazione avversa al vaccino Covid di Pfizer nella sperimentazione clinica - The Expose https://t.co/NrGnKTuYzH\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NrGnKTuYzH'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Scioccante l'86% dei bambini ha subito una reazione avversa al vaccino Covid di Pfizer nella sperimentazione clinica - The Expose \"}, {'verified': False, 'country': 'USA', 'id': '1440964537289777152', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Strong progress on clinical trial reporting by German universities, with 131 additional results uploaded this summer alone\\n\\n-&gt; some have uploaded nearly all missing results \\n\\n-&gt; kudos @UniLeipzig &amp; @TU_Muenchen &amp; @UniCologne &amp; @ChariteBerlin \\n\\nhttps://t.co/D9n3azITuy @bfarm_de https://t.co/cWwf1NvXuY', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['UniLeipzig', 'TU_Muenchen', 'UniCologne', 'ChariteBerlin', 'bfarm_de'], 'tweet_urls': ['https://t.co/D9n3azITuy'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Strong progress on clinical trial reporting by German universities, with 131 additional results uploaded this summer alone\\n\\n-&gt; some have uploaded nearly all missing results \\n\\n-&gt; kudos  &amp;  &amp;  &amp;  \\n\\n  https://t.co/cWwf1NvXuY'}, {'verified': False, 'country': 'USA', 'id': '1440964363284852737', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study Scavenger Clinical Trial Platform\\nLabcorp Madison Paid Clinical Study for healthy women for research trial 8468-429 in Madison, WI. Compensation $10,608\\n\\nhttps://t.co/u6SIWMshPH\\n\\n#Healthy #Volunteers #Studies #ClinicalTrials #Clinicalresearch  #Medicalresearch #phase1', 'tweet_lang': 'en', 'hashtags': ['Healthy', 'Volunteers', 'Studies', 'ClinicalTrials', 'Clinicalresearch', 'Medicalresearch', 'phase1'], 'mentions': [], 'tweet_urls': ['https://t.co/u6SIWMshPH'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study Scavenger Clinical Trial Platform\\nLabcorp Madison Paid Clinical Study for healthy women for research trial 8468-429 in Madison, WI. Compensation $10,608\\n\\n\\n\\n       '}, {'verified': True, 'country': 'USA', 'id': '1440964216966496257', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'As it pushes oral #Covid #vaccine into mid-stage clinical trial, $VXRT inks new lease, re-ups subleased space  https://t.co/uIHFNEPp5N', 'tweet_lang': 'en', 'hashtags': ['Covid', 'vaccine'], 'mentions': [], 'tweet_urls': ['https://t.co/uIHFNEPp5N'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'As it pushes oral   into mid-stage clinical trial, $VXRT inks new lease, re-ups subleased space  '}, {'verified': False, 'country': 'USA', 'id': '1440964156589477890', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u2705JMP Clinical\u30ae\u30e3\u30e9\u30ea\u30fc: \u6709\u5bb3\u4e8b\u8c61\u30c4\u30ea\u30fc\u30de\u30c3\u30d7\\n\u85ac\u7269\u306e\u6709\u5bb3\u4e8b\u8c61\u3092\u8272\u3068\u30b5\u30a4\u30ba\u306e\u9055\u3044\u3067\u304f\u3063\u304d\u308a\u793a\u305b\u308b\u30c4\u30ea\u30fc\u30de\u30c3\u30d7\u3002JMP Clinical\u3067\u4f5c\u6210\u53ef\u80fd\u3067\u3059\u3002\\n\\n\ud83d\udca1\u6700\u65b0JMP 16\u308230\u65e5\u9593\u7121\u6599\uff01\u30c8\u30e9\u30a4\u30a2\u30eb\u7248\u306f\u30b3\u30c1\u30e9\u2192https://t.co/OsUROEQpRh\\n\\n#JMP #SAS #\u7d71\u8a08\u30bd\u30d5\u30c8 #\u30c7\u30fc\u30bf\u5206\u6790 #\u30c7\u30fc\u30bf\u30b5\u30a4\u30a8\u30f3\u30b9 https://t.co/PAPhgQVind', 'tweet_lang': 'en', 'hashtags': ['JMP', 'SAS', '\u7d71\u8a08\u30bd\u30d5\u30c8', '\u30c7\u30fc\u30bf\u5206\u6790', '\u30c7\u30fc\u30bf\u30b5\u30a4\u30a8\u30f3\u30b9'], 'mentions': [], 'tweet_urls': ['https://t.co/OsUROEQpRh'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u2705JMP Clinical\u30ae\u30e3\u30e9\u30ea\u30fc: \u6709\u5bb3\u4e8b\u8c61\u30c4\u30ea\u30fc\u30de\u30c3\u30d7\\n\u85ac\u7269\u306e\u6709\u5bb3\u4e8b\u8c61\u3092\u8272\u3068\u30b5\u30a4\u30ba\u306e\u9055\u3044\u3067\u304f\u3063\u304d\u308a\u793a\u305b\u308b\u30c4\u30ea\u30fc\u30de\u30c3\u30d7\u3002JMP Clinical\u3067\u4f5c\u6210\u53ef\u80fd\u3067\u3059\u3002\\n\\n\ud83d\udca1\u6700\u65b0JMP 16\u308230\u65e5\u9593\u7121\u6599\uff01\u30c8\u30e9\u30a4\u30a2\u30eb\u7248\u306f\u30b3\u30c1\u30e9\u2192\\n\\n     https://t.co/PAPhgQVind'}, {'verified': False, 'country': 'USA', 'id': '1440963054901075970', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Senior Clinical Trial Manager - Home based / office based - Belgium - DOCS Global https://t.co/1Kd9wyEhIM', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1Kd9wyEhIM'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Senior Clinical Trial Manager - Home based / office based - Belgium - DOCS Global '}, {'verified': False, 'country': 'USA', 'id': '1440962559989977088', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Sr. Clinical Trial Manager *** EMEA *** Single Sponsor\\n - DOCS Global\\n - France\\nFind Out More! https://t.co/EDDvZ6M5Un https://t.co/jafyfTQWFc', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/EDDvZ6M5Un'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Sr. Clinical Trial Manager *** EMEA *** Single Sponsor\\n - DOCS Global\\n - France\\nFind Out More!  https://t.co/jafyfTQWFc'}, {'verified': False, 'country': 'USA', 'id': '1440962479773847554', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Sr. Global Clinical Trial Assistant/ Warsaw\\n - DOCS Global\\n - Poland\\nFind Out More! https://t.co/cf7x5nbxns https://t.co/L2iWO1EphB', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/cf7x5nbxns'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Sr. Global Clinical Trial Assistant/ Warsaw\\n - DOCS Global\\n - Poland\\nFind Out More!  https://t.co/L2iWO1EphB'}, {'verified': False, 'country': 'USA', 'id': '1440962304133189633', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Senior Global Clinical Trial Manager/ Home-based/ UK\\n - DOCS Global\\n - United Kingdom\\nFind Out More! https://t.co/5wNVTkyQaM https://t.co/r8iOKcT2oS', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/5wNVTkyQaM'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Senior Global Clinical Trial Manager/ Home-based/ UK\\n - DOCS Global\\n - United Kingdom\\nFind Out More!  https://t.co/r8iOKcT2oS'}, {'verified': False, 'country': 'USA', 'id': '1440962185849720833', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Senior Global Clinical Trial Manager *** COUNTRY*** Home based / office based\\n - DOCS Global\\n - Poland\\nFind Out More! https://t.co/NMlBzNCi1R https://t.co/EWEMDagS7F', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NMlBzNCi1R'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Senior Global Clinical Trial Manager *** COUNTRY*** Home based / office based\\n - DOCS Global\\n - Poland\\nFind Out More!  https://t.co/EWEMDagS7F'}, {'verified': False, 'country': 'USA', 'id': '1440961906563485699', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Taiwan vaccine maker Medigen plans to conduct Phase 3 clinical trial in Europe:\\nhttps://t.co/7byqe9jMQm', 'tweet_lang': 'en', 'hashtags': ['Taiwan'], 'mentions': [], 'tweet_urls': ['https://t.co/7byqe9jMQm'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' vaccine maker Medigen plans to conduct Phase 3 clinical trial in Europe:\\n'}, {'verified': False, 'country': 'USA', 'id': '1440961464915857410', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Manager/ Home-based/ Permanent\\n - DOCS Global\\n - United Kingdom\\nFind Out More! https://t.co/nu67teTJU4 https://t.co/jYl4sDA9Ec', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/nu67teTJU4'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Manager/ Home-based/ Permanent\\n - DOCS Global\\n - United Kingdom\\nFind Out More!  https://t.co/jYl4sDA9Ec'}, {'verified': False, 'country': 'USA', 'id': '1440961461510189056', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Manager/ Home-based/ Permanent/ EMEA\\n - DOCS Global\\n - United Kingdom\\nFind Out More! https://t.co/T1ibnXHlKp https://t.co/g08YrExC8e', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/T1ibnXHlKp'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Manager/ Home-based/ Permanent/ EMEA\\n - DOCS Global\\n - United Kingdom\\nFind Out More!  https://t.co/g08YrExC8e'}, {'verified': False, 'country': 'USA', 'id': '1440961422545010688', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Manager /Global Pharma /  EMEA / Home based\\n - DOCS Global\\n - United Kingdom\\nFind Out More! https://t.co/DYAzCVHwfs https://t.co/Qotzw6BbJk', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/DYAzCVHwfs'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Manager /Global Pharma /  EMEA / Home based\\n - DOCS Global\\n - United Kingdom\\nFind Out More!  https://t.co/Qotzw6BbJk'}, {'verified': False, 'country': 'USA', 'id': '1440961419764174848', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Manager/ Top Pharma/  Homebased/ Permanent\\n - DOCS Global\\n - United Kingdom\\nFind Out More! https://t.co/BuYaspKSb5 https://t.co/1Fzd8QeeTv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/BuYaspKSb5'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Manager/ Top Pharma/  Homebased/ Permanent\\n - DOCS Global\\n - United Kingdom\\nFind Out More!  https://t.co/1Fzd8QeeTv'}, {'verified': False, 'country': 'USA', 'id': '1440961412227010560', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Manager/ EMEA/ Top Global Pharma/ Home-based\\n - DOCS Global\\n - United Kingdom\\nFind Out More! https://t.co/d4mmDCLiRf https://t.co/L5H1ysf1c1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/d4mmDCLiRf'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Manager/ EMEA/ Top Global Pharma/ Home-based\\n - DOCS Global\\n - United Kingdom\\nFind Out More!  https://t.co/L5H1ysf1c1'}, {'verified': False, 'country': 'USA', 'id': '1440961353259307015', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Global Clinical Trial Lead (m/w)\\n - DOCS Global\\n - Germany\\nFind Out More! https://t.co/m0uhlMEAL2 https://t.co/sQkscpzq0J', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/m0uhlMEAL2'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Global Clinical Trial Lead (m/w)\\n - DOCS Global\\n - Germany\\nFind Out More!  https://t.co/sQkscpzq0J'}, {'verified': False, 'country': 'USA', 'id': '1440961243259494400', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We are excited to be recruiting to the first industry sponsored ALS clinical trial in Norway, phase 3  masitinib + riluzole. Interview in Norwegian with national PI Angelina Maniaol: https://t.co/a2eiXhABlG @Inven2as', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['Inven2as'], 'tweet_urls': ['https://t.co/a2eiXhABlG'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We are excited to be recruiting to the first industry sponsored ALS clinical trial in Norway, phase 3  masitinib + riluzole. Interview in Norwegian with national PI Angelina Maniaol:  '}, {'verified': False, 'country': 'USA', 'id': '1440960947926061056', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Manager\\n - DOCS Global\\n - Berkshire\\nFind Out More! https://t.co/t5AzvuSDBK https://t.co/sv8mr0zjYL', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/t5AzvuSDBK'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Manager\\n - DOCS Global\\n - Berkshire\\nFind Out More!  https://t.co/sv8mr0zjYL'}, {'verified': False, 'country': 'USA', 'id': '1440960920142876672', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Manager/ Senior CTM/ Poland/ Home based / office based\\n - DOCS Global\\n - Poland\\nFind Out More! https://t.co/Ps2DTpJs0T https://t.co/8vUEkywhjE', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Ps2DTpJs0T'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Manager/ Senior CTM/ Poland/ Home based / office based\\n - DOCS Global\\n - Poland\\nFind Out More!  https://t.co/8vUEkywhjE'}, {'verified': False, 'country': 'USA', 'id': '1440960913058762755', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Associate in Cambridge\\n - DOCS Global\\n - Cambridge\\nFind Out More! https://t.co/FiJQkd1Dq9 https://t.co/OaBlME66fb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/FiJQkd1Dq9'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Associate in Cambridge\\n - DOCS Global\\n - Cambridge\\nFind Out More!  https://t.co/OaBlME66fb'}, {'verified': False, 'country': 'USA', 'id': '1440960906163331073', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Manager (m/f)\\n - DOCS Global\\n - Germany\\nFind Out More! https://t.co/IB9CeZSjX4 https://t.co/KOR5aWLnbh', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/IB9CeZSjX4'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Manager (m/f)\\n - DOCS Global\\n - Germany\\nFind Out More!  https://t.co/KOR5aWLnbh'}, {'verified': False, 'country': 'USA', 'id': '1440960867433078788', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Associate (CTA) *** UK, Gatwick *** office-based/home-based\\n - DOCS Global\\n - Gatwick\\nFind Out More! https://t.co/L5uBSL7DI8 https://t.co/VTOjm4sikg', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/L5uBSL7DI8'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Associate (CTA) *** UK, Gatwick *** office-based/home-based\\n - DOCS Global\\n - Gatwick\\nFind Out More!  https://t.co/VTOjm4sikg'}, {'verified': False, 'country': 'USA', 'id': '1440960834570752002', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Assistant II  (SrCTA)  - Bucharest, Romania  - Home based / office based\\n - DOCS Global\\n - Romania\\nFind Out More! https://t.co/AXjmgDlVuC https://t.co/YT6Q0ulRyp', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/AXjmgDlVuC'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Assistant II  (SrCTA)  - Bucharest, Romania  - Home based / office based\\n - DOCS Global\\n - Romania\\nFind Out More!  https://t.co/YT6Q0ulRyp'}, {'verified': False, 'country': 'USA', 'id': '1440960825498419200', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Assistant (CTA) - Milan\\n - DOCS Global\\n - Milan\\nFind Out More! https://t.co/VqwACHSSkm https://t.co/DD014fN6zd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VqwACHSSkm'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Assistant (CTA) - Milan\\n - DOCS Global\\n - Milan\\nFind Out More!  https://t.co/DD014fN6zd'}, {'verified': False, 'country': 'USA', 'id': '1440960740186329090', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Clinical Trial Assistant (CTA) Office based Paris\\n - DOCS Global\\n - France\\nFind Out More! https://t.co/gw9XR6S4Ei https://t.co/XYU0kmVAt3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gw9XR6S4Ei'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Clinical Trial Assistant (CTA) Office based Paris\\n - DOCS Global\\n - France\\nFind Out More!  https://t.co/XYU0kmVAt3'}, {'verified': True, 'country': 'USA', 'id': '1440960581985521665', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"We still need a full-scale clinical trial, but we\\'ve moved to this stage much more quickly than would ever have been possible without the help of #AI.\" - Professor Chris Jones, Leader of the ICR\\'s Glioma Team \\n\\nRead more in the @Independent \u2b07\ufe0f\\nhttps://t.co/RO770VFpPQ', 'tweet_lang': 'en', 'hashtags': ['AI'], 'mentions': ['Independent'], 'tweet_urls': ['https://t.co/RO770VFpPQ'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"We still need a full-scale clinical trial, but we\\'ve moved to this stage much more quickly than would ever have been possible without the help of .\" - Professor Chris Jones, Leader of the ICR\\'s Glioma Team \\n\\nRead more in the  \u2b07\ufe0f\\n'}, {'verified': False, 'country': 'USA', 'id': '1440960544815542274', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Individualised, targeted step count intervention following gastrointestinal cancer surgery: The Fit-4-Home randomised clinical trial @SOuRCe_RPA @RPA_IAS @SydneyLHD @SHPartners @Sydney_Uni @SydneyResearch @WileyHealth https://t.co/gUIUPnOSdV', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['SOuRCe_RPA', 'RPA_IAS', 'SydneyLHD', 'SHPartners', 'Sydney_Uni', 'SydneyResearch', 'WileyHealth'], 'tweet_urls': ['https://t.co/gUIUPnOSdV'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Individualised, targeted step count intervention following gastrointestinal cancer surgery: The Fit-4-Home randomised clinical trial        '}, {'verified': False, 'country': 'USA', 'id': '1440960015188234240', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! (Senior) Clinical Trial Manager (m/f)\\n - DOCS Global\\n - Germany\\nFind Out More! https://t.co/GwJ6rh25iA https://t.co/dk6TjqKvdD', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/GwJ6rh25iA'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! (Senior) Clinical Trial Manager (m/f)\\n - DOCS Global\\n - Germany\\nFind Out More!  https://t.co/dk6TjqKvdD'}, {'verified': False, 'country': 'USA', 'id': '1440959430732955648', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'ACDM Honors PHASTAR with Award for Innovation in the Management of Clinical Trial Data \u2026 -  https://t.co/M3C0w2gVaz #datascience #intoAInews', 'tweet_lang': 'en', 'hashtags': ['datascience', 'intoAInews'], 'mentions': [], 'tweet_urls': ['https://t.co/M3C0w2gVaz'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'ACDM Honors PHASTAR with Award for Innovation in the Management of Clinical Trial Data \u2026 -    '}, {'verified': False, 'country': 'USA', 'id': '1440958706905194501', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL | medRxiv https://t.co/JqpajK3QlC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JqpajK3QlC'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL | medRxiv '}, {'verified': False, 'country': 'USA', 'id': '1440958614303281154', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'DOCS Global: (Senior) Clinical Trial Manager (m/f)\\nhttps://t.co/d3aT3Kmysv\\n#LifeScienceJobsGermany #PharmaGermany #BiotechGermany #PharmiWebGermany https://t.co/X1I2TNuAji', 'tweet_lang': 'en', 'hashtags': ['LifeScienceJobsGermany', 'PharmaGermany', 'BiotechGermany', 'PharmiWebGermany'], 'mentions': [], 'tweet_urls': ['https://t.co/d3aT3Kmysv'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'DOCS Global: (Senior) Clinical Trial Manager (m/f)\\n\\n    https://t.co/X1I2TNuAji'}, {'verified': False, 'country': 'USA', 'id': '1440958601057689601', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'DOCS Global: Clinical Trial Manager (m/f)\\nhttps://t.co/ITOGLIGLOD\\n#LifeScienceJobsGermany #PharmaGermany #BiotechGermany #PharmiWebGermany https://t.co/Lgg1zDaWr6', 'tweet_lang': 'en', 'hashtags': ['LifeScienceJobsGermany', 'PharmaGermany', 'BiotechGermany', 'PharmiWebGermany'], 'mentions': [], 'tweet_urls': ['https://t.co/ITOGLIGLOD'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'DOCS Global: Clinical Trial Manager (m/f)\\n\\n    https://t.co/Lgg1zDaWr6'}, {'verified': False, 'country': 'USA', 'id': '1440958598478286849', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'DOCS Global: Global Clinical Trial Lead (m/w)\\nhttps://t.co/0wkzFN8AbX\\n#LifeScienceJobsGermany #PharmaGermany #BiotechGermany #PharmiWebGermany https://t.co/JEzcCuecND', 'tweet_lang': 'en', 'hashtags': ['LifeScienceJobsGermany', 'PharmaGermany', 'BiotechGermany', 'PharmiWebGermany'], 'mentions': [], 'tweet_urls': ['https://t.co/0wkzFN8AbX'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'DOCS Global: Global Clinical Trial Lead (m/w)\\n\\n    https://t.co/JEzcCuecND'}, {'verified': False, 'country': 'USA', 'id': '1440957855591436289', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u201cCOVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India (Oct 20)\u201d\\n\\n\u2026but it\u2019s just a coincidence that the vaccine trial locations correlate with the origin of all the new variants? \ud83e\udd14 https://t.co/oiP81kNVWz', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/oiP81kNVWz'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u201cCOVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India (Oct 20)\u201d\\n\\n\u2026but it\u2019s just a coincidence that the vaccine trial locations correlate with the origin of all the new variants? \ud83e\udd14 '}, {'verified': False, 'country': 'USA', 'id': '1440957823437901826', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/6zOZxrTPjs', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6zOZxrTPjs'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ''}, {'verified': False, 'country': 'USA', 'id': '1440957506440683523', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A study and safety for 3-17 yrs vaccinated with Sinovac\\n\\nSafety,Tolerability&amp;Immunogenicity of an Inactivated SARS-CoV-2 Vaccine(CoronaVac)in Healthy Children&amp;Adolescents:A Randomised, Double-Blind, and Placebo-Controlled, Phase 1/2 Clinical Trial @SSRN https://t.co/hJ9Fc89a39', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['SSRN'], 'tweet_urls': ['https://t.co/hJ9Fc89a39'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A study and safety for 3-17 yrs vaccinated with Sinovac\\n\\nSafety,Tolerability&amp;Immunogenicity of an Inactivated SARS-CoV-2 Vaccine(CoronaVac)in Healthy Children&amp;Adolescents:A Randomised, Double-Blind, and Placebo-Controlled, Phase 1/2 Clinical Trial  '}, {'verified': False, 'country': 'USA', 'id': '1440957278618722304', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I predict Success for the clinical trial [BETA] NCT03941834 @MrnaSwap\\n\\nGet 99x max payout even for failed #clinical trials.\\nGet 0% impermanent loss for #liquidity provision.\\nOnly @MrnaSwap https://t.co/qC8Lv4BdZD', 'tweet_lang': 'en', 'hashtags': ['clinical', 'liquidity'], 'mentions': ['MrnaSwap', 'MrnaSwap'], 'tweet_urls': ['https://t.co/qC8Lv4BdZD'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I predict Success for the clinical trial [BETA] NCT03941834 \\n\\nGet 99x max payout even for failed  trials.\\nGet 0% impermanent loss for  provision.\\nOnly  '}, {'verified': False, 'country': 'USA', 'id': '1440956529503465479', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I predict Success for the clinical trial [BETA]NCT03298451 @MrnaSwap\\n\\nGet 99x max payout even for failed #clinical trials.\\nGet 0% impermanent loss for #liquidity provision.\\nOnly @MrnaSwap https://t.co/KJodeLGK4T', 'tweet_lang': 'en', 'hashtags': ['clinical', 'liquidity'], 'mentions': ['MrnaSwap', 'MrnaSwap'], 'tweet_urls': ['https://t.co/KJodeLGK4T'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I predict Success for the clinical trial [BETA]NCT03298451 \\n\\nGet 99x max payout even for failed  trials.\\nGet 0% impermanent loss for  provision.\\nOnly  '}, {'verified': False, 'country': 'USA', 'id': '1440955989180567555', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I predict Success for the clinical trial [BETA]NCT03298451 \\n@MrnaSwap\\n\\nGet 99x max payout even for failed #clinical trials.\\nGet 0% impermanent loss for #liquidity provision.\\nOnly \\n@MrnaSwap', 'tweet_lang': 'en', 'hashtags': ['clinical', 'liquidity'], 'mentions': ['MrnaSwap', 'MrnaSwap'], 'tweet_urls': [], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I predict Success for the clinical trial [BETA]NCT03298451 \\n\\n\\nGet 99x max payout even for failed  trials.\\nGet 0% impermanent loss for  provision.\\nOnly \\n'}, {'verified': False, 'country': 'USA', 'id': '1440954755602210820', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I predict Success for the clinical trial [BETA]NCT03298451 @MrnaSwap\\n\\nGet 99x max payout even for failed #clinical trials.\\nGet 0% impermanent loss for #liquidity provision.\\nOnly @MrnaSwap https://t.co/rSIhEOpPtM', 'tweet_lang': 'en', 'hashtags': ['clinical', 'liquidity'], 'mentions': ['MrnaSwap', 'MrnaSwap'], 'tweet_urls': ['https://t.co/rSIhEOpPtM'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I predict Success for the clinical trial [BETA]NCT03298451 \\n\\nGet 99x max payout even for failed  trials.\\nGet 0% impermanent loss for  provision.\\nOnly  '}, {'verified': False, 'country': 'USA', 'id': '1440953634565537792', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Latest Job! Remote in Germany, Clinical Trial manager\\n - NonStop Consulting\\n - Germany, Nordrhein-Westfalen, Cologne\\nFind Out More! https://t.co/v0uNmaNQ6v https://t.co/2a62vpwkia', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/v0uNmaNQ6v'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Latest Job! Remote in Germany, Clinical Trial manager\\n - NonStop Consulting\\n - Germany, Nordrhein-Westfalen, Cologne\\nFind Out More!  https://t.co/2a62vpwkia'}, {'verified': False, 'country': 'USA', 'id': '1440953623580655616', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'NonStop Consulting: Remote in Germany, Clinical Trial manager\\nhttps://t.co/N58hI29oVt\\n#LifeScienceJobsGermany #PharmaGermany #BiotechGermany #PharmiWebGermany https://t.co/rpiOcWPa79', 'tweet_lang': 'en', 'hashtags': ['LifeScienceJobsGermany', 'PharmaGermany', 'BiotechGermany', 'PharmiWebGermany'], 'mentions': [], 'tweet_urls': ['https://t.co/N58hI29oVt'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'NonStop Consulting: Remote in Germany, Clinical Trial manager\\n\\n    https://t.co/rpiOcWPa79'}]"